A	O
systematic	O
review	O
of	O
randomised	O
control	O
trials	O
examining	O
LC	O
n	O
-	O
3PUFA	O
supplementation	O
during	O
pregnancy	O
found	B
no	O
clear	O
association	O
between	O
supplement	O
use	O
and	O
infant	O
cognitive	O
outcomes	O
[	O
33	O
].	O

The	O
emulsifier	O
PROSOL	O
(	O
sodium	O
stearoyl	O
-	O
2	O
-	O
lactylate	O
)	O
increases	O
IMF	O
deposition	O
and	O
QG	O
in	O
Korean	O
cattle	O
[	O
108	O
].	O

Also	O
,	O
vitamin	O
D	O
supplements	O
were	O
used	O
by	O
almost	O
half	O
of	O
the	O
women	O
but	O
most	O
(	O
88	O
%)	O
used	O
multivitamins	O
containing	O
5	O
–	O
10	O
μg	O
of	O
vitamin	O
D3	O
.	O

The	O
infant	O
reported	O
here	O
was	O
managed	O
as	O
a	O
case	O
of	O
acute	O
laryngotracheobronchitis	O
initially	O
as	O
there	O
was	O
no	O
evidence	O
of	O
rickets	O
and	O
the	O
diagnosis	O
of	O
hypocalcemia	O
was	O
made	O
only	O
after	O
he	O
had	O
convulsions	O
.	O

A	O
population	O
-	O
based	O
study	O
in	O
Utah	O
(	O
US	O
)	O
looked	O
at	O
prenatal	O
variables	O
of	O
autistic	O
children	O
and	O
focused	O
on	O
gestational	O
weight	O
.	O

It	O
is	O
associated	O
with	O
inadequate	O
invasion	O
of	O
extravillous	O
trophoblasts	O
and	O
inadequate	O
angiogenesis	O
,	O
with	O
insufficient	O
conversion	O
of	O
arterial	O
spiral	O
arteries	O
in	O
the	O
decidua	O
[	O
1	O
].	O

The	O
"	O
middle	O
level	O
symptoms	O
group	O
"	O
was	O
defined	O
as	O
participants	O
not	O
included	O
in	O
the	O
low	O
level	O
or	O
high	O
level	O
groups	O
.	O

Linear	O
regression	O
analysis	O
revealed	B
that	O
the	O
second	O
trimester	O
visfatin	O
level	O
was	O
a	O
significant	O
predictor	O
of	O
birth	O
height	O
in	O
group	O
B	O
(	O
Table	O
3	O
).	O

The	O
first	O
step	O
in	O
treatment	O
of	O
urticaria	O
and	O
angioedema	O
in	O
pregnancy	O
is	O
identification	O
and	O
avoidance	O
of	O
causative	O
factors	O
.	O

Two	O
different	O
types	O
of	O
adipose	O
tissue	O
have	O
been	O
described	O
:	O
brown	O
adipose	O
tissue	O
(	O
BAT	O
),	O
composed	O
mainly	O
of	O
brown	O
adipocytes	O
,	O
and	O
white	O
adipose	O
tissue	O
(	O
WAT	O
),	O
defined	O
by	O
a	O
majority	O
of	O
white	O
adipocytes	O
,	O
both	O
tissues	O
being	O
able	O
to	O
accumulate	O
lipids	O
in	O
intracellular	O
droplets	O
.	O

CONCLUSION	O
In	O
this	O
article	O
,	O
we	O
reviewed	O
several	O
factors	O
(	O
genetic	O
,	O
management	O
,	O
and	O
nutritional	O
factors	O
)	O
affecting	O
IMF	O
deposition	O
in	O
cattle	O
(	O
Table	O
2	O
).	O

We	O
also	O
stratified	O
based	O
on	O
fetal	O
sex	O
to	O
evaluate	O
possible	B
effect	O
measure	O
modifications	O
according	O
to	O
whether	O
the	O
mother	O
was	O
carry	O
a	O
male	O
or	O
female	O
fetus	O
.	O

Conclusions	O
and	O
public	O
health	O
implications	O
We	O
conclude	O
that	O
a	O
higher	O
maternal	O
intake	O
of	O
free	O
sugar	O
during	O
pregnancy	O
may	B
increase	O
the	O
risk	O
of	O
atopy	O
and	O
atopic	O
asthma	O
in	O
the	O
offspring	O
.	O

All	O
nutrient	O
values	O
were	O
energy	O
-	O
adjusted	O
using	O
the	O
residuals	O
method	O
.	O

Glucocorticoids	O
should	O
be	O
administered	O
early	O
to	O
patients	O
with	O
severe	O
anaphylaxis	O
.	O

Another	O
signaling	O
pathway	O
identified	O
to	O
be	O
regulated	O
in	O
a	O
diet	O
-	O
dependent	O
manner	O
is	O
the	O
'	O
VEGF	O
(	O
vascular	O
endothelial	O
growth	O
factor	O
)	O
signaling	O
'	O
pathway	O
,	O
which	O
is	O
known	O
from	O
gene	O
deletion	O
studies	O
to	O
be	O
essential	O
in	O
developmental	O
processes	O
[	O
36	O
,	O
37	O
].	O

Most	O
sleep	O
studies	O
,	O
however	O
,	O
have	O
excluded	O
pregnant	O
women	O
;	O
hence	O
very	O
little	O
is	O
known	O
about	O
how	O
insufficient	O
sleep	O
and	O
sleep	O
disordered	O
breathing	O
during	O
gestation	O
contribute	O
to	O
increased	O
risks	O
of	O
medical	O
complications	O
of	O
pregnancy	O
including	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
).	O

At	O
the	O
time	O
of	O
enrolment	O
,	O
we	O
will	O
assign	O
each	O
mother	O
a	O
box	O
consisting	O
of	O
8	O
months	O
of	O
supply	O
of	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

PubMed	O
Central	O
:	O

To	O
ensure	O
the	O
absence	O
of	O
a	O
DNA	O
contamination	O
within	O
the	O
isolated	O
RNA	O
a	O
PCR	O
amplification	O
with	O
the	O
porcine	O
glyceraldehyde	O
-	O
3	O
-	O
phosphate	O
dehydrogenase	O
(	O
GAPDH	O
)	O
gene	O
was	O
done	O
(	O
Forward	O
primer	O
:	O
aagcagggatgatgttctgg	O
;	O
Reverse	O
primer	O
:	O
atgcctcctgtaccaccaac	O
).	O

The	O
effect	O
of	O
maternal	O
dairy	O
intake	O
on	O
infant	O
gut	O
microbiota	O
was	O
primarily	O
observed	O
in	O
infants	O
delivered	O
by	O
Cesarean	O
section	O
.	O

Surveys	O
indicate	B
that	O
only	O
52	O
%	O
of	O
rural	O
women	O
reported	O
any	O
use	O
of	O
iron	O
/	O
folic	O
acid	O
in	O
their	O
last	O
pregnancy	O
but	O
this	O
dropped	O
to	O
39	O
%	O
for	O
the	O
poorest	O
households	O
,	O
and	O
to	O
34	O
%	O
for	O
women	O
with	O
no	O
education	O
(	O
3	O
).	O

For	O
instance	O
,	O
women	O
with	O
asthma	O
or	O
allergic	O
diseases	O
require	O
drug	O
therapy	O
during	O
pregnancy	O
to	O
prevent	O
symptoms	O
severe	O
enough	O
to	O
be	O
life	O
threatening	O
to	O
the	O
mother	O
or	O
the	O
fetus	O
(	O
eg	O
,	O
severe	O
acute	O
asthma	O
that	O
can	O
result	O
in	O
hypoxia	O
).	O

Being	O
raised	O
on	O
a	O
farm	O
[	O
102	O
–	O
114	O
]	O
or	O
in	O
a	O
rural	O
area	O
[	O
115	O
]	O
has	B
been	I
shown	O
in	O
some	B
studies	O
to	O
protect	O
against	O
asthma	O
,	O
hay	O
fever	O
,	O
and	O
atopic	O
sensitization	O
.	O

High	O
birth	O
weight	O
is	O
an	O
important	O
predictor	O
of	O
adult	O
obesity	O
[	O
171	O
],	O
and	O
a	O
higher	O
body	O
mass	O
index	O
(	O
BMI	O
)	O
has	B
been	I
linked	O
to	O
greater	O
risk	O
for	O
adult	O
-	O
onset	O
glioma	O
[	O
172	O
].	O

Following	O
fertilization	O
epigenetic	O
marks	O
are	O
removed	O
to	O
generate	O
a	O
totipotent	O
zygote	O
,	O
capable	O
of	O
producing	O
all	O
the	O
different	O
cell	O
types	O
required	O
to	O
form	O
a	O
new	O
individual	O
.	O

A	O
significant	O
correlation	O
was	O
observed	O
between	O
the	O
first	O
and	O
second	O
trimesters	O
visfatin	O
level	O
with	O
infant	O
’	O
s	O
height	O
in	O
both	O
groups	O
,	O
such	O
that	O
this	O
relationship	O
was	O
positive	O
in	O
group	O
A	O
and	O
negative	O
in	O
group	O
B	O
.	O

Eight	O
viable	O
fetuses	O
per	O
sow	O
were	O
collected	O
starting	O
at	O
the	O
tip	O
of	O
the	O
left	O
uterus	O
horn	O
and	O
alternating	O
between	O
left	O
and	O
right	O
horn	O
.	O

They	O
did	O
not	O
differ	O
concerning	O
the	O
two	O
above	O
-	O
mentioned	O
variables	O
,	O
P	O
=	O
0	O
.	O
09	O
and	O
p	O
=	O
0	O
.	O
13	O
,	O
respectively	O
.	O

During	O
pregnancy	O
.	O

The	O
females	O
with	O
caloric	O
restriction	O
were	O
fed	O
with	O
a	O
daily	O
amount	O
of	O
food	O
corresponding	O
to	O
the	O
80	O
%	O
of	O
the	O
calories	O
that	O
the	O
control	O
rats	O
were	O
fed	O
in	O
the	O
previous	O
day	O
of	O
the	O
experiment	O
,	O
according	O
to	O
the	O
body	O
weight	O
(	O
20	O
%	O
of	O
caloric	O
restriction	O
).	O

We	O
computed	O
generalized	O
UniFrac	O
distances	O
between	O
pairs	O
of	O
samples	O
using	O
OTU	O
tables	O
and	O
the	O
midpoint	O
rooted	O
phylogenetic	O
tree	O
.	O

In	O
humans	O
,	O
a	O
unique	O
patient	O
suffering	O
from	O
extreme	O
diabetes	O
due	O
to	O
a	O
mutation	O
in	O
the	O
insulin	O
receptor	O
gene	O
had	O
to	O
undergo	O
total	O
thyroidectomy	O
because	O
of	O
the	O
presence	O
of	O
a	O
papillary	O
carcinoma	O
.	O

This	O
review	O
will	O
examine	O
the	O
pharmacological	O
options	O
for	O
the	O
management	O
of	O
gestational	O
diabetes	O
,	O
as	O
well	O
as	O
the	B
evidence	I
for	I
blood	O
glucose	O
monitoring	O
,	O
dietary	O
and	O
exercise	O
therapy	O
.	O

In	O
the	O
United	O
States	O
,	O
about	O
18	O
%	O
to	O
30	O
%	O
of	O
women	O
in	O
the	O
childbearing	O
age	O
have	O
allergic	O
diseases	O
,	O
especially	O
rhinitis	O
[	O
8	O
]	O
and	O
asthma	O
[	O
9	O
].	O

In	O
a	O
study	O
by	O
Cekmez	O
et	O
al	O
.	O

This	O
is	O
where	O
dose	O
/	O
level	O
of	O
exposure	O
and	O
relevance	O
to	O
humans	O
is	O
crucial	O
,	O
but	O
considerations	O
of	O
alternative	O
replacements	O
are	O
also	O
important	O
.	O

Response	O
to	O
an	O
immunisation	O
is	O
regarded	O
as	O
a	O
good	O
marker	O
to	O
measure	O
immune	O
function	O
in	O
vivo	O
[	O
61	O
]	O
and	O
the	O
response	O
will	O
be	O
in	O
the	O
log	O
phase	O
6	O
weeks	O
after	O
immunisation	O
,	O
which	O
is	O
the	O
most	O
sensitive	O
stage	O
to	O
measure	O
differences	O
in	O
response	O
among	O
infants	O
.	O

This	O
accounts	B
for	I
the	O
low	O
rate	O
of	O
these	O
health	O
talks	O
in	O
this	O
study	O
as	O
opposed	O
to	O
other	O
studies	O
[	O
26	O
].	O

Methods	O
The	O
cross	O
sectional	O
study	O
was	O
carried	O
out	O
in	O
the	O
Buea	O
Health	O
District	O
,	O
one	O
of	O
the	O
18	O
health	O
districts	O
in	O
the	O
South	O
West	O
Region	O
of	O
Cameroon	O
with	O
an	O
estimated	O
population	O
of	O
86	O
,	O
272	O
inhabitants	O
[	O
9	O
].	O

Vitamin	O
D	O
,	O
which	O
has	O
a	O
unique	O
role	O
in	O
brain	O
homeostasis	O
,	O
embryogenesis	O
and	O
neurodevelopment	O
,	O
neural	O
differentiation	O
,	O
and	O
gene	O
regulation	O
,	O
has	B
recently	I
been	I
proposed	B
as	O
a	O
possible	B
environmental	O
risk	O
factor	O
for	O
autism	O
during	O
early	O
childhood	O
.	O

It	O
has	B
also	O-
been	I
recognized	O
that	O
the	O
pace	O
of	O
such	O
change	O
is	O
sometimes	B
too	O
rapid	O
to	O
be	O
accounted	O
for	O
by	O
natural	O
selection	O
.	O

However	O
,	O
the	O
present	O
study	O
is	O
the	O
first	B
national	O
survey	O
on	O
vitamin	O
D	O
status	O
among	O
pregnant	O
women	O
in	O
Belgium	O
.	O

2	O
)	O
.	O

;	O
P	O
=	O
.	O
002	O
).	O

These	O
speculations	B
relate	O
two	O
studies	O
in	O
which	O
supplementation	O
of	O
a	O
single	O
large	O
dose	O
(	O
300	O
00033or	O
500	O
00023IU	O
)	O
of	O
vitamin	O
D	O
for	O
reducing	O
fractures	O
in	O
elderly	O
women	O
led	O
to	O
an	O
increase	O
in	O
fractures	O
,	O
plus	O
similar	O
discrepancies	O
in	O
prostate	O
cancer	O
research	O
with	O
vitamin	O
D	O
.	O
22Our	O
findings	O
and	O
particularly	O
the	O
slightly	O
higher	O
repeat	O
episodes	O
of	O
pneumonia	O
in	O
the	O
vitamin	O
D	O
group	O
could	B
be	I
due	O
to	O
such	O
fluctuations	O
if	O
the	O
hypothesis	B
is	O
true	O
.	O

Introduction	O
Thyroid	O
cancer	O
,	O
the	O
most	O
common	O
endocrine	O
malignancy	O
,	O
is	O
often	O
detected	O
in	O
young	O
patients	O
and	O
is	O
more	O
frequently	O
diagnosed	O
in	O
women	O
.	O

However	O
,	O
feed	O
efficiency	O
decreases	O
as	O
animals	O
age	O
due	O
to	O
a	O
decrease	O
in	O
the	O
rate	O
of	O
muscle	O
growth	O
[	O
70	O
].	O

However	O
,	O
dietary	O
protein	O
levels	O
do	O
not	O
affect	O
IMF	O
deposition	O
in	O
Angus	O
or	O
Shorthorn	O
steers	O
(	O
reviewed	O
in	O
Bindon	O
[	O
115	O
]).	O

Differences	O
between	O
male	O
and	O
female	O
offspring	O
(	O
CC	O
)	O
were	O
also	O
observed	O
.	O

Detectable	O
differences	O
would	O
range	O
from	O
6	O
.	O
2	O
%	O
(	O
with	O
follow	O
-	O
up	O
of	O
80	O
%	O
of	O
children	O
),	O
to	O
6	O
.	O
7	O
%	O
(	O
with	O
follow	O
-	O
up	O
of	O
70	O
%	O
of	O
children	O
;	O
alpha	O
0	O
.	O
05	O
;	O
power	O
80	O
%).	O

Maternal	O
Diet	O
During	O
Pregnancy	O
A	O
Cochrane	O
database	O
meta	O
-	O
analysis	O
of	O
4	O
clinical	O
studies	O
concluded	O
that	O
antigen	O
avoidance	O
during	O
pregnancy	O
is	O
unlikely	O
to	O
reduce	O
the	O
child	O
'	O
s	O
risk	O
of	O
developing	O
atopic	O
disease	O
,	O
and	O
dietary	O
restrictions	O
could	B
adversely	O
affect	O
maternal	O
or	O
fetal	O
nutrition	O
[	O
99	O
].	O

However	O
,	O
according	B
to	I
national	O
figures	O
from	O
the	O
National	O
Food	O
Administration	O
,	O
a	O
low	O
number	O
of	O
Swedish	O
women	O
took	O
fish	O
oil	O
supplements	O
(	O
1	O
%)	O
at	O
the	O
time	O
of	O
the	O
study	O
.	O

These	O
modifications	O
alter	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
(	O
such	O
as	O
transcription	O
factors	O
and	O
RNA	O
polymerases	O
)	O
so	O
that	O
it	O
is	O
the	O
overall	O
combined	O
effect	O
of	O
the	O
histone	O
code	O
that	O
determines	O
an	O
active	O
or	O
repressive	O
chromatin	O
structure	O
and	O
thus	O
regulates	O
gene	O
expression	O
.	O

Investigators	O
have	B
shown	I
that	O
self	O
-	O
reported	O
snoring	O
correlates	O
well	O
with	O
objective	B
findings	I
from	O
nocturnal	O
polysomnography	O
,	O
especially	O
in	O
frequent	O
snorers	O
[	O
40	O
].	O

When	O
considering	O
temporal	O
aspects	O
to	O
reproductive	O
,	O
developmental	O
and	O
endocrine	O
disrupting	O
effects	O
,	O
the	O
TGs	O
currently	O
in	O
use	O
may	B
not	O
incorporate	O
either	O
the	O
most	O
relevant	O
life	O
stage	O
(	O
s	O
),	O
the	O
most	O
sensitive	O
endpoints	O
for	O
epigenetic	O
perturbation	O
and	O
/	O
or	O
sufficient	O
duration	O
of	O
observation	O
to	O
detect	O
later	O
-	O
onset	O
effects	O
.	O

Due	O
to	O
the	O
high	O
mutagenic	O
potential	O
of	O
5mC	O
to	O
spontaneously	O
deaminate	O
to	O
thymine	O
,	O
the	O
mammalian	O
genome	O
is	O
largely	O
depleted	O
of	O
CpGs	O
(	O
Bird1980	O
;	O
Bird	O
&	O
Taggart1980	O
),	O
with	O
the	O
exception	O
of	O
distinct	O
regions	O
known	O
as	O
CpG	O
islands	O
(	O
CGIs	O
)	O
(	O
Bird	O
et	O
al	O
.	O
1985	O
).	O

In	O
Australia	O
and	O
New	O
Zealand	O
,	O
the	O
deficiency	O
cut	O
-	O
offs	O
are	O
based	O
on	O
the	O
role	O
of	O
vitamin	O
D	O
in	O
bone	O
health	O
where	O
serum	O
25	O
(	O
OH	O
)	O
D	O
≥	O
50	O
nmol	O
/	O
L	O
at	O
the	O
end	O
of	O
winter	O
is	O
required	O
for	O
optimal	O
musculoskeletal	O
health	O
[	O
1	O
].	O

Fetal	O
nutritional	O
programming	O
Fetal	O
programming	O
or	O
prenatal	O
programing	O
is	O
the	B
concept	I
that	O
mammalian	O
embryonic	O
and	O
fetal	O
development	O
are	O
linked	O
to	O
environmental	O
changes	O
,	O
thus	O
affecting	O
the	O
entire	O
life	O
[	O
152	O
].	O

Oral	O
antihistamines	O
should	O
be	O
avoided	O
during	O
the	O
first	O
trimester	O
,	O
unless	O
definitely	O
clinically	O
indicated	O
,	O
and	O
then	O
should	O
be	O
used	O
at	O
the	O
lowest	O
effective	O
dose	O
,	O
starting	O
with	O
chlorpheniramine	O
,	O
loratadine	O
,	O
or	O
cetirizine	O
.	O

The	O
researchers	O
believe	B
the	O
antioxidant	O
properties	O
of	O
garlic	O
,	O
along	O
with	O
the	O
chelating	O
efficacy	O
exhibited	O
,	O
led	O
to	O
the	O
success	O
of	O
the	O
treatment	O
.	O

Similar	B
studies	I
were	O
conducted	O
illustrating	B
that	O
relative	O
microcephaly	O
was	O
more	O
frequent	O
in	O
children	O
with	O
ASD	O
.	O

In	O
intervention	O
clusters	O
trained	O
BRAC	O
village	O
volunteers	O
will	O
identify	O
pregnant	O
women	O
&	O
provide	O
iron	O
-	O
folic	O
acid	O
supplements	O
.	O

Within	O
the	O
14	O
h	O
after	O
birth	O
,	O
pups	O
were	O
weighed	O
,	O
sexed	O
,	O
and	O
culled	O
to	O
comprise	O
up	O
to	O
8	O
pups	O
per	O
mother	O
(	O
4	O
males	O
and	O
4	O
females	O
where	O
possible	O
).	O

According	O
to	O
a	O
directive	O
of	O
the	O
Commission	O
of	O
European	O
Communities	O
from	O
2005	O
,	O
the	O
most	O
allergenic	O
foods	O
have	O
to	O
be	O
labeled	O
because	O
of	O
their	O
potency	O
of	O
eliciting	O
severe	O
allergic	O
reactions	O
:	O
these	O
are	O
crustacean	O
,	O
fish	O
,	O
nuts	O
,	O
milk	O
,	O
egg	O
,	O
wheat	O
/	O
gluten	O
,	O
peanuts	O
,	O
soy	O
,	O
sesame	O
,	O
mustard	O
,	O
and	O
celery	O
.	O

Glyburide	O
(	O
Glibenclamide	O
)	O
American	O
authors	O
have	O
stated	B
that	O
glyburide	O
has	O
replaced	O
insulin	O
as	O
first	O
line	O
pharmacological	O
treatment	O
of	O
GDM	O
in	O
many	O
practices	O
.	O
56This	O
has	O
largely	O
occurred	O
on	B
the	I
basis	I
of	I
a	O
randomized	O
controlled	O
trial	O
where	O
404	O
women	O
with	O
GDM	O
were	O
treated	O
with	O
glyburide	O
(	O
up	O
to	O
20	O
mg	O
/	O
day	O
)	O
or	O
insulin57In	O
this	O
study	O
,	O
the	O
level	O
of	O
glycemic	O
control	O
achieved	O
was	O
the	O
same	O
in	O
both	O
groups	O
(	O
mean	O
glucose	O
concentration	O
during	O
treatment	O
with	O
glyburide	O
5	O
.	O
9	O
±	O
0	O
.	O
9	O
mmol	O
/	O
L	O
compared	O
to	O
5	O
.	O
9	O
±	O
1	O
.	O
0	O
mmol	O
/	O
L	O
in	O
insulin	O
group	O
).	O

The	O
castration	O
rate	O
of	O
bulls	O
has	O
been	O
increasing	O
in	O
Korea	O
in	O
the	O
21st	O
century	O
,	O
and	O
it	O
was	O
about	O
95	O
%	O
in	O
2013	O
[	O
59	O
].	O

Furthermore	O
,	O
a	O
higher	O
proportion	O
of	O
the	O
women	O
in	O
the	O
middle	O
and	O
high	O
level	O
symptoms	O
groups	O
had	O
grown	O
up	O
outside	O
of	O
the	O
Nordic	O
countries	O
than	O
women	O
in	O
the	O
low	O
level	O
symptoms	O
group	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

After	O
that	O
,	O
several	B
studies	I
have	O
validated	B
its	O
use	O
throughout	O
the	O
antenatal	O
period	O
[	O
37	O
–	O
39	O
].	O

While	O
in	O
a	O
study	O
by	O
Cassidy	O
-	O
Bushrow	O
et	O
al	O
.,	O
in	O
African	O
-	O
American	O
women	O
,	O
an	O
inverse	O
relationship	O
was	O
observed	B
between	O
maternal	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
at	O
the	O
early	O
stages	O
of	O
pregnancy	O
and	O
antenatal	O
depression	O
.	O

However	O
,	O
the	O
neonatal	O
mortality	O
analyses	O
were	O
post	O
-	O
hoc	O
analyses	O
,	O
and	O
the	O
sample	O
size	O
was	O
small	O
resulting	O
in	O
poor	O
precision	O
in	O
the	O
effect	O
estimates	O
,	O
and	O
reduced	O
power	O
to	O
explore	O
all	O
the	O
factors	O
modifying	O
the	O
effects	O
on	O
neonatal	O
mortality	O
.	O

However	O
in	O
our	O
community	O
,	O
ANC	O
user	O
'	O
s	O
perceptions	O
of	O
quality	O
are	O
not	O
known	O
.	O

DNA	O
methylation	O
also	O
alters	O
the	O
interaction	O
between	O
DNA	O
and	O
DNA	O
binding	O
proteins	O
to	O
regulate	O
gene	O
expression	O
.	O

(	O
B	O
–	O
D	O
)	O
Bonferrroni	O
post	O
-	O
hoc	O
test	O
:*/**	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
for	O
CC	O
vs	O
.	O
RC	O
males	O
;#	O
P	O
<	O
0	O
.	O
05	O
for	O
CC	O
vs	O
.	O
RC	O
females	O
;&/&&/&&&	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
CC	O
males	O
vs	O
.	O
females	O
;$/$$/$$$	O
P	O
<	O
0	O
.	O
05	O
/	O
0	O
.	O
01	O
/	O
0	O
.	O
001	O
for	O
RC	O
males	O
vs	O
.	O
females	O
.	O

Confirmation	O
and	O
expansion	O
of	O
these	O
findings	O
in	O
additional	O
populations	O
,	O
with	O
additional	O
environmental	O
data	O
and	O
more	O
comprehensive	O
methylation	O
profiles	O
as	O
well	O
as	O
studies	O
of	O
the	O
mechanism	O
of	O
these	O
alterations	O
,	O
will	O
provide	O
additional	O
valuable	O
insights	O
into	O
the	O
epigenetic	O
mechanisms	O
controlling	O
fetal	O
growth	O
.	O

Caption	O
(	O
FIG	O
):	O
FIG	O
.	O

In	O
addition	O
to	O
a	O
lower	O
birth	O
weight	O
population	O
,	O
a	O
secondary	O
analysis	O
longitudinal	O
design	O
study	O
using	O
cranial	O
ultrasound	O
evidence	O
of	O
14	O
study	O
participants	O
diagnosed	O
with	O
ASD	O
identified	B
that	O
children	O
with	O
ventricular	O
enlargement	O
were	O
strong	O
indicators	O
of	O
the	O
potential	B
risk	O
for	O
autism	O
spectrum	O
disorders	O
[	O
50	O
].	O

3	O
.	O
4	O
.	O
4	O
.	O

Comparing	O
to	O
the	O
control	O
group	O
,	O
depression	O
level	O
decreased	O
in	O
both	O
intervention	O
groups	O
[	O
67	O
].	O

The	O
fact	O
that	O
we	O
did	B
not	I
observe	O
differences	O
in	O
other	O
subtypes	O
of	O
SeroR	O
may	B
indicate	B
that	O
SeroR2A	O
is	O
more	O
sensitive	O
to	O
BDNF	O
-	O
induced	O
changes	O
by	O
the	O
vitamin	O
diets	O
.	O

However	O
,	O
women	O
attending	O
for	O
their	O
subsequent	O
pregnancies	O
and	O
those	O
at	O
their	O
third	O
or	O
more	O
visits	O
were	O
more	O
tolerant	O
of	O
the	O
services	O
provided	O
at	O
the	O
health	O
centres	O
.	O

Young	O
[	O
81	O
]	O
suggested	B
that	O
energy	O
requirements	O
increase	O
during	O
winter	O
or	O
when	O
animals	O
are	O
under	O
cold	O
stress	O
,	O
as	O
increased	O
heat	O
production	O
is	O
needed	O
to	O
maintain	O
body	O
temperature	O
by	O
shivering	O
or	O
other	O
thermogenic	O
process	O
.	O

In	O
the	O
case	O
of	O
preterm	O
delivery	O
,	O
vitamin	O
D	O
status	O
measured	O
closer	O
to	O
the	O
delivery	O
date	O
was	O
more	O
significantly	O
associated	O
with	O
preterm	O
delivery	O
than	O
earlier	O
measures	O
[	O
26	O
].	O

The	O
primary	O
outcome	O
variable	O
was	O
a	O
composite	O
of	O
neonatal	O
hypoglycemia	O
,	O
respiratory	O
distress	O
,	O
need	O
for	O
phototherapy	O
,	O
birth	O
trauma	O
,	O
Apgar	O
score	O
less	O
than	O
7	O
,	O
or	O
prematurity	O
.	O

According	O
to	O
GPPAQ	O
,	O
participants	O
were	O
categorized	O
into	O
4	O
levels	O
of	O
physical	O
activity	O
based	O
on	O
hours	O
/	O
week	O
.	O

Therefore	O
,	O
an	O
alteration	O
in	O
the	O
hypothalamic	O
levels	O
of	O
endocannabinoids	O
in	O
newborn	O
animals	O
,	O
as	O
was	O
previously	B
described	B
by	O
Ramírez	O
-	O
López	O
et	O
al	O
.	O

The	O
spicules	O
of	O
bone	O
contained	O
osteocytes	O
and	O
were	O
lined	O
by	O
benign	O
-	O
appearing	O
osteoblasts	O
(	O
Fig	O
3	O
).	O

The	O
same	O
relationship	O
was	O
observed	O
for	O
women	O
with	O
9	O
–	O
12	O
years	O
of	O
formal	O
education	O
regarding	O
folic	O
acid	O
use	O
(	O
p	O
<	O
.	O
001	O
),	O
iron	O
(	O
p	O
=	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
).	O

Results	O
were	O
qualitatively	O
the	O
same	O
when	O
infants	O
born	O
before	O
37	O
weeks	O
gestation	O
were	O
excluded	O
(	O
see	O
Additional	O
file	O
1	O
:	O
Supplementary	O
Information	O
).	O

Experimental	O
Section	O
2	O
.	O
1	O
.	O

Less	O
than	O
half	O
the	O
participants	O
(	O
42	O
.	O
0	O
%)	O
declared	O
they	O
received	O
advice	O
on	O
diet	O
during	O
pregnancy	O
and	O
83	O
.	O
5	O
%	O
stated	O
they	O
were	O
advised	O
to	O
breastfeed	O
(	O
Table	O
1	O
).	O

A	O
computational	O
analysis	O
of	O
these	O
data	O
revealed	B
that	O
many	O
of	O
the	O
proteins	O
dysregulated	O
in	O
the	O
DVD	O
model	B
have	B
also	O-
been	I
shown	O
to	O
be	O
altered	O
in	O
schizophrenia	O
post	O
-	O
mortem	O
brain	O
studies	O
[	O
18	O
].	O

A	O
study	O
of	O
32	O
women	O
randomized	O
to	O
circuit	O
type	O
exercise	O
three	O
times	O
a	O
week	O
or	O
control	O
,	O
found	B
that	O
resistance	O
training	O
resulted	O
in	O
lower	O
postprandial	O
glucose	O
levels	O
,	O
and	O
a	O
delay	O
in	O
the	O
requirement	O
of	O
insulin	O
.	O
33Amongst	O
women	O
with	O
a	O
prepregnancy	O
BMI	O
>	O
25	O
,	O
those	O
who	O
were	O
in	O
the	O
exercise	O
arm	O
were	O
less	O
likely	O
to	O
require	O
insulin	O
.	O

There	O
were	O
fewer	O
deaths	O
than	O
we	O
predicted	O
in	O
both	O
groups	O
,	O
possibly	B
due	O
to	O
the	O
intense	O
health	O
surveillance	O
possible	B
during	O
our	O
study	O
.	O

Given	B
the	O
a	O
priori	O
nature	O
of	O
the	O
hypothesis	B
being	O
tested	O
,	O
and	O
the	O
fact	O
that	O
some	B
outcomes	O
of	O
interest	O
are	O
highly	O
correlated	O
,	O
it	O
did	O
not	O
seem	O
appropriate	O
to	O
correct	O
for	O
multiple	O
testing	O
.	O

The	O
expression	O
of	O
214	O
probe	O
-	O
sets	O
was	O
increased	O
in	O
the	O
LP	O
offspring	O
compared	O
with	O
AP	O
offspring	O
.	O

Furthermore	O
,	O
they	O
were	O
less	O
satisfied	O
with	O
the	O
comfort	O
in	O
the	O
sitting	O
area	O
and	O
the	O
way	O
the	O
staff	O
attended	O
to	O
them	O
.	O

However	O
,	O
there	O
is	O
also	O
limited	B
evidence	I
for	O
a	O
U	O
-	O
shaped	O
association	O
where	O
high	O
25OHD	O
concentrations	O
(>	O
80	O
nmol	O
/	O
L	O
)	O
may	B
be	I
related	O
to	O
higher	O
risk	O
of	O
SGA	O
[	O
9	O
].	O

New	O
drugs	O
with	O
anti	O
-	O
angiogenetic	O
,	O
anti	O
-	O
tyrosine	O
kinase	O
and	O
anti	O
-	O
VEGF	O
effects	O
are	O
currently	O
under	B
observation	I
.	O

Similarly	O
,	O
a	O
pooled	O
analysis	O
from	O
Pakistan	O
on	O
8512	O
live	O
births	O
reported	O
maternal	O
antenatal	O
IFA	O
supplements	O
significantly	O
reduced	O
the	O
adjusted	O
risk	O
of	O
death	O
on	O
day	O
0	O
by	O
33	O
%	O
and	O
during	O
the	O
neonatal	O
period	O
by	O
29	O
%.	O

Each	O
point	O
represents	O
an	O
individual	O
,	O
and	O
lines	O
indicate	O
the	O
distance	O
from	O
tertile	O
centroid	O
.	O

However	O
,	O
in	O
Cameroon	O
,	O
MMR	O
has	O
risen	O
by	O
8	O
%	O
from	O
680	O
to	O
872	O
deaths	O
per	O
100	O
000	O
in	O
the	O
past	O
9	O
years	O
after	O
the	O
initial	O
decrease	O
[	O
3	O
].	O

The	O
costs	O
of	O
the	O
intervention	O
will	O
include	O
cost	O
and	O
distribution	O
of	O
the	O
supplements	O
,	O
training	O
of	O
SS	O
workers	O
,	O
organisational	O
costs	O
associated	O
with	O
the	O
administration	O
of	O
the	O
programme	O
and	O
the	O
cost	O
of	O
incentives	O
.	O

Cross	O
-	O
sectional	O
,	O
observational	O
,	O
and	O
randomized	O
control	O
trials	O
'	O
literature	O
on	O
the	O
subject	O
published	O
between	O
2000	O
and	O
2011	O
served	O
as	O
the	O
main	O
sources	O
of	O
information	O
.	O

a	O
Principal	O
coordinate	O
plot	O
of	O
generalized	O
UniFrac	O
distances	O
(	O
PERMANOVA	O
p	O
=	O
0	O
.	O
034	O
for	O
maternal	O
dairy	O
as	O
a	O
continuous	O
variable	O
),	O
colored	O
by	O
maternal	O
dairy	O
intake	O
tertiles	O
.	O

Once	O
again	O
some	O
of	O
the	O
most	O
active	O
TEs	O
also	O
escape	O
this	O
second	O
phase	O
of	O
epigenetic	O
re	O
-	O
programing	O
,	O
thereby	O
maintaining	O
genome	O
stability	O
.	O

The	O
occurrence	O
of	O
MTC	O
in	O
both	O
sporadic	O
and	O
familial	O
forms	O
makes	O
the	O
clinical	O
approach	O
to	O
this	O
tumour	O
different	O
from	O
that	O
to	O
other	O
thyroid	O
tumours	O
.	O

This	O
observation	O
is	O
similar	B
to	I
that	O
seen	O
in	O
Uganda	O
[	O
17	O
]	O
and	O
Zimbabwe	O
[	O
18	O
]	O
where	O
it	O
was	O
also	B
shown	I
that	O
the	O
quality	O
of	O
care	O
provided	O
was	O
contributory	O
.	O

One	O
possibility	B
that	O
emerges	B
from	O
our	O
data	O
is	O
that	O
male	O
offspring	O
can	B
increase	O
their	O
body	O
weight	O
by	O
either	O
a	O
reduction	O
of	O
energy	O
expenditure	O
or	O
higher	O
metabolism	O
efficiency	O
.	O

The	O
spread	O
and	O
importance	O
of	O
postpartum	O
depression	O
have	O
led	O
researchers	O
to	O
create	O
preventative	O
methods	O
such	O
as	O
educational	O
programs	O
,	O
modified	O
care	O
,	O
dietary	O
supplements	O
,	O
antidepressant	O
medication	O
and	O
social	O
support	O
[	O
12	O
–	O
14	O
].	O

SPSS	O
16	O
.	O
0	O
(	O
SPSS	O
,	O
Inc	O
.,	O
Chicago	O
,	O
IL	O
,	O
USA	O
)	O
was	O
used	O
for	O
all	O
statistical	O
analyses	O
.	O

The	O
median	O
age	O
at	O
diagnosis	O
is	O
low	O
,	O
below	O
40	O
years	O
in	O
most	O
populations	O
.	O

Although	O
a	O
recent	B
pilot	I
randomized	O-
trial	I
[	O
39	O
]	O
found	O
no	O
significant	O
impact	O
of	O
a	O
low	O
glycemic	O
index	O
diet	O
on	O
the	O
offspring	O
weight	O
of	O
overweight	O
/	O
obese	O
mothers	O
,	O
future	O
,	O
larger	O
randomized	O
trials	O
and	O
research	O
with	O
more	O
frequent	O
assessments	O
of	O
diet	O
in	O
pregnancy	O
are	O
needed	O
to	O
untangle	B
the	O
relationship	O
between	O
weight	O
status	O
,	O
time	O
in	O
pregnancy	O
of	O
nutrient	O
exposures	O
,	O
and	O
offspring	O
weight	O
outcomes	O
.	O

Autism	O
and	O
autism	O
spectrum	O
disorders	O
(	O
ASDs	O
),	O
including	O
Asperger	O
'	O
s	O
syndrome	O
and	O
pervasive	O
developmental	O
disorder	O
,	O
have	O
become	O
increasingly	O
diagnosed	O
over	O
the	O
past	O
decade	O
.	O

Furthermore	O
,	O
multivitamin	O
supplements	O
available	O
during	O
the	O
study	O
period	O
contained	O
very	O
little	O
(	O
maximum	O
50	O
IU	O
),	O
if	O
any	O
,	O
vitamin	O
D	O
and	O
thus	O
are	O
an	O
unlikely	O
source	O
of	O
variation	O
within	O
the	O
population	O
.	O

Trajectory	O
of	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
in	O
relation	O
to	O
neonatal	O
birth	O
size	O
and	O
fetal	O
survival	O
:	O
a	O
prospective	O
cohort	O
study	O
Abstract	O
Background	O
We	O
investigated	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
in	O
early	O
and	O
late	O
pregnancy	O
with	O
neonatal	O
small	O
for	O
gestational	O
age	O
(	O
SGA	O
),	O
low	O
birth	O
weight	O
(	O
LBW	O
)	O
and	O
preterm	O
delivery	O
.	O

It	O
has	B
long	O-
been	I
proposed	B
that	O
the	O
mother	O
should	O
avoid	O
such	O
foods	O
containing	O
potential	B
allergens	O
during	O
pregnancy	O
and	O
lactation	O
to	O
prevent	O
food	O
sensitization	O
in	O
the	O
child	O
.	O

In	O
this	O
review	O
,	O
we	O
first	O
provide	O
an	O
overview	O
of	O
muscle	O
and	O
fat	O
cell	O
growth	O
in	O
ruminants	O
.	O

Further	O
,	O
a	O
cause	O
-	O
and	O
-	O
effect	O
relationship	O
can	O
not	O
be	O
concluded	O
from	O
this	O
study	O
.	O

IUFD	O
was	O
defined	O
as	O
pregnancy	O
loss	O
at	O
gestational	O
week	O
≥	O
22	O
+	O
0	O
.	O

Apart	O
from	O
the	O
long	O
-	O
term	O
health	O
consequences	O
,	O
severe	O
growth	O
-	O
restricted	O
foetuses	O
are	O
at	O
increased	O
risk	O
of	O
stillbirth	O
,	O
and	O
the	O
live	O
births	O
have	O
an	O
increased	O
risk	O
of	O
neonatal	O
death	O
,	O
morbidity	O
and	O
permanent	O
deficits	O
in	O
growth	O
and	O
neurocognitive	O
development	O
[	O
5	O
,	O
6	O
].	O

(	O
2013	O
)	O
Shenker	O
et	O
al	O
.	O

2010	O
;	O
Pavanello	O
et	O
al	O
.	O

Forty	O
participants	O
in	O
this	O
study	O
had	O
plasma	O
samples	O
collected	O
at	O
two	O
subsequent	O
yearly	O
visits	O
,	O
spaced	O
roughly	O
twelve	O
months	O
apart	O
.	O

The	O
smallest	O
and	O
the	O
heaviest	O
fetus	O
within	O
one	O
litter	O
were	O
selected	O
for	O
transcriptome	O
analysis	O
.	O

2008	O
).	O

According	O
to	O
USDA	O
nutrition	O
data	O
,	O
the	O
main	O
food	O
sources	O
of	O
Vitamin	O
D	O
are	O
cheese	O
(	O
7	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
egg	O
yolk	O
(	O
5	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
canned	O
sardine	O
(	O
4	O
.	O
8	O
μg	O
/	O
100	O
g	O
),	O
butter	O
(	O
1	O
.	O
4	O
μg	O
/	O
100	O
g	O
),	O
and	O
animal	O
organs	O
and	O
meat	O
products	O
(	O
less	O
than	O
1	O
%)	O
[	O
5	O
].	O

In	O
conclusion	O
,	O
vitamin	O
D	O
deficiency	O
is	O
highly	O
prevalent	O
among	O
pregnant	O
women	O
in	O
Belgium	O
and	O
this	O
raises	O
concerns	O
about	O
the	O
health	O
consequences	O
for	O
the	O
mother	O
and	O
the	O
offspring	O
.	O

For	O
example	O
,	O
we	O
have	B
shown	I
that	O
while	O
habituated	O
DVD	O
rats	O
have	O
normal	O
locomotion	O
activity	O
in	O
the	O
open	O
field	O
at	O
baseline	O
,	O
they	O
have	O
pronounced	O
hyperlocomotion	O
after	O
exposure	O
to	O
MK	O
-	O
801	O
[	O
10	O
],[	O
12	O
].	O

In	O
this	O
study	O
,	O
we	O
observed	O
marginal	O
sex	O
-	O
specific	O
differences	O
between	O
early	O
pregnancy	O
vitamin	O
D	O
status	O
and	O
pregnancy	O
outcome	O
where	O
by	O
high	O
vitamin	O
D	O
status	O
and	O
carrying	O
a	O
male	O
fetus	O
was	O
moderately	O
associated	O
with	O
decreasing	O
the	O
risk	O
of	O
having	O
any	O
pregnancy	O
complication	O
.	O

In	O
one	B
study	I
,	O
aspart	O
was	O
detected	O
in	O
the	O
cord	O
blood	O
for	O
one	O
subject	O
.	O
45However	O
,	O
as	O
it	O
was	B
not	I
detected	O
in	O
other	O
subjects	O
,	O
the	O
authors	O
postulated	B
that	O
this	O
was	O
due	O
to	O
the	O
disruption	O
of	O
the	O
uterine	O
-	O
placental	O
barrier	O
during	O
delivery	O
,	O
when	O
the	O
mother	O
had	O
been	O
receiving	O
an	O
aspart	O
infusion	O
.	O

Medical	O
history	O
of	O
bone	O
mineral	O
metabolic	O
disease	O
;	O
2	O
).	O

We	O
performed	O
crude	O
and	O
adjusted	O
analyses	O
for	O
each	O
dietary	O
food	O
group	O
variable	O
individually	O
,	O
normalized	O
by	O
maternal	O
calorie	O
consumption	O
,	O
and	O
maternal	O
aMED	O
score	O
and	O
MUFA	O
:	O
SFA	O
ratio	O
in	O
vaginally	O
delivered	O
infants	O
.	O

Maternal	O
serum	O
vitamin	O
D	O
levels	O
tend	O
to	O
be	O
closely	O
correlated	O
with	O
infant	O
cord	O
serum	O
levels	O
[	O
146	O
,	O
147	O
].	O

Feed	O
efficiency	O
decreases	O
as	O
animal	O
age	O
and	O
slaughter	O
weight	O
exceed	O
a	O
certain	O
level	O
.	O

Furthermore	O
,	O
it	O
is	O
perhaps	B
unsurprising	O
that	O
women	O
with	O
higher	O
educational	O
achievement	O
and	O
also	O
those	O
with	O
greater	O
engagement	O
with	O
prenatal	O
care	O
had	O
better	O
nutritional	O
knowledge	O
and	O
used	O
supplements	O
more	O
.	O

Supplementing	O
rumen	O
-	O
protected	O
vitamin	O
C	O
in	O
a	O
high	O
sulfur	O
diet	O
increased	O
the	O
MS	O
and	O
the	O
percentage	O
of	O
Choice	O
grade	O
beef	O
in	O
Angus	O
cross	O
steers	O
[	O
151	O
].	O

The	O
research	O
team	O
took	O
written	O
approval	O
for	O
the	O
study	O
from	O
Directorate	O
General	O
of	O
Health	O
Service	O
(	O
DGHS	O
)	O
under	O
Ministry	O
of	O
Health	O
&	O
Family	O
Welfare	O
before	O
allocating	O
the	O
clusters	O
to	O
a	O
treatment	O
group	O
or	O
the	O
trial	O
interventions	O
begin	O
.	O

A	O
positive	O
score	O
on	O
any	O
of	O
these	O
three	O
symptoms	O
indicates	O
an	O
allergic	O
phenotype	O
.	O

Results	O
A	O
total	O
of	O
1055	O
newborns	O
were	O
included	O
in	O
the	O
study	O
:	O
62	O
.	O
4	O
%	O
were	O
African	O
Americans	O
and	O
49	O
.	O
4	O
%	O
were	O
female	O
.	O

This	O
data	O
-	O
driven	O
clustering	O
allowed	O
us	O
to	O
define	O
stable	O
classes	O
of	O
CpG	O
loci	O
demonstrating	O
similar	O
patterns	O
of	O
methylation	O
,	O
which	O
we	O
used	O
to	O
examine	O
associations	O
between	O
methylation	O
of	O
these	O
classes	O
of	O
CpGs	O
and	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
.	O

The	O
inclusion	O
criteria	O
applied	O
during	O
recruitment	O
screening	O
are	O
:	O
1	O
)	O
Confirmed	O
pregnancy	O
and	O
planning	O
to	O
deliver	O
her	O
baby	O
at	O
RMMCH	O
;	O
2	O
)	O
<	O
18	O
weeks	O
’	O
gestational	O
age	O
;	O
3	O
)	O
Born	O
in	O
South	O
Africa	O
,	O
Lesotho	O
,	O
Swaziland	O
,	O
Zimbabwe	O
,	O
Botswana	O
or	O
Namibia	O
and	O
has	O
been	O
living	O
in	O
South	O
Africa	O
for	O
at	O
least	O
12	O
months	O
;	O
4	O
)	O
Able	O
to	O
communicate	O
effectively	O
in	O
one	O
of	O
the	O
following	O
languages	O
:	O
English	O
,	O
Afrikaans	O
,	O
Sotho	O
,	O
Zulu	O
or	O
Xhosa	O
.	O

The	O
mean	O
age	O
of	O
the	O
respondents	O
was	O
25	O
.	O
2	O
years	O
(	O
SD	O
5	O
.	O
1	O
).	O

Development	O
of	O
new	O
fusion	O
technologies	O
(	O
e	O
.	O
g	O
.,	O
nutrigenomics	O
)	O
with	O
genetic	O
,	O
epigenetic	O
,	O
and	O
nutritional	O
factors	O
may	B
be	I
more	O
efficient	O
to	O
optimize	O
IMF	O
deposition	O
and	O
improve	O
feed	O
efficiency	O
.	O

The	O
current	O
body	O
of	O
evidence	B
for	O
environmentally	O
induced	O
epigenetic	O
toxicity	O
is	O
predominantly	O
a	O
collection	O
of	O
human	O
epidemiological	O
data	O
and	O
exploratory	O
in	O
vivo	O
high	O
(	O
often	O
single	O
)	O
dose	O
range	O
studies	O
,	O
performed	O
,	O
not	O
for	O
regulatory	O
purposes	O
,	O
but	O
to	O
investigate	O
the	O
theoretical	B
potential	B
and	O
putative	O
mechanisms	O
of	O
epigenetic	O
toxicity	O
in	O
biological	O
systems	O
.	O

Long	O
-	O
term	O
effect	O
of	O
prenatal	O
caloric	O
restriction	O
on	O
adiposity	O
in	O
adult	O
offspring	O
We	O
detected	O
a	O
prenatal	O
diet	O
effect	O
on	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perirenal	O
and	O
abdominal	O
fat	O
relative	O
to	O
body	O
weight	O
(	O
Table2	O
).	O

Hypothalamic	O
gene	O
expression	O
of	O
feeding	O
-	O
related	O
neuropeptides	O
including	O
neuropeptide	O
Y	O
,	O
pro	O
-	O
opiomelanocortin	O
(	O
POMC	O
),	O
insulin	O
receptor	O
,	O
leptin	O
receptor	O
,	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
),	O
receptors	O
for	O
dopamine	O
(	O
DopaR1	O
/	O
2	O
/	O
5	O
)	O
and	O
serotonin	O
(	O
SeroR1A	O
/	O
2A	O
/	O
2C	O
),	O
as	O
well	O
as	O
global	O
DNA	O
methylation	O
and	O
brain	O
and	O
plasma	O
folate	O
concentrations	O
were	O
measured	O
at	O
29	O
weeks	O
post	O
-	O
weaning	O
.	O

Imprinted	O
genes	O
are	O
generally	O
widely	O
and	O
highly	O
expressed	O
during	O
prenatal	O
development	O
and	O
predominantly	O
down	O
-	O
regulated	O
after	O
birth	O
.	O

Conflict	O
of	O
interest	O
statement	O
The	O
authors	O
declare	O
that	O
the	O
research	O
was	O
conducted	O
in	O
the	O
absence	O
of	O
any	O
commercial	O
or	O
financial	O
relationships	O
that	O
could	O
be	O
construed	O
as	O
a	O
potential	O
conflict	O
of	O
interest	O
.	O

Methods	O
Animals	O
and	O
sample	O
collection	O
Animal	O
care	O
and	O
tissue	O
collection	O
processes	O
followed	O
the	O
guidelines	O
of	O
the	O
German	O
Law	O
of	O
Animal	O
Protection	O
and	O
the	O
experimental	O
protocol	O
was	O
approved	O
by	O
the	O
Animal	O
Care	O
Committee	O
of	O
the	O
State	O
Mecklenburg	O
-	O
Vorpommern	O
(	O
Landesamt	O
für	O
Landwirtschaft	O
,	O
Lebensmittelsicherheit	O
und	O
Fischerei	O
,	O
Mecklenburg	O
-	O
Vorpommern	O
,	O
Germany	O
;	O
LVL	O
MV	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
1	O
-	O
006	O
/	O
04	O
;	O
LALLF	O
M	O
-	O
V	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
2	O
-	O
05	O
/	O
06	O
;	O
LALLF	O
M	O
-	O
V	O
/	O
TSD	O
/	O
7221	O
.	O
3	O
-	O
1	O
.	O
2	O
-	O
013	O
/	O
06	O
).	O

Alternately	O
,	O
it	O
might	B
be	O
that	O
immunological	O
effectiveness	O
of	O
supplementation	O
is	O
highly	O
dependent	O
upon	O
other	O
factors	O
as	O
yet	O
unidentified	O
,	O
or	O
other	O
prevalent	O
factors	O
in	O
this	O
high	O
-	O
risk	O
population	O
(	O
for	O
example	O
,	O
other	O
malnutrition	O
factors	O
and	O
that	O
5	O
·	O
5	O
%	O
of	O
the	O
children	O
in	O
our	O
study	O
had	O
a	O
Z	O
score	O
of	O
weight	O
for	O
age	O
below	O
−	O
3	O
).	O

Obviously	O
,	O
the	O
increased	O
mRNA	O
expression	O
of	O
genes	O
related	O
to	O
cell	O
cycle	O
regulators	O
within	O
developmental	O
period	O
I	O
in	O
LP	O
offspring	O
accounts	O
for	O
compensatory	O
regulations	O
regarding	O
the	O
lowered	O
fetal	O
weight	O
due	O
to	O
the	O
gestational	O
diet	O
.	O

Newborn	O
weight	O
is	O
measured	O
with	O
a	O
calibrated	O
digital	O
infant	O
scale	O
to	O
the	O
nearest	O
10	O
g	O
.	O
In	O
order	O
to	O
minimize	O
intra	O
-	O
observer	O
variability	O
all	O
circumferences	O
and	O
CHL	O
are	O
measured	O
with	O
an	O
inelastic	O
tape	O
to	O
the	O
nearest	O
0	O
.	O
5	O
cm	O
(	O
metal	O
measuring	O
tape	O
not	O
used	O
to	O
prevent	O
possible	O
lacerations	O
).	O

Apart	O
from	O
this	O
function	O
,	O
these	O
proteins	O
are	O
essential	O
for	O
the	O
insertion	O
of	O
dopamine	O
receptor	O
2	O
(	O
DRD2	O
)	O
into	O
the	O
nonsynaptic	O
membrane	O
of	O
dopaminergic	O
neurons	O
[	O
32	O
].	O

The	O
respondents	O
also	O
wished	O
that	O
the	O
health	O
talks	O
(	O
16	O
.	O
3	O
%)	O
should	O
be	O
more	O
regular	O
and	O
that	O
primigravida	O
should	O
be	O
encouraged	O
to	O
come	O
regularly	O
.	O

In	O
addition	O
,	O
current	O
OECD	O
human	O
health	O
-	O
related	O
TGs	O
have	O
the	O
potential	B
for	O
adaptation	O
to	O
incorporate	O
adverse	O
epigenetic	O
endpoints	O
(	O
Greally	O
&	O
Jacobs2013	O
).	O

Nutritional	O
factors	O
,	O
including	O
fat	O
metabolism	O
,	O
digestion	O
and	O
absorption	O
of	O
feed	O
,	O
glucose	O
/	O
starch	O
availability	O
,	O
and	O
vitamin	O
A	O
,	O
D	O
,	O
and	O
C	O
levels	O
are	O
important	O
for	O
IMF	O
deposition	O
.	O

The	O
comparisons	O
of	O
the	O
relative	O
mRNA	O
abundances	O
depending	O
on	O
dietary	O
group	O
and	O
ontogenetic	O
stages	O
provide	O
an	O
overall	O
view	B
of	O
the	O
developmental	O
plasticity	O
of	O
the	O
liver	O
.	O

The	O
P8	O
rump	O
fat	O
depth	O
was	O
generally	O
greater	O
in	O
Hereford	O
than	O
Angus	O
,	O
and	O
Meat	O
Standard	O
Australia	O
(	O
MSA	O
)	O
MS	O
was	O
generally	O
lower	O
in	O
Hereford	O
than	O
in	O
Angus	O
and	O
Wagyu	O
×	O
Angus	O
.	O

Findings	O
1524	O
children	O
were	O
assigned	O
to	O
receive	O
vitamin	O
D3and	O
1522	O
placebo	O
.	O

Discussion	O
This	O
clinical	O
trial	O
evaluated	O
the	O
effect	O
of	O
2000	O
IU	O
of	O
vitamin	O
D3supplement	O
per	O
day	O
during	O
late	O
pregnancy	O
on	O
perinatal	O
depression	O
.	O

In	O
vivo	O
testing	O
should	O
generally	O
be	O
postponed	O
until	O
after	O
pregnancy	O
,	O
unless	O
diagnosis	O
for	O
therapeutic	O
intervention	O
is	O
urgently	O
needed	O
.	O

Methods	O
Study	O
population	O
Subjects	O
for	O
the	O
present	O
study	O
were	O
from	O
the	O
New	O
Hampshire	O
Birth	O
Cohort	O
Study	O
(	O
NHBCS	O
)	O
who	O
provided	O
infant	O
stool	O
samples	O
at	O
6	O
-	O
week	O
postpartum	O
.	O

Setting	O
The	O
study	O
is	O
situated	O
in	O
Johannesburg	O
,	O
the	O
largest	O
city	O
in	O
South	O
Africa	O
.	O

In	O
the	O
present	O
study	O
,	O
we	O
used	O
the	O
cut	O
-	O
off	O
point	O
of	O
>	O
13	O
as	O
greater	O
likelihood	O
of	O
having	O
depression	O
disorder	O
,	O
according	B
to	I
Mazhari	O
and	O
Nakhaee	O
’	O
s	O
study	O
in	O
Iranian	O
population	O
[	O
42	O
].	O

Early	O
life	O
nutrition	O
,	O
the	O
developing	O
immune	O
system	O
and	O
subsequent	O
allergic	O
manifestations	O
Over	O
the	O
last	O
half	O
-	O
century	O
,	O
chronic	O
disease	O
incidence	O
,	O
including	O
allergic	O
manifestations	O
(	O
AM	O
),	O
has	O
increased	O
exponentially	O
in	O
developed	O
nations	O
and	O
amongst	O
the	O
wealthy	O
in	O
developing	O
nations	O
.	O

Results	O
Geographical	O
accessibility	O
and	O
perceived	O
quality	O
of	O
care	O
were	O
the	O
predominant	O
reasons	O
for	O
choosing	O
or	O
changing	O
a	O
site	O
for	O
ANC	O
.	O

Objective	O
To	O
identify	O
the	O
presence	O
of	O
GDM	O
risk	O
factors	O
during	O
pregnancy	O
at	O
the	O
time	O
of	O
diagnosis	O
of	O
this	O
pathology	O
.	O

Insulin	O
is	O
still	O
the	O
mainstay	O
of	O
pharmacological	O
treatment	O
of	O
GDM	O
,	O
and	O
this	O
is	O
ideally	O
administered	O
in	O
a	O
basal	O
bolus	O
regimen	O
.	O

However	O
,	O
there	O
were	O
no	O
petechial	O
lesions	O
,	O
lower	O
limb	O
edema	O
,	O
or	O
focal	O
neurological	O
deficit	O
.	O

Asthma	O
and	O
allergic	O
disorders	O
can	B
affect	O
the	O
course	O
and	O
outcome	O
of	O
the	O
pregnancy	O
.	O

Conclusions	O
Level	O
of	O
nutritional	O
knowledge	O
has	O
a	O
strong	O
independent	O
association	O
with	O
the	O
use	O
of	O
supplements	O
during	O
pregnancy	O
.	O

Numerous	O
individual	O
nutrients	O
consumed	O
by	O
the	O
mother	O
during	O
pregnancy	O
have	B
been	I
suggested	B
as	O
being	O
preventive	O
for	O
development	O
of	O
atopic	O
diseases	O
in	O
the	O
child	O
;	O
these	O
include	O
apples	O
or	O
fish	O
,[	O
80	O
]	O
vitamin	O
D	O
,[	O
107	O
]	O
vitamin	O
E	O
,[	O
108	O
]	O
and	O
various	O
probiotics	O
,	O
the	O
latter	O
having	B
been	I
shown	I
to	O
be	O
effective	O
in	O
mouse	O
models	B
[	O
109	O
]	O
and	O
human	O
studies	O
[	O
110	O
].	O

“	O
We	O
’	O
re	O
going	O
to	O
make	O
sure	O
people	O
know	O
their	O
risks	O
and	O
can	O
take	O
action	O
.”	O
PubMed	O
Central	O
:	O

Hyperplasia	O
of	O
fat	O
cells	O
mainly	O
occurs	O
from	O
conception	O
until	O
birth	O
,	O
and	O
hypertrophy	O
is	O
a	O
greater	O
contributor	O
to	O
IMF	O
deposition	O
than	O
is	O
hyperplasia	O
from	O
250	O
d	O
of	O
age	O
to	O
slaughter	O
[	O
16	O
,	O
17	O
].	O

Pyrosequencing	O
of	O
these	O
repeat	O
elements	O
was	O
successful	O
in	O
380	O
samples	O
;	O
we	O
noted	O
no	O
significant	O
differences	O
in	O
the	O
demographics	O
or	O
clinical	O
characteristics	O
of	O
these	O
samples	O
compared	O
with	O
the	O
larger	O
population	O
.	O

These	O
metabolites	O
were	O
analyzed	O
using	O
commercial	O
kits	O
according	O
to	O
the	O
manufacturer	O
'	O
s	O
instructions	O
and	O
a	O
Hitachi	O
737	O
Automatic	O
Analyzer	O
(	O
Hitachi	O
Ltd	O
,	O
Tokyo	O
,	O
Japan	O
).	O

Several	O
small	B
studies	I
comparing	O
metformin	O
to	O
insulin	O
for	O
the	O
treatment	O
of	O
GDM	O
have	B
also	O-
been	I
performed	O
(	O
Table	O
5	O
).	O

Moreover	O
,	O
alcohol	O
consumption	O
has	B
been	I
shown	O
to	O
induce	O
higher	O
IgE	O
levels	O
against	O
aeroallergens	O
in	O
atopic	O
patients	O
[	O
76	O
].	O

According	B
to	I
our	O
knowledge	O
,	O
this	O
study	O
was	O
the	O
first	B
trial	O
held	O
on	O
vitamin	O
D	O
and	O
perinatal	O
depression	O
.	O

The	O
study	O
nurses	O
obtain	O
maternal	O
weight	O
before	O
birth	O
with	O
a	O
calibrated	O
digital	O
scale	O
.	O

Data	O
on	O
education	O
level	O
(≤	O
primary	O
level	O
,	O
secondary	O
level	O
or	O
university	O
level	O
)	O
and	O
origin	O
(	O
continent	O
of	O
birth	O
:	O
Northern	O
Europe	O
,	O
Continental	O
Europe	O
,	O
America	O
,	O
Asia	O
,	O
Africa	O
)	O
were	O
collected	O
from	O
study	O
questionnaires	O
.	O

Differentiated	O
Thyroid	O
Cancer	O
(	O
DTC	O
)	O
–	O
cancer	O
arising	O
from	O
follicular	O
thyroid	O
cells	O
Mostly	O
diagnosed	O
in	O
young	O
people	O
,	O
DTC	O
usually	B
has	O
a	O
good	O
prognosis	O
with	O
an	O
overall	O
90	O
-	O
95	O
%	O
long	O
-	O
term	O
disease	O
-	O
free	O
survival	O
for	O
early	O
stage	O
or	O
low	O
risk	O
tumours	O
,	O
which	O
represent	O
the	O
vast	O
majority	O
of	O
tumours	O
diagnosed	O
below	O
40	O
-	O
45	O
years	O
of	O
age	O
.	O

Lower	O
levels	O
of	O
PUFA	O
have	B
been	I
found	B
in	O
brain	O
content	O
,	O
red	O
blood	O
cells	O
and	O
skin	O
fibroblast	O
among	O
patients	O
with	O
schizophrenia	O
,	O
compared	O
with	O
a	O
healthy	O
population	O
[	O
13	O
,	O
16	O
].	O

The	O
children	O
of	O
mothers	O
participating	O
in	O
the	O
NICHD	O
trial	O
were	O
then	O
seen	O
at	O
yearly	O
follow	O
-	O
up	O
visits	O
for	O
three	O
years	O
between	O
the	O
ages	O
of	O
2	O
and	O
7	O
as	O
part	O
of	O
an	O
IRB	O
-	O
approved	O
follow	O
-	O
up	O
study	O
funded	O
by	O
the	O
Thrasher	O
Research	O
Fund	O
(	O
HR	O
#	O
19641	O
,	O
CTRC	O
protocol	O
870	O
).	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
during	O
pregnancy	O
and	O
atopy	O
without	O
asthma	O
,	O
nonatopic	O
and	O
atopic	O
asthma	O
#	O
in	O
the	O
offspringMaternal	O
free	O
sugar	O
intake	O
during	O
pregnancyp	O
-	O
trendQuintile	O
1Quintile	O
2Quintile	O
3Quintile	O
4Quintile	O
5Per	O
quintileAtopy	O
without	O
asthma	O
n	O
=	O
794	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
78	O
(	O
0	O
.	O
61	O
–	O
1	O
.	O
01	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
96	O
(	O
0	O
.	O
73	O
–	O
1	O
.	O
25	O
)	O
1	O
.	O
09	O
(	O
0	O
.	O
80	O
–	O
1	O
.	O
50	O
)	O
1	O
.	O
04	O
(	O
0	O
.	O
97	O
–	O
1	O
.	O
12	O
)	O
0	O
.	O
30	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
77	O
(	O
0	O
.	O
60	O
–	O
0	O
.	O
99	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
72	O
–	O
1	O
.	O
25	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
85	O
–	O
1	O
.	O
62	O
)	O
1	O
.	O
05	O
(	O
0	O
.	O
98	O
–	O
1	O
.	O
13	O
)	O
0	O
.	O
19	O
Nonatopic	O
asthma	O
n	O
=	O
301	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
82	O
(	O
0	O
.	O
57	O
–	O
1	O
.	O
16	O
)	O
0	O
.	O
67	O
(	O
0	O
.	O
46	O
–	O
0	O
.	O
99	O
)	O
0	O
.	O
77	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
16	O
)	O
0	O
.	O
83	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
34	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
85	O
–	O
1	O
.	O
06	O
)	O
0	O
.	O
34	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
000	O
.	O
87	O
(	O
0	O
.	O
61	O
–	O
1	O
.	O
25	O
)	O
0	O
.	O
73	O
(	O
0	O
.	O
49	O
–	O
1	O
.	O
08	O
)	O
0	O
.	O
78	O
(	O
0	O
.	O
52	O
–	O
1	O
.	O
18	O
)	O
0	O
.	O
71	O
(	O
0	O
.	O
43	O
–	O
1	O
.	O
15	O
)	O
0	O
.	O
92	O
(	O
0	O
.	O
82	O
–	O
1	O
.	O
03	O
)	O
0	O
.	O
14	O
Atopic	O
asthma	O
n	O
=	O
337	O
Adjusted	O
OR	O
¶(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
66	O
(	O
1	O
.	O
14	O
–	O
2	O
.	O
41	O
)	O
1	O
.	O
17	O
(	O
0	O
.	O
78	O
–	O
1	O
.	O
77	O
)	O
2	O
.	O
09	O
(	O
1	O
.	O
39	O
–	O
3	O
.	O
14	O
)	O
1	O
.	O
79	O
(	O
1	O
.	O
11	O
–	O
2	O
.	O
90	O
)	O
1	O
.	O
14	O
(	O
1	O
.	O
03	O
–	O
1	O
.	O
27	O
)	O
0	O
.	O
01	O
Adjusted	O
OR	O
+(	O
95	O
%	O
CI	O
)	O
1	O
.	O
001	O
.	O
75	O
(	O
1	O
.	O
20	O
–	O
2	O
.	O
56	O
)	O
1	O
.	O
27	O
(	O
0	O
.	O
84	O
–	O
1	O
.	O
93	O
)	O
2	O
.	O
18	O
(	O
1	O
.	O
45	O
–	O
3	O
.	O
30	O
)	O
2	O
.	O
01	O
(	O
1	O
.	O
23	O
–	O
3	O
.	O
29	O
)	O
1	O
.	O
17	O
(	O
1	O
.	O
05	O
–	O
1	O
.	O
30	O
)	O
0	O
.	O
004	O
#:	O
no	O
atopy	O
or	O
asthma	O
was	O
considered	O
as	O
baseline	O
category	O
(	O
n	O
=	O
3796	O
);¶:	O
controlling	O
for	O
energy	O
intake	O
;+:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

This	O
suggests	B
that	O
our	O
microarray	O
data	O
are	O
reliable	O
.	O

The	O
main	O
problems	O
are	O
:	O
i	O
)	O
to	O
reach	O
an	O
adequate	O
balance	O
of	O
maternal	O
thyroid	O
hormones	O
that	O
is	O
absolutely	O
required	O
by	O
the	O
foetal	O
central	O
nervous	O
system	O
for	O
normal	O
maturation7	O
,	O
ii	O
)	O
to	O
maintain	O
maternal	O
levels	O
of	O
l	O
-	O
thyroxin	O
to	O
avoid	O
possible	B
recurrence	O
or	O
spread	O
of	O
disease	O
,	O
and	O
iii	O
)	O
to	O
perform	O
safe	O
follow	O
-	O
up	O
controls	O
for	O
the	O
mother	O
and	O
to	O
plan	O
further	O
therapy	O
when	O
needed	O
.	O

At	O
30	O
weeks	O
,	O
341	O
(	O
94	O
%;	O
160	O
overweight	O
/	O
obese	O
and	O
181	O
normal	O
weight	O
)	O
attended	O
the	O
assessment	O
visit	O
.	O

However	O
,	O
adequate	O
maternal	O
intakes	O
of	O
zinc	O
and	O
vitamin	O
A	O
may	B
also	O
be	O
important	O
for	O
optimal	O
pregnancy	O
outcomes	O
,	O
as	O
well	O
as	O
for	O
maternal	O
and	O
offspring	O
health	O
[	O
11	O
–	O
13	O
].	O

Studies	O
have	B
shown	I
that	O
low	O
serum	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
is	O
associated	O
with	O
psychological	O
symptoms	O
like	O
anxiety	O
,	O
depression	O
and	O
reduced	O
cognitive	O
function	O
[	O
26	O
,	O
27	O
].	O

(	O
2013	O
)¶/*/†	O
Vucetic	O
et	O
al	O
.	O

Based	O
on	O
aggregated	O
evidence	O
from	O
animal	O
and	O
human	O
studies	O
,	O
Witter	O
et	O
al	O
.	O

In	O
Models	O
1	O
and	O
4	O
),	O
higher	O
cathelicidin	O
concentrations	O
were	O
significantly	O
associated	O
with	O
male	O
gender	O
(	O
beta	O
=	O
0	O
.	O
318	O
,	O
p	O
=	O
0	O
.	O
047	O
),	O
indicating	B
that	O
after	O
adjusting	O
for	O
the	O
other	O
variables	O
in	O
the	O
model	B
,	O
males	O
’	O
cathelicidin	O
levels	O
were	O
1	O
.	O
4	O
times	O
higher	O
than	O
females	O
’.	O

If	O
there	O
were	O
two	O
types	O
of	O
infection	O
during	O
a	O
single	O
visit	O
to	O
the	O
physician	O
or	O
hospital	O
,	O
that	O
event	O
was	O
counted	O
as	O
a	O
single	O
event	O
.	O

Potentially	B
the	O
most	O
significant	O
nutritional	O
intervention	O
has	O
been	O
the	O
prenatal	O
supplementation	O
of	O
folate	O
,	O
which	O
has	B
been	I
shown	O
to	O
reduce	O
the	O
incidence	O
of	O
neural	O
tube	O
defects	O
[	O
3	O
],	O
limb	O
malformations	O
,	O
urogenital	O
abnormalities	O
,	O
cardiovascular	O
malformations	O
[	O
4	O
],	O
and	O
cleft	O
lip	O
or	O
palate	O
[	O
5	O
].	O

At	O
14	O
weeks	O
gestation	O
,	O
on	O
average	O
,	O
participants	O
reported	O
sociodemographic	O
,	O
behavioral	O
,	O
and	O
health	O
characteristics	O
in	O
a	O
structured	O
interview	O
.	O

Therefore	O
,	O
the	O
down	O
-	O
regulation	O
of	O
cell	O
cycle	O
regulating	O
pathways	O
might	B
lead	O
to	O
a	O
lengthened	O
cell	O
cycle	O
in	O
LP	O
fetuses	O
and	O
offspring	O
[	O
27	O
]	O
and	O
cumulate	O
in	O
growth	O
retardation	O
in	O
LP	O
fetuses	O
.	O

These	O
differences	O
cannot	O
be	O
compared	O
directly	O
due	O
to	O
discrepancies	O
in	O
national	O
guidelines	O
and	O
the	O
financial	O
barriers	O
in	O
some	O
regions	O
[	O
27	O
].	O

The	O
experiment	O
comprises	O
a	O
valuable	O
model	B
especially	O
for	O
'	O
fetal	O
'	O
programming	O
,	O
because	O
cross	O
-	O
fostering	O
enabled	O
assessment	O
of	O
solely	O
the	O
nutritional	O
effects	O
during	O
gestation	O
.	O

Blood	O
samples	O
were	O
obtained	O
during	O
yearly	O
visits	O
from	O
133	O
children	O
,	O
ages	O
2	O
–	O
7	O
,	O
whose	O
mothers	O
had	O
participated	O
in	O
a	O
pregnancy	O
vitamin	O
D	O
supplementation	O
RCT	O
.	O

We	O
also	O
searched	O
for	O
unpublished	O
studies	O
,	O
PhD	O
dissertations	O
,	O
internal	O
reports	O
,	O
and	O
conference	O
proceedings	O
/	O
abstracts	O
.	O

Health	O
and	O
dietary	O
information	O
were	O
obtained	O
from	O
parental	O
report	O
and	O
confirmed	O
by	O
medical	O
records	O
from	O
the	O
primary	O
care	O
physician	O
or	O
the	O
hospital	O
.	O

At	O
the	O
beginning	O
of	O
the	O
test	O
,	O
the	O
rats	O
were	O
individually	O
housed	O
and	O
exposed	O
to	O
the	O
two	O
types	O
of	O
food	O
(	O
chocolate	O
and	O
standard	O
chow	O
)	O
for	O
4	O
days	O
.	O

The	O
inverse	O
probability	O
weighting	O
analysis	O
also	O
produced	O
similar	O
results	O
(	O
data	O
not	O
shown	O
).	O

Research	O
on	O
the	O
reliability	O
of	O
parental	O
reports	O
on	O
child	O
development	O
is	O
conflicting	O
[	O
31	O
],	O
Daniels	O
et	O
al	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
6	O
month	O
infant	O
general	O
health	O
and	O
health	O
utilisation	O
outcomes	O
by	O
treatment	O
groupOutcomeLifestyle	O
Advice	O
(	O
N	O
=	O
1071	O
)	O
Standard	O
Care	O
(	O
N	O
=	O
1065	O
)	O
Unadjusted	O
Treatment	O
Effect	O
(	O
95	O
%	O
CI	O
)	O
Unadjusted	O
P	O
-	O
valueAdjusted	O
Treatment	O
Effect	O
(	O
95	O
%	O
CI	O
)	O
Adjusted	O
P	O
-	O
valueWell	O
Since	O
Discharge491	O
(	O
83	O
.	O
50	O
)	O
548	O
(	O
87	O
.	O
82	O
)	O
0	O
.	O
95	O
(	O
0	O
.	O
91	O
,	O
1	O
.	O
00	O
)	O
0	O
.	O
0330	O
.	O
96	O
(	O
0	O
.	O
92	O
,	O
1	O
.	O
01	O
)	O
0	O
.	O
131Visited	O
Doctor	O
/	O
Hospital	O
Since	O
Discharge251	O
(	O
42	O
.	O
83	O
)	O
267	O
(	O
42	O
.	O
86	O
)	O
1	O
.	O
00	O
(	O
0	O
.	O
88	O
,	O
1	O
.	O
14	O
)	O
0	O
.	O
9930	O
.	O
97	O
(	O
0	O
.	O
85	O
,	O
1	O
.	O
11	O
)	O
0	O
.	O
690Admitted	O
to	O
Hospital36	O
(	O
14	O
.	O
34	O
)	O
33	O
(	O
12	O
.	O
36	O
)	O
1	O
.	O
16	O
(	O
0	O
.	O
75	O
,	O
1	O
.	O
80	O
)	O
0	O
.	O
5071	O
.	O
08	O
(	O
0	O
.	O
68	O
,	O
1	O
.	O
71	O
)	O
0	O
.	O
740	O
Values	O
are	O
number	O
and	O
percentage	O
,	O
and	O
treatment	O
effects	O
are	O
relative	O
risks	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
Adjusted	O
analyses	O
included	O
the	O
stratification	O
variables	O
BMI	O
category	O
,	O
parity	O
and	O
centre	O
.	O

Concerning	O
the	O
number	O
of	O
ANC	O
visits	O
,	O
the	O
health	O
centres	O
follow	O
the	O
Western	O
model	B
of	O
clinic	O
visits	O
with	O
an	O
average	O
of	O
10	O
to	O
12	O
visits	O
.	O

The	O
infant	O
assessment	O
includes	O
HIV	O
status	O
history	O
and	O
a	O
general	O
,	O
ear	O
,	O
nose	O
and	O
throat	O
,	O
respiratory	O
,	O
cardiovascular	O
,	O
abdominal	O
and	O
neurological	O
examination	O
as	O
well	O
as	O
any	O
current	O
complaints	O
.	O

Moreover	O
,	O
subsequent	B
studies	I
have	O
further	B
demonstrated	B
that	O
early	O
life	O
trauma	O
or	O
parental	O
stress	O
can	B
induce	O
altered	O
miRNA	O
expression	O
in	O
sperm	O
,	O
which	O
in	O
turn	O
can	B
transmit	O
behavioral	O
and	O
metabolic	O
abnormalities	O
through	O
to	O
the	O
next	O
murine	O
generation	O
(	O
Rodgers	O
et	O
al	O
.	O
2013	O
;	O
Gapp	O
et	O
al	O
.	O
2014	O
;	O
Rodgers	O
et	O
al	O
.	O
2015	O
).	O

Phylogenetic	O
trees	O
were	O
constructed	O
using	O
the	O
FastTree	O
method	O
[	O
41	O
].	O

The	O
order	O
of	O
introduction	O
seems	O
to	O
have	O
little	O
effect	O
on	O
AM	O
.	O

All	O
analyses	O
were	O
performed	O
using	O
Stata	O
9	O
.	O
0	O
statistical	O
software	O
(	O
Stata	O
,	O
College	O
Station	O
,	O
TX	O
).	O

These	O
cells	O
,	O
which	O
will	O
be	O
discussed	O
below	O
,	O
present	O
a	O
phenotype	O
with	O
metabolic	O
properties	O
that	O
are	O
closest	O
to	O
brown	O
than	O
to	O
white	O
adipocytes	O
.	O

PA01	O
.	O
78	O
.	O

Vitamin	O
D	O
does	O
not	O
occur	O
naturally	O
in	O
foods	O
.	O

We	O
ascertained	O
causes	O
of	O
death	O
through	O
scrutiny	O
of	O
hospital	O
notes	O
,	O
and	O
verbal	O
autopsy	O
interviews	O
with	O
the	O
WHO	O
standard	O
questionnaire	O
and	O
review	O
of	O
the	O
interview	O
data	O
by	O
two	O
physicians	O
independently	O
.	O

Interestingly	O
,	O
the	O
decreased	O
gene	O
expression	O
of	O
Ppar	O
γ	O
has	B
been	I
linked	O
to	O
inflammatory	O
processes	O
associated	O
with	O
obesity	O
and	O
insulin	O
resistance	O
(	O
Odegaard	O
et	O
al	O
.,	O
2007	O
;	O
Reynolds	O
et	O
al	O
.,	O
2014	O
),	O
an	O
issue	O
that	O
enhances	B
the	O
importance	O
of	O
the	O
inflammatory	O
responses	O
in	O
the	O
developmental	O
programming	O
.	O

Further	O
studies	O
are	O
required	O
to	O
confirm	O
these	O
findings	O
.	O

The	O
assured	O
and	O
well	O
-	O
evaluated	O
risk	O
factors	O
revealed	B
for	O
sensitization	O
in	O
mother	O
and	O
child	O
are	O
very	O
limited	B
,	O
to	O
date	O
,	O
and	O
include	O
alcohol	O
consumption	O
,	O
exposure	O
to	O
tobacco	O
smoke	O
,	O
maternal	O
diet	O
and	O
diet	O
of	O
the	O
newborn	O
,	O
drug	O
usage	O
,	O
and	O
insufficient	O
exposure	O
to	O
environmental	O
bacteria	O
.	O

Conclusions	O
Iron	O
deficiency	O
remains	B
the	O
most	O
important	O
cause	O
of	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
.	O

In	O
pooled	O
data	O
of	O
different	O
sexes	O
(	O
cows	O
,	O
bulls	O
,	O
and	O
steers	O
)	O
of	O
Korean	O
cattle	O
,	O
MS	O
and	O
LM	O
area	O
increased	O
with	O
increasing	O
carcass	O
weight	O
from	O
143	O
to	O
536	O
kg	O
[	O
39	O
].	O

Measurement	O
data	O
were	O
presented	O
as	O
mean	O
±	O
for	O
standard	O
deviation	O
.	O

Several	B
studies	I
have	O
suggested	B
the	O
association	O
between	O
perinatal	O
factors	O
and	O
the	O
onset	O
of	O
autism	O
.	O

Although	O
prepregnancy	O
weight	O
was	O
self	O
-	O
reported	O
,	O
our	O
research	O
has	O
found	O
that	O
women	O
in	O
this	O
study	O
were	O
quite	O
accurate	O
in	O
recalling	O
prepregnancy	O
weight	O
[	O
16	O
].	O

The	O
etiology	O
of	O
this	O
disease	O
is	O
largely	O
unknown	O
.	O

Maternal	O
Disease	O
In	O
addition	O
to	O
environmental	O
factors	O
,	O
infection	O
and	O
disease	O
may	B
play	O
a	O
role	O
in	O
the	O
development	O
of	O
autism	O
.	O

Our	O
pilot	O
study	O
was	O
also	O
limited	B
by	O
the	O
relatively	O
small	B
sample	O
of	O
GDM	O
cases	O
(	O
n	O
=	O
68	O
)	O
and	O
the	O
imprecision	O
of	O
relative	O
risk	O
estimates	B
which	O
were	O
reflected	O
by	O
their	O
wide	O
95	O
%	O
confidence	O
intervals	O
.	O

The	O
registration	O
ID	O
isACTRN12612000588897	O
.	O

Few	B
case	O
reports	O
have	O
suggested	B
an	O
interaction	O
between	O
season	O
or	O
latitude	O
and	O
psychological	O
problems	O
[	O
28	O
,	O
29	O
].	O

DNA	O
methylation	O
analysis	O
.	O

The	O
intake	O
of	O
vitamin	O
and	O
mineral	O
supplements	O
was	O
significantly	O
less	O
common	O
in	O
women	O
who	O
declared	O
the	O
pregnancy	O
was	O
unwanted	O
.	O

Subjects	O
in	O
this	O
study	O
reside	O
in	O
an	O
areas	O
from	O
39	O
″	O
26	O
’	O
N	O
to	O
41	O
″	O
03	O
’	O
N	O
.	O

However	O
in	O
a	O
cross	O
-	O
sectional	O
study	O
in	O
Japan	O
,	O
higher	O
dietary	O
vitamin	O
D	O
intake	O
was	O
independently	O
associated	O
with	O
a	O
lower	O
prevalence	O
of	O
depressive	O
symptoms	O
during	O
pregnancy	O
[	O
66	O
].	O

The	O
effects	O
of	O
roughage	O
/	O
concentrate	O
ratio	O
on	O
body	O
fat	O
deposition	O
and	O
the	O
expression	O
of	O
angiogenic	O
and	O
adipogenic	O
factors	O
in	O
adipose	O
tissue	O
have	O
been	O
examined	O
in	O
fattening	O
Wagyu	O
steers	O
[	O
122	O
].	O

The	O
PCM	O
-	O
I	O
consists	O
of	O
items	O
derived	O
from	O
:	O
1	O
)	O
the	O
Kilifi	O
Developmental	O
Inventory	O
(	O
KDI	O
)	O
[	O
63	O
],	O
previously	O
used	O
by	O
the	O
investigators	O
to	O
determine	O
psychomotor	O
development	O
in	O
an	O
infant	O
population	O
in	O
South	O
Africa	O
[	O
64	O
],	O
2	O
)	O
the	O
Developmental	O
Milestone	O
Checklist	O
(	O
DMC	O
-	O
II	O
)	O
[	O
65	O
,	O
66	O
],	O
and	O
3	O
)	O
the	O
Profile	O
of	O
Social	O
-	O
Emotional	O
Development	O
(	O
PSED	O
),	O
which	O
is	O
based	O
in	O
part	O
on	O
the	O
Brief	O
Infant	O
/	O
Toddler	O
Social	O
Emotional	O
Assessment	O
[	O
67	O
].	O

‡	O
Studies	O
demonstrating	B
the	O
same	O
environmentally	O
induced	O
adverse	O
phenotype	O
(	O
s	O
)	O
and	O
specific	O
epigenetic	O
change	O
(	O
s	O
)	O
in	O
both	O
animal	O
model	B
(	O
s	O
)	O
and	O
human	O
cohort	O
(	O
s	O
).	O

There	O
were	O
no	O
statistically	O
significant	O
differences	O
in	O
the	O
incidence	O
of	O
infant	O
BMI	O
z	O
-	O
score	O
≥	O
90th	O
centile	O
for	O
infants	O
born	O
to	O
women	O
in	O
the	O
Lifestyle	O
Advice	O
group	O
,	O
compared	O
with	O
the	O
Standard	O
Care	O
group	O
(	O
Lifestyle	O
Advice	O
233	O
(	O
21	O
.	O
71	O
%)	O
vs	O
.	O
Standard	O
Care	O
233	O
(	O
21	O
.	O
90	O
%);	O
adjusted	O
relative	O
risk	O
(	O
aRR	O
)	O
0	O
.	O
99	O
;	O
95	O
%	O
confidence	O
interval	O
0	O
.	O
82	O
to	O
1	O
.	O
18	O
;	O
p	O
=	O
0	O
.	O
88	O
).	O

Litter	O
size	O
during	O
suckling	O
was	O
standardised	O
to	O
11	O
piglets	O
per	O
sow	O
.	O

2	O
.	O

2011	O
).	O

We	O
observed	O
differential	O
expression	O
of	O
genes	O
related	O
to	O
lipid	O
metabolism	O
(	O
e	O
.	O
g	O
.	O

These	O
results	O
suggest	B
that	O
visfatin	O
may	B
play	O
an	O
important	O
role	O
in	O
maternal	O
-	O
fetal	O
metabolic	O
interaction	O
.	O

The	O
induction	O
of	O
adverse	O
DNA	O
mutations	O
by	O
environmental	O
factors	O
that	O
lead	O
to	O
disease	O
,	O
particularly	O
cancer	O
,	O
is	O
well	O
established	O
and	O
recognized	O
by	O
regulatory	O
bodies	O
worldwide	O
.	O

The	O
HV	O
pup	O
diet	O
brought	O
BDNF	O
expression	O
to	O
control	O
levels	O
but	O
the	O
HFol	O
pup	O
diet	O
only	B
attenuated	O
the	O
decrease	O
in	O
expression	O
caused	O
by	O
the	O
HV	O
gestational	O
diet	O
(	O
P	O
=	O
0	O
.	O
02	O
)	O
(	O
Figure	O
5a	O
).	O

In	O
summary	O
,	O
evaluations	O
carried	O
out	O
in	O
the	O
present	O
study	O
indicate	B
that	O
during	O
early	O
pregnancy	O
mothers	O
of	O
low	O
birth	O
weight	O
infant	O
had	O
a	O
different	O
dietary	O
pattern	O
and	O
more	O
adhered	O
to	O
the	O
western	O
dietary	O
pattern	O
compared	O
to	O
mothers	O
of	O
normal	O
weight	O
birth	O
infant	O
.	O

Due	O
to	O
the	O
high	O
prevalence	O
of	O
HIV	O
in	O
the	O
country	O
(	O
36	O
%	O
of	O
women	O
aged	O
30	O
–	O
34	O
years	O
[	O
31	O
]),	O
their	O
inclusion	O
will	O
make	O
generalisation	O
to	O
the	O
wider	O
South	O
African	O
population	O
a	O
possibility	B
.	O

Also	O
,	O
the	O
median	O
gestation	O
when	O
women	O
start	O
antenatal	O
care	O
(	O
and	O
would	O
have	O
access	O
to	O
iron	O
/	O
folic	O
acid	O
supplements	O
)	O
is	O
5	O
.	O
2	O
months	O
(	O
3	O
)	O
.	O

However	O
,	O
studies	O
in	O
women	O
from	O
Australia	O
and	O
New	O
Zealand	O
are	O
less	O
consistent	O
.	O

Bonferroni	O
analysis	O
indicated	B
that	O
RC	O
females	O
presented	O
a	O
significant	O
decrease	O
in	O
the	O
gene	O
expression	O
of	O
Acaca	O
,	O
Fasn	O
,	O
Cpt1a	O
,	O
Acox1	O
,	O
Insig1	O
,	O
and	O
Hmgcr	O
in	O
liver	O
,	O
and	O
Scd1	O
in	O
PAT	O
compared	O
to	O
that	O
of	O
CC	O
ones	O
(	O
Figures5A	O
–	O
C	O
).	O

Furthermore	O
,	O
we	O
have	O
utilised	O
robust	O
methodology	O
to	O
obtain	O
anthropometric	O
measures	O
of	O
the	O
infants	O
at	O
6	O
months	O
of	O
age	O
,	O
adhering	O
to	O
a	O
standardised	O
,	O
research	O
quality	O
protocol	O
.	O

Correlations	O
between	O
continuous	O
.	O

PubMed	O
Central	O
:	O

Thus	O
,	O
the	O
incorporation	O
of	O
epigenetics	O
within	O
chemical	O
regulation	O
could	B
ultimately	O
reduce	O
animal	O
usage	O
and	O
the	O
time	O
and	O
cost	O
of	O
chemical	O
research	O
and	O
development	O
,	O
while	O
simultaneously	O
improving	O
the	O
protection	O
of	O
public	O
health	O
worldwide	O
.	O

Two	O
controls	O
were	O
chosen	O
per	O
case	O
,	O
matched	O
for	O
village	O
of	O
residence	O
,	O
age	O
,	O
sex	O
and	O
language	O
group	O
,	O
Reinterviewing	O
was	O
performed	O
to	O
a	O
limited	O
extent	O
to	O
assess	O
the	O
accuracy	O
of	O
replies	O
to	O
questionnaires	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
.	O

Data	O
,	O
experimental	O
design	O
,	O
materials	O
and	O
methods	O
Liver	O
samples	O
Sows	O
were	O
divided	O
randomly	O
into	O
control	O
and	O
betaine	O
groups	O
(	O
8	O
per	O
group	O
)	O
while	O
sows	O
were	O
fed	O
basal	O
diet	O
and	O
received	O
betaine	O
-	O
supplemented	O
(	O
3	O
g	O
/	O
kg	O
)	O
diet	O
respectively	O
throughout	O
the	O
pregnancy	O
.	O

Results	O
We	O
identified	O
637	O
spots	O
in	O
DVD	O
deplete	O
samples	O
and	O
655	O
spots	O
in	O
Control	O
samples	O
(	O
seeFigure	O
1for	O
a	O
representative	O
gel	O
).	O

Vitamin	O
and	O
mineral	O
supplements	O
are	O
recommended	O
for	O
women	O
with	O
multiple	O
pregnancy	O
,	O
those	O
who	O
misuse	O
alcohol	O
or	O
drugs	O
,	O
or	O
have	O
an	O
unbalanced	O
diet	O
[	O
32	O
].	O

To	O
date	O
,	O
there	O
has	B
been	I
limited	B
investigation	O
of	O
the	O
relation	O
of	O
maternal	O
diet	O
with	O
the	O
developing	O
infant	O
gut	O
microbiome	O
.	O

Such	O
differences	O
are	O
largely	B
driven	I
by	I
diverse	O
genetic	O
backgrounds	O
.	O

Eligible	O
studies	O
were	O
those	O
with	O
healthy	O
pregnant	O
women	O
,	O
full	O
term	O
births	O
and	O
offspring	O
with	O
no	O
anomalies	O
or	O
diseases	O
.	O

However	O
,	O
none	B
of	O
these	O
covariates	O
change	O
the	O
estimates	B
substantially	O
,	O
and	O
was	O
therefore	O
not	O
included	O
in	O
the	O
final	O
multivariate	O
model	B
cSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
)	O
and	O
docosapentaenoic	O
acid	O
dAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vitamin	O
B12	O
,	O
alcohol	O
and	O
dietary	O
intake	O
of	O
fat	O
other	O
than	O
eicosapentaenoic	O
acid	O
,	O
docosahexaenoic	O
acid	O
and	O
docosapentaenoic	O
acid	O
eSum	O
of	O
arachidonic	O
and	O
linoleic	O
acids	O
fAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vitamin	O
B12	O
,	O
alcohol	O
and	O
dietary	O
intake	O
of	O
other	O
than	O
omega	O
-	O
6	O
fatty	O
acids	O
gSum	O
of	O
eicosapentaenoic	O
acid	O
(	O
EPA	O
),	O
docosahexaenoic	O
acid	O
(	O
DHA	O
),	O
docosapentaenoic	O
acid	O
and	O
α	O
-	O
linolenic	O
acid	O
hAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vitamin	O
B12	O
,	O
alcohol	O
and	O
dietary	O
intake	O
of	O
other	O
than	O
omega	O
-	O
3	O
fatty	O
acids	O
The	O
intake	O
of	O
vitamin	O
D	O
was	O
significantly	O
associated	O
with	O
a	O
decreased	O
relative	O
risk	O
of	O
both	O
the	O
middle	O
and	O
high	O
levels	O
of	O
psychotic	O
-	O
like	O
symptoms	O
(	O
Table4	O
).	O

Thus	O
it	B
is	I
possible	I
that	O
the	O
study	O
of	O
Suzuki	O
et	O
al	O
.	O

In	O
our	O
study	O
,	O
measures	O
of	O
reliability	O
,	O
including	O
a	O
Cronbach	O
’	O
s	O
alpha	O
and	O
a	O
test	O
-	O
retest	O
correlation	O
were	O
0	O
.	O
86	O
and	O
0	O
.	O
92	O
,	O
respectively	O
.	O

A	O
similar	O
pattern	O
was	O
demonstrated	B
in	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
.	O

Due	O
to	O
its	O
longer	O
half	O
-	O
life	O
,	O
25	O
-(	O
OH	O
)	O
D	O
is	B
considered	I
the	O
best	O
bio	O
-	O
marker	O
of	O
vitamin	O
D	O
status	O
.	O

The	O
steers	O
of	O
the	O
normally	O
weaned	O
steers	O
supplemented	O
with	O
grain	O
were	O
raised	O
under	O
the	O
same	O
conditions	O
as	O
the	O
normally	O
weaned	O
animals	O
,	O
but	O
they	O
were	O
supplemented	O
with	O
grain	O
for	O
55	O
d	O
on	O
pasture	O
(	O
study	O
1	O
,	O
177	O
to	O
231	O
d	O
of	O
age	O
;	O
study	O
2	O
,	O
158	O
to	O
213	O
d	O
of	O
age	O
).	O

In	O
marked	O
contrast	O
,	O
the	O
Kenyan	O
study	O
by	O
Ouma	O
and	O
collaborators	O
[	O
24	O
]	O
and	O
that	O
in	O
Nigeria	O
by	O
Dairo	O
and	O
Owoyokun	O
[	O
25	O
]	O
found	O
that	O
only	O
10	O
.	O
4	O
%	O
and	O
up	O
to	O
89	O
.	O
6	O
%	O
of	O
pregnant	O
women	O
were	O
informed	O
of	O
pregnancy	O
danger	O
signs	O
respectively	O
.	O

Other	O
adverse	O
outcomes	O
have	B
also	O-
been	I
attributed	O
to	O
oral	O
corticosteroids	O
,	O
including	O
an	O
increased	O
risk	O
of	O
preeclampsia	O
,[	O
13	O
,	O
14	O
]	O
preterm	O
birth	O
,[	O
12	O
,	O
15	O
]	O
and	O
lower	O
birth	O
weight	O
[	O
16	O
].	O

PubMed	O
Central	O
:	O

In	O
multinomial	O
logistic	O
regression	O
analyses	O
,	O
increased	O
fruit	O
intake	O
was	O
associated	O
with	O
an	O
increased	O
odds	O
of	O
belonging	O
to	O
the	O
high	O
Streptococcus	O
/	O
Clostridium	O
group	O
among	O
infants	O
born	O
vaginally	O
(	O
OR	O
(	O
95	O
%	O
CI	O
)	O
=	O
2	O
.	O
73	O
(	O
1	O
.	O
36	O
,	O
5	O
.	O
46	O
)).	O

The	O
reactions	O
occurred	O
within	O
1	O
to	O
3	O
days	O
postpartum	O
and	O
resolved	O
within	O
1	O
to	O
2	O
days	O
.	O

For	O
6	O
women	O
information	O
on	O
the	O
age	O
was	O
missing	O
.	O

Furthermore	O
,	O
the	O
effectiveness	O
of	O
this	O
intervention	O
has	B
been	I
evaluated	O
mostly	O
in	O
terms	O
of	O
improvement	O
in	O
haemoglobin	O
concentration	O
,	O
rather	O
than	O
maternal	O
or	O
infant	O
health	O
[	O
35	O
].	O

The	O
above	O
studies	O
provide	O
reassurance	O
that	O
moderate	O
intensity	O
activities	O
such	O
as	O
walking	O
for	O
20	O
–	O
30	O
minutes	O
each	O
day	O
,	O
and	O
attendance	O
at	O
antenatal	O
exercise	O
classes	O
can	B
be	O
safely	O
encouraged	O
,	O
and	O
that	O
modest	O
improvements	O
in	O
glycemic	O
control	O
might	B
be	O
achieved	O
.	O

Analysis	O
of	O
Samples	O
Approximately	O
5	O
ml	O
whole	O
blood	O
was	O
collected	O
by	O
venipuncture	O
in	O
a	O
non	O
-	O
heparinized	O
tube	O
.	O

[	O
3	O
]	O
A	O
fatal	O
case	O
of	O
biphasic	O
wheezing	O
in	O
an	O
infant	O
attributed	O
to	O
hypocalcemia	O
has	B
been	I
described	O
in	B
literature	I
.	O

In	O
each	O
region	O
the	O
obstetric	O
clinics	O
were	O
ordered	O
by	O
province	O
and	O
size	O
based	O
on	O
the	O
number	O
of	O
deliveries	O
during	O
the	O
past	O
year	O
and	O
60	O
clusters	O
of	O
4	O
clinics	O
were	O
selected	O
per	O
region	O
using	O
systematic	O
sampling	O
in	O
order	O
to	O
have	O
enough	O
replacement	O
clinics	O
in	O
case	O
some	O
refused	O
to	O
participate	O
.	O

However	O
,	O
in	O
this	O
study	O
no	O
regulation	O
of	O
both	O
'	O
insulin	O
signaling	O
'	O
and	O
'	O
IGF1	O
signaling	O
'	O
was	O
observed	O
in	O
liver	O
tissue	O
of	O
LP	O
porcine	O
offspring	O
,	O
possibly	B
due	O
to	O
maturation	O
-,	O
species	O
-,	O
tissue	O
-,	O
sex	O
-	O
and	O
time	O
-	O
dependent	O
regulations	O
.	O

3	O
.	O

As	O
it	O
is	O
not	O
expressed	O
in	O
mature	O
brown	O
adipocytes	O
,	O
BMP7	O
appears	O
to	O
exert	O
its	O
action	O
on	O
BAT	O
as	O
an	O
endocrine	O
factor	O
.	O

She	O
denied	O
contractions	O
,	O
vaginal	O
bleeding	O
,	O
or	O
leakage	O
of	O
fluid	O
.	O

We	O
cannot	O
overlook	O
that	O
the	O
long	O
time	O
adherence	O
to	O
a	O
specific	O
diet	O
affects	O
health	O
outcomes	O
.	O

We	O
compared	O
baseline	O
characteristics	O
and	O
the	O
distribution	O
of	O
our	O
prestated	O
confounders	O
for	O
intervention	O
and	O
placebo	O
groups	O
.	O

Phase	O
3	O
data	O
are	O
collected	O
at	O
36	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
).	O

Responses	O
were	O
recorded	O
as	O
integers	O
.	O

Any	O
relationship	O
with	O
glioma	O
risk	O
is	O
probably	O
complex	O
and	O
must	O
be	O
interpreted	O
in	O
light	O
of	O
differences	O
in	O
farming	O
practices	O
and	O
the	O
protective	O
ability	O
of	O
farming	O
environments	O
,	O
especially	O
with	O
respect	O
to	O
microbial	O
exposures	O
[	O
102	O
,	O
103	O
,	O
114	O
].	O

Discussion	O
Current	O
study	O
on	O
812	O
subjects	O
is	O
one	O
of	O
the	O
largest	O
studies	O
evaluating	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
during	O
the	O
first	O
-	O
trimester	O
period	O
of	O
pregnancy	O
and	O
neonatal	O
anthropometric	O
measurements	O
.	O

Foetal	O
crown	O
-	O
rump	O
length	O
is	O
used	O
to	O
determine	O
gestational	O
age	O
of	O
participants	O
in	O
their	O
first	O
trimester	O
[	O
55	O
].	O

Acute	O
aortic	O
dissection	O
during	O
the	O
third	O
trimester	O
of	O
pregnancy	O
has	B
been	I
attributed	O
to	O
hemodynamic	O
alterations	O
that	O
occur	O
in	O
late	O
pregnancy	O
.	O

Between	O
31	O
March	O
2011	O
when	O
the	O
first	O
potential	O
subject	O
with	O
the	O
opportunity	O
to	O
collect	O
a	O
6	O
-	O
week	O
infant	O
stool	O
sample	O
from	O
was	O
screened	O
for	O
eligibility	O
and	O
30	O
June	O
2015	O
when	O
the	O
data	O
were	O
frozen	O
for	O
this	O
analysis	O
,	O
6569	O
women	O
were	O
screened	O
for	O
eligibility	O
and	O
1334	O
were	O
eligible	O
.	O

Higher	O
VDR	O
/	O
RXR	O
binding	O
may	B
decrease	O
formation	O
of	O
the	O
PPARG	O
/	O
RXR	O
heterodimer	O
,	O
thus	O
inhibiting	O
adipogenesis	O
(	O
Figure	O
4	O
).	O

Reports	O
from	O
lower	O
-	O
risk	O
groups	O
have	O
indicated	B
that	O
vitamin	O
D	O
deficiency	O
occurs	O
in	O
25	O
–	O
55	O
%	O
of	O
pregnant	O
women	O
[	O
11	O
–	O
13	O
].	O

However	O
,	O
the	O
mechanisms	O
of	O
action	O
and	O
protective	O
abilities	O
of	O
PUFA	O
could	B
differ	O
between	O
different	O
diseases	O
.	O

Translation	O
of	O
a	O
gestational	O
diabetes	O
nutrition	O
model	B
of	O
care	O
into	O
practice	O
:	O
results	O
from	O
an	O
implementation	O
project	O
Background	O
Reduced	O
need	O
for	O
insulin	O
therapy	O
in	O
Gestational	O
Diabetes	O
Mellitus	O
(	O
GDM	O
)	O
has	B
been	I
documented	O
in	O
a	O
study	O
validating	O
American	O
Nutrition	O
Practice	O
Guidelines	O
,	O
which	O
recommend	O
at	O
least	O
3	O
dietitian	O
visits	O
.	O

Q	O
:	O
quintile	O
.#:	O
controlling	O
for	O
energy	O
intake	O
,	O
smoking	O
,	O
infections	O
,	O
supplements	O
,	O
antibiotics	O
and	O
paracetamol	O
use	O
during	O
pregnancy	O
;	O
maternal	O
educational	O
level	O
,	O
housing	O
tenure	O
,	O
financial	O
difficulties	O
,	O
ethnicity	O
,	O
age	O
,	O
parity	O
,	O
history	O
of	O
atopic	O
diseases	O
,	O
anxiety	O
,	O
sex	O
of	O
child	O
,	O
season	O
of	O
birth	O
,	O
multiple	O
pregnancy	O
and	O
breastfeeding	O
duration	O
.	O

The	O
newborn	O
in	O
this	O
case	O
also	O
had	O
hypernatremia	O
thereby	O
raising	O
possibilities	B
of	O
vasopressinase	O
crossing	O
the	O
placenta	O
.	O

Our	O
primary	O
endpoint	O
was	O
the	O
first	O
episode	O
of	O
pneumonia	O
from	O
the	O
time	O
of	O
enrolment	O
confirmed	O
by	O
chest	O
radiograph	O
(	O
consolidation	O
or	O
infiltrates	O
).	O

†	O
Studies	O
validating	B
loss	O
of	O
both	O
epigenetic	O
change	O
(	O
s	O
)	O
and	O
adverse	O
effect	O
(	O
s	O
)	O
following	O
appropriate	O
inhibition	O
,	O
treatment	O
or	O
knock	O
out	O
/	O
down	O
.	O

006	O
26769	O
.	O
4	O
0	O
.	O
003	O
No320533	O
.	O
3533	O
.	O
3	O
Obstetrician	O
Yes18555	O
.	O
425576	O
.	O
325576	O
.	O
3	O
No710	O
.	O
61725	O
.	O
81725	O
.	O
8Total	O
number	O
or	O
prenatal	O
visits	O
≤	O
422	O
.	O
8	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
1825	O
.	O
0	O
<	O
0	O
.	O
001	O
>	O
419057	O
.	O
925477	O
.	O
425477	O
.	O
4Gestational	O
age	O
at	O
registration	O
(	O
months	O
)	O
<	O
418053	O
.	O
7	O
<	O
0	O
.	O
001	O
19257	O
.	O
3	O
0	O
.	O
019	O
24472	O
.	O
8	O
<	O
0	O
.	O
001	O
≥	O
41218	O
.	O
52741	O
.	O
52843	O
.	O
1Nutritional	O
questionnaire	O
score	O
Low710	O
.	O
1	O
<	O
0	O
.	O
001	O
2333	O
.	O
3	O
<	O
0	O
.	O
001	O
2231	O
.	O
9	O
<	O
0	O
.	O
001	O
Medium13747	O
.	O
114756	O
.	O
819274	O
.	O
3	O
High4865	O
.	O
84967	O
.	O
65879	O
.	O
7	O
The	O
proportion	O
of	O
less	O
well	O
-	O
educated	O
women	O
(	O
less	O
than	O
8	O
years	O
of	O
school	O
completed	O
)	O
using	O
folic	O
acid	O
(	O
p	O
=	O
.	O
007	O
),	O
iron	O
(	O
p	O
<	O
.	O
001	O
)	O
and	O
multivitamins	O
(	O
p	O
<	O
.	O
001	O
)	O
increased	O
with	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

These	O
drugs	O
,	O
such	O
as	O
Fluoxetine	O
,	O
Sertraline	O
,	O
and	O
Citalopram	O
,	O
work	O
by	O
inhibiting	O
the	O
reuptake	O
of	O
the	O
neurotransmitter	O
serotonin	O
,	O
resulting	O
in	O
a	O
greater	O
amount	O
of	O
serotonin	O
at	O
the	O
synapse	O
.	O

The	O
overall	O
characteristics	O
of	O
the	O
study	O
population	O
across	O
different	O
categories	O
of	O
dietary	O
patterns	O
are	O
presented	O
inTable	O
6	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
5	O
Primer	O
used	O
to	O
verify	O
microarray	O
experiments	O
in	O
liver	O
tissue	O
by	O
qRT	O
-	O
PCRGene	O
nameProbe	O
-	O
set	O
IDSequence	O
5	O
'	O
-	O
3	O
'	O
T	O
(°	O
C	O
)	O
Size	O
(	O
bp	O
)	O
CCND2Ssc	O
.	O
15749	O
.	O
1	O
.	O
S1_atFor	O
AGGAGCAGATTGAGGTCGTG86185Rev	O
CAACCAGAGAGAAGGAAGGAGANCAPGSsc	O
.	O
28512	O
.	O
1	O
.	O
S1_atFor	O
CTTGTAGATTTGACGAGACCA60156Rev	O
GGCTTTAGTATAGACCCGAACMGMTSsc	O
.	O
19639	O
.	O
1	O
.	O
A1_atFor	O
GCAACTACTCGGGAGGAATG88171Rev	O
CTGCGAACGCTCAGTCTTGGADD45BSsc	O
.	O
14764	O
.	O
1	O
.	O
A1_atFor	O
GGACTTAGACTTTGGGACTTG60140Rev	O
GTAAGCCTCCCATCTCTCTTSDHBSsc	O
.	O
8939	O
.	O
1	O
.	O
S1_atFor	O
GCAGGACCCGTTCTCTCTGT60170Rev	O
GGTTACAGTCACGTTAGGTTGGPPARGC1ASsc	O
.	O
16864	O
.	O
1	O
.	O
S1_atFor	O
GTAAATCTGCGGGATGATGG60208Rev	O
TGGTGGAAGCAGGATCAAAGPRKAA1Ssc	O
.	O
8107	O
.	O
1	O
.	O
A1_atFor	O
TTGTTAATTTCATAAACTTTGCTTC60193Rev	O
GTGCAGCCTTGACATACTCPRKAA2Ssc	O
.	O
16257	O
.	O
1	O
.	O
S1_atFor	O
TCTGTAATTCTGTTTTGCCTACGA60168Rev	O
AGCAAGAAGGTGATGCCAAGRPL10	O
*	O
Ssc	O
.	O
9130	O
.	O
1	O
.	O
A1_atFor	O
CTGTGTTCGTCTTTTCTTCC60199Rev	O
TCATCCACTTTTGCCTTCT	O
CCND2	O
-	O
cyclin	O
D2	O
;	O
NCAPG	O
-	O
non	O
-	O
SMC	O
condensin	O
I	O
complex	O
,	O
subunit	O
G	O
;	O
MGMT	O
-	O
O	O
-	O
6	O
-	O
methylguanine	O
-	O
DNA	O
methyltransferase	O
;	O
GADD45B	O
-	O
growth	O
arrest	O
and	O
DNA	O
-	O
damage	O
-	O
inducible	O
,	O
β	O
;	O
SDHB	O
-	O
succinate	O
dehydrogenase	O
complex	O
,	O
subunit	O
B	O
,	O
iron	O
sulfur	O
(	O
Ip	O
);	O
PPARGC1A	O
-	O
Peroxisome	O
proliferator	O
activated	O
receptor	O
γ	O
coactivator	O
-	O
1	O
α	O
;	O
PRKAA1	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
1	O
chain	O
;	O
PRKAA2	O
-	O
5	O
'-	O
AMP	O
-	O
activated	O
protein	O
kinase	O
,	O
catalytic	O
α	O
2	O
chain	O
;	O
RPL10	O
-	O
Ribosomal	O
protein	O
10	O
;	O
*	O
house	O
keeping	O
gene	O
.	O

Although	O
no	O
causality	O
was	O
found	B
,	O
it	O
was	O
determined	O
that	O
prenatal	O
folic	O
acid	O
supplements	O
taken	O
during	O
pregnancy	O
were	O
associated	O
with	O
a	O
decreased	O
risk	O
of	O
autistic	O
disorder	O
.	O

Competing	O
interests	O
The	O
authors	O
declare	O
that	O
they	O
have	O
no	O
competing	O
interests	O
.	O

As	O
mentioned	O
above	O
,	O
BAT	O
is	O
the	O
effector	O
organ	O
of	O
non	O
-	O
shivering	O
thermogenesis	O
(	O
both	O
cold	O
and	O
diet	O
-	O
induced	O
)	O
that	O
,	O
by	O
utilizing	O
large	O
quantities	O
of	O
glucose	O
and	O
lipids	O
from	O
the	O
circulation	O
,	O
can	O
promote	O
negative	O
energy	O
balance	O
.	O

Spots	O
were	O
dried	O
in	O
a	O
Vacuum	O
Concentrator	O
(	O
Eppendorf	O
,	O
Hamburg	O
Germany	O
)	O
for	O
25	O
min	O
and	O
rehydrated	O
at	O
4	O
°	O
C	O
in	O
tryptic	O
digest	O
solution	O
(	O
10	O
ng	O
/	O
µl	O
porcine	O
sequencing	O
grade	O
trypsin	O
(	O
Promega	O
)	O
in	O
50	O
mM	O
NH4HCO3	O
)	O
for	O
1	O
h	O
.	O
Remaining	O
tryptic	O
digest	O
solution	O
was	O
removed	O
and	O
gel	O
pieces	O
suspended	O
overnight	O
at	O
37	O
°	O
C	O
in	O
50	O
mM	O
NH4HCO3	O
.	O

The	O
temperature	O
profiles	O
comprised	O
an	O
initial	O
denaturation	O
step	O
at	O
95	O
°	O
C	O
for	O
10	O
min	O
and	O
40	O
cycles	O
consisting	O
of	O
denaturation	O
at	O
95	O
°	O
C	O
for	O
15	O
s	O
,	O
annealing	O
at	O
60	O
°	O
C	O
for	O
10	O
s	O
and	O
extension	O
/	O
fluorescence	O
acquisition	O
at	O
72	O
°	O
C	O
for	O
15	O
s	O
.	O
For	O
all	O
the	O
assays	O
threshold	O
cycles	O
were	O
converted	O
to	O
copy	O
numbers	O
using	O
a	O
standard	O
curve	O
generated	O
by	O
amplifying	O
serial	O
dilutions	O
of	O
an	O
external	O
PCR	O
standard	O
(	O
107	O
-	O
102copies	O
).	O

The	O
aim	O
is	O
to	O
achieve	O
normoglycemia	O
whilst	O
providing	O
the	O
required	O
nutrients	O
for	O
normal	O
fetal	O
growth	O
and	O
maternal	O
health	O
.	O

The	O
protocol	O
was	O
approved	O
by	O
the	O
Animal	O
Ethics	O
Committee	O
of	O
the	O
Complutense	O
University	O
of	O
Madrid	O
.	O

It	O
is	O
noted	O
that	O
the	O
detection	B
rate	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D2	O
in	O
the	O
study	O
is	O
19	O
.	O
4	O
%,	O
higher	O
than	O
the	O
usual	O
5	O
%	O
in	O
the	O
general	O
population	O
[	O
3	O
].	O

Real	O
-	O
time	O
RT	O
-	O
PCR	O
was	O
performed	O
on	O
the	O
ABI	O
PRISM	O
7000	O
Sequence	O
Detection	O
System	O
(	O
SDS	O
)	O
using	O
Taqman	O
assays	O
for	O
the	O
following	O
genes	O
purchased	O
from	O
ABI	O
(	O
Foster	O
City	O
,	O
CA	O
,	O
USA	O
):	O
neuropeptide	O
Y	O
(	O
NPY	O
;	O
Cat	O
#	O
Rn01410146_m1	O
);	O
pro	O
-	O
opiomelanocortin	O
(	O
POMC	O
;	O
Cat	O
#	O
Rn00595020_m1	O
);	O
insulin	O
receptor	O
(	O
InsR	O
;	O
Cat	O
#	O
Rn00567070_m1	O
);	O
leptin	O
receptor	O
(	O
LepR	O
;	O
Cat	O
#	O
Rn01433205_m1	O
);	O
brain	O
-	O
derived	O
neurotrophic	O
factor	O
(	O
BDNF	O
;	O
Cat	O
#	O
Rn02531967_s1	O
);	O
dopamine	O
receptor	O
1	O
(	O
DopaR1	O
;	O
Cat	O
#	O
Rn03062203_s1	O
);	O
dopamine	O
receptor	O
2	O
(	O
DopaR2	O
;	O
Cat	O
#	O
Rn00561126_m1	O
);	O
dopamine	O
receptor	O
5	O
(	O
DopaR5	O
;	O
Cat	O
#	O
Rn00562768_s1	O
);	O
serotonin	O
receptor	O
1A	O
(	O
SeroR1A	O
;	O
Cat	O
#	O
Rn00561409_s1	O
);	O
serotonin	O
receptor	O
2A	O
(	O
SeroR2A	O
;	O
Cat	O
#	O
Rn01468302_m1	O
);	O
serotonin	O
receptor	O
2C	O
(	O
SeroR2C	O
;	O
Cat	O
#	O
Rn00562748_m1	O
).	O

Maternal	O
allergy	O
assessment	O
The	O
International	O
Study	O
for	O
Asthma	O
and	O
Allergies	O
in	O
Childhood	O
(	O
ISAAC	O
)	O
questionnaire	O
[	O
48	O
]	O
is	O
used	O
to	O
assess	O
allergy	O
symptoms	O
in	O
maternal	O
participants	O
at	O
phases	O
1	O
to	O
3	O
during	O
pregnancy	O
,	O
and	O
7	O
postnatally	O
.	O

The	O
study	O
was	O
approved	O
by	O
the	O
Institutional	O
Review	O
Boards	O
at	O
the	O
Miriam	O
Hospital	O
,	O
in	O
Providence	O
,	O
RI	O
.,	O
Women	O
and	O
Infants	O
Hospital	O
of	O
Rhode	O
Island	O
Providence	O
,	O
RI	O
and	O
California	O
Polytechnic	O
State	O
University	O
,	O
in	O
San	O
Luis	O
Obispo	O
,	O
Calif	O
.	O
2	O
.	O
2	O
.	O

Thus	O
the	O
experimental	O
data	O
will	O
complement	O
previous	O
findings	O
from	O
rodent	O
models	O
and	O
epidemiological	O
human	O
data	O
.	O

Thus	O
,	O
environmental	O
exposures	O
to	O
those	O
oocytes	O
and	O
spermatozoa	O
that	O
go	O
onto	O
produce	O
an	O
embryo	O
(	O
pre	O
-	O
conception	O
exposures	O
)	O
are	O
also	O
an	O
important	O
consideration	O
.	O

2	O
.	O

The	O
subjects	O
with	O
the	O
three	O
highest	O
cathelicidin	O
concentration	O
values	O
had	O
characteristics	O
including	O
25	O
(	O
OH	O
)	O
D	O
,	O
BMI	O
,	O
percent	O
fat	O
,	O
race	O
/	O
ethnicity	O
,	O
and	O
age	O
,	O
which	O
were	O
comparable	O
to	O
the	O
corresponding	O
variable	O
represented	O
in	O
the	O
entire	O
cohort	O
.	O

The	O
approach	O
to	O
examining	O
the	O
relationship	O
between	O
repetitive	O
element	O
methylation	O
and	O
gene	O
-	O
associated	O
methylation	O
was	O
not	B
designed	I
to	I
assess	O
specific	O
loci	O
or	O
genes	O
associated	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
but	O
rather	O
to	O
evaluate	O
whether	O
methylation	O
of	O
particular	O
groups	O
of	O
CpG	O
loci	O
with	O
like	O
methylation	O
patterns	O
or	O
similar	O
bioinformatic	O
attributes	O
were	O
coordinately	O
associated	O
with	O
LINE	O
-	O
1	O
or	O
AluYb8	O
methylation	O
,	O
because	O
this	O
could	B
inform	O
on	O
the	O
process	O
responsible	O
for	O
the	O
variation	O
between	O
the	O
two	O
.	O

The	O
current	O
recommendation	O
of	O
health	O
care	O
professionals	O
is	O
to	O
avoid	O
anticonvulsant	O
drug	O
use	O
such	O
as	O
valproate	O
during	O
pregnancy	O
.	O

[	O
15	O
]	O
indicating	B
that	O
the	O
body	O
of	O
evidence	O
is	O
supportive	B
of	O
fish	O
intake	O
during	O
pregnancy	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t003_Table	O
3	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
3	O
Evidence	O
Rating	O
Table	O
[	O
13	O
].	O
ComponentRatingCommentsEvidence	O
BaseSatisfactoryNHMRC	O
Level	O
III	O
(	O
cohort	O
studies	O
)	O
with	O
moderate	O
risk	O
of	O
bias	O
[	O
20	O
].	O
ConsistencyGoodSeven	B
out	O
of	O
eight	O
studies	O
demonstrated	O
a	O
positive	O
association	O
between	O
fish	O
intake	O
and	O
foetal	O
neurodevelopment	O
.	O
Clinical	O
impactSatisfactoryTrend	B
towards	O
improved	O
neurodevelopment	O
with	O
significant	O
results	O
in	O
several	O
domains	O
.	O
GeneralisabilityGoodAll	O
studies	O
in	O
pregnant	O
women	O
.	O
ApplicabilityPoorA	O
variety	O
of	O
populations	O
studied	O
from	O
different	O
countries	O
where	O
type	O
of	O
fish	O
and	O
the	O
level	O
of	O
contaminants	O
would	O
likely	O
vary	O
.	O

In	O
addition	O
the	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
was	O
significantly	O
lower	O
in	O
summer	O
,	O
spring	O
and	O
autumn	O
compared	O
to	O
winter	O
(	O
Table	O
4	O
).	O
10	O
.	O
1371	O
/	O
journal	O
.	O
pone	O
.	O
0043868	O
.	O
t004	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
4	O
Risk	O
of	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
in	O
Belgium	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
(	O
n	O
=	O
1100	O
),	O
results	O
of	O
multiple	O
logistic	O
regressions	O
.	O
N	O
of	O
subjectsN	O
of	O
deficient	O
casesOR	O
[	O
95	O
%	O
Conf	O
Interval	O
]	O
p	O
Season	O
Winter4702781	O
.	O
000Spring3841270	O
.	O
2340	O
.	O
1650	O
.	O
332	O
<	O
0	O
.	O
001Summer93120	O
.	O
1000	O
.	O
0490	O
.	O
203	O
<	O
0	O
.	O
001Autumn3511660	O
.	O
5500	O
.	O
3910	O
.	O
7750	O
.	O
001BMI	O
*	O
1	O
.	O
0511	O
.	O
0221	O
.	O
080	O
<	O
0	O
.	O
001	O
Smoking	O
yes2191181	O
.	O
000no10784650	O
.	O
7010	O
.	O
4801	O
.	O
0250	O
.	O
067	O
Use	O
of	O
multivitamins	O
containing	O
vitamin	O
D	O
no4893171	O
.	O
000yes8092660	O
.	O
2240	O
.	O
1680	O
.	O
300	O
<	O
0	O
.	O
001	O
Ethnicity	O
Caucasian	O
,	O
white9553691	O
.	O
000Asiatic33192	O
.	O
8231	O
.	O
2356	O
.	O
4540	O
.	O
014African	O
(	O
black	O
)	O
64341	O
.	O
3090	O
.	O
6942	O
.	O
4680	O
.	O
406North	O
African1741306	O
.	O
0483	O
.	O
8139	O
.	O
595	O
<	O
0	O
.	O
001Hispanic1275	O
.	O
3051	O
.	O
54918	O
.	O
1670	O
.	O
008	O
Education	O
level	O
Secondary	O
education	O
or	O
less7194131	O
.	O
000High	O
school3531080	O
.	O
4880	O
.	O
3490	O
.	O
681	O
<	O
0	O
.	O
001University195520	O
.	O
5090	O
.	O
3310	O
.	O
7830	O
.	O
002	O
Frequency	O
of	O
fish	O
consumption	O
(	O
non	O
-	O
fatty	O
fish	O
)	O
Never2261171	O
.	O
000Less	O
than	O
once	O
a	O
month225900	O
.	O
5640	O
.	O
3540	O
.	O
8970	O
.	O
0161	O
–	O
3	O
days	O
a	O
month5052160	O
.	O
8390	O
.	O
5641	O
.	O
2480	O
.	O
3861	O
day	O
per	O
week2701240	O
.	O
7940	O
.	O
5061	O
.	O
2480	O
.	O
3182	O
–	O
4	O
days	O
a	O
week	O
or	O
more	O
frequent69350	O
.	O
5620	O
.	O
2891	O
.	O
0950	O
.	O
090	O
Sometimes	O
going	O
on	O
holidays	O
to	O
sunny	O
climates	O
Yes8823661	O
.	O
000No4082151	O
.	O
7031	O
.	O
2482	O
.	O
3240	O
.	O
001	O
First	O
trimester	O
BMI	O
used	O
as	O
a	O
proxy	O
for	O
prepregnancy	O
BMI	O
.	O

Glioma	O
patients	O
are	O
known	O
to	O
suffer	O
from	O
an	O
impaired	O
immune	O
system	O
[	O
99	O
],	O
and	O
the	O
reduced	O
association	O
with	O
allergies	O
alternatively	O
could	B
be	I
due	O
to	O
immunosuppression	O
induced	O
by	O
the	O
tumor	O
(	O
i	O
.	O
e	O
.,	O
reverse	O
causality	O
)	O
[	O
84	O
].	O

However	O
,	O
there	O
were	O
elements	O
of	O
dissatisfaction	O
with	O
health	O
centre	O
services	O
,	O
poor	O
sitting	O
facilities	O
,	O
amenities	O
,	O
few	O
health	O
education	O
talks	O
and	O
poor	O
nursing	O
skills	O
.	O

Treatment	O
of	O
atopic	O
dermatitis	O
during	O
pregnancy	O
should	O
emphasize	O
avoidance	O
of	O
triggering	O
factors	O
and	O
reliance	O
on	O
topical	O
treatment	O
in	O
an	O
attempt	O
to	O
reduce	O
dryness	O
and	O
pruritus	O
,	O
modulate	O
inflammation	O
,	O
and	O
treat	O
secondary	O
infections	O
.	O

Free	O
sugar	O
does	O
not	O
include	O
lactose	O
when	O
naturally	O
present	O
in	O
milk	O
and	O
milk	O
products	O
or	O
the	O
sugars	O
contained	O
within	O
the	O
cellular	O
structure	O
of	O
fruits	O
and	O
vegetables	O
.	O

After	O
multivariate	O
adjustment	O
,	O
the	O
intake	O
of	O
omega	O
-	O
6	O
fatty	O
acids	O
was	O
significantly	O
associated	O
with	O
a	O
decreased	O
relative	O
risk	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O

PubMed	O
Central	O
:	O

1	O
Seasonal	O
variation	O
in	O
serum	O
25	O
(	O
OH	O
)	O
D	O
.	O
a	O
.	O

Slaughter	O
age	O
IMF	O
content	O
increases	O
with	O
increasing	O
age	O
in	O
most	O
cattle	O
breeds	O
.	O

Furthermore	O
,	O
men	O
were	O
not	O
included	O
in	O
the	O
study	O
and	O
there	O
is	O
gender	O
difference	O
in	O
the	O
prevalence	O
of	O
psychosis	O
[	O
59	O
].	O

The	O
ICDS	O
scheme	O
was	O
introduced	O
on	O
a	O
nationwide	O
scale	O
to	O
upgrade	O
the	O
nutritional	O
and	O
health	O
status	O
of	O
children	O
(	O
0	O
-	O
6	O
years	O
);	O
to	O
develop	O
a	O
framework	O
for	O
ensuring	O
adequate	O
physical	O
,	O
psychological	O
and	O
social	O
development	O
of	O
the	O
child	O
;	O
to	O
minimize	O
the	O
incidence	O
of	O
morbidity	O
,	O
malnutrition	O
,	O
school	O
dropout	O
and	O
mortality	O
;	O
to	O
establish	O
effective	O
collaboration	O
between	O
different	O
departments	O
working	O
for	O
promoting	O
child	O
development	O
;	O
and	O
finally	O
to	O
enable	O
mothers	O
to	O
participate	O
actively	O
for	O
meeting	O
the	O
health	O
and	O
nutritional	O
needs	O
of	O
the	O
child	O
through	O
proper	O
nutrition	O
and	O
health	O
education	O
(	O
1	O
,	O
4	O
).	O

They	O
were	O
originally	O
thought	B
to	I
be	O
factors	O
inducing	O
bone	O
formation	O
,	O
but	O
were	O
then	O
described	O
to	O
be	O
involved	O
in	O
the	O
development	O
and	O
function	O
of	O
many	O
tissues	O
,	O
such	O
as	O
the	O
intestine	O
,	O
brain	O
and	O
WAT	O
(	O
Hogan	O
,	O
1996	O
).	O

Methods	O
This	O
randomized	O
clinical	O
trial	O
was	O
done	O
in	O
pregnant	O
women	O
who	O
were	O
under	O
prenatal	O
care	O
in	O
a	O
teaching	O
hospital	O
in	O
Shiraz	O
,	O
Iran	O
.	O

When	O
using	O
cut	O
-	O
off	O
point	O
of	O
>	O
13	O
,	O
susceptibility	O
to	O
prenatal	O
depression	O
decreases	O
to	O
8	O
.	O
2	O
%.	O

By	O
self	O
-	O
selection	O
,	O
those	O
who	O
manifest	O
seasonal	O
allergies	O
may	B
choose	O
a	O
career	O
path	O
other	O
than	O
farming	O
(	O
i	O
.	O
e	O
.,	O
healthy	O
worker	O
effect	O
)	O
[	O
116	O
].	O

In	O
total	O
,	O
28	O
individual	O
liver	O
mRNA	O
samples	O
were	O
analyzed	O
in	O
duplicate	O
per	O
stage	O
.	O

The	O
distinction	O
is	O
important	O
because	O
adjustment	O
for	O
covariates	O
along	O
the	O
causal	O
pathway	O
may	B
spuriously	O
attenuate	O
estimates	B
of	O
association	O
.	O

Post	O
-	O
partum	O
management	O
of	O
gestational	O
diabetes	O
The	O
medical	O
management	O
of	O
gestational	O
diabetes	O
should	O
not	O
conclude	O
with	O
the	O
delivery	O
of	O
the	O
fetus	O
.	O

These	O
CpG	O
rich	O
CGIs	O
are	O
non	O
-	O
randomly	O
distributed	O
throughout	O
the	O
mammalian	O
genome	O
,	O
being	O
predominantly	O
associated	O
with	O
regulatory	O
elements	O
such	O
as	O
promoters	O
(	O
Deaton	O
&	O
Bird2011	O
).	O

Both	O
chemically	O
induced	O
DNA	O
adducts	O
and	O
those	O
generated	O
as	O
a	O
consequence	O
of	O
reactive	O
oxygen	O
species	O
damage	O
resulting	O
from	O
chemical	O
exposure	O
can	B
interfere	O
with	O
the	O
ability	O
of	O
epigenetic	O
machinery	O
to	O
interact	O
with	O
DNA	O
(	O
Baccarelli	O
&	O
Bollati2009	O
;	O
Ruiz	O
-	O
Hernandez	O
et	O
al	O
.	O
2015	O
).	O

We	O
will	O
estimate	O
incremental	O
cost	O
-	O
effectiveness	O
ratios	O
as	O
incremental	O
cost	O
per	O
neonate	O
death	O
avoided	O
;	O
per	O
low	O
birth	O
weight	O
infant	O
avoided	O
and	O
per	O
life	O
-	O
year	O
saved	O
.	O

The	O
concentrate	O
constitutes	O
36	O
.	O
8	O
%	O
to	O
86	O
.	O
4	O
%	O
of	O
feed	O
from	O
11	O
to	O
18	O
months	O
of	O
age	O
.	O

PubMed	O
Central	O
:	O

Our	O
objectives	O
were	O
to	O
study	O
the	O
associations	O
between	O
vitamin	O
D	O
status	O
in	O
both	O
early	O
and	O
late	O
pregnancy	O
,	O
as	O
well	O
as	O
change	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
with	O
neonatal	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

The	O
coordination	O
of	O
several	O
factors	O
affects	O
IMF	O
deposition	O
.	O

Thus	O
,	O
focal	O
cortical	O
dysplasias	O
may	B
be	I
a	O
risk	O
factor	O
for	O
ASD	O
patients	O
.	O

After	O
multivariate	O
adjustment	O
,	O
the	O
risk	O
of	O
high	O
level	O
psychotic	O
-	O
like	O
symptoms	O
for	O
intake	O
of	O
omega	O
-	O
3	O
or	O
marine	O
fatty	O
acids	O
was	O
24	O
%	O
lower	O
in	O
the	O
third	O
quartile	O
compared	O
to	O
the	O
lowest	O
.	O

Larger	O
studies	O
are	O
needed	O
to	O
determine	O
whether	O
maternal	O
dietary	O
patterns	O
lead	O
to	O
significant	O
modifications	O
in	O
neonatal	O
anthropometric	O
measurements	O
.	O

The	O
intake	O
of	O
fatty	O
acids	O
and	O
vitamin	O
D	O
was	O
categorized	O
into	O
quartiles	O
,	O
with	O
the	O
lowest	O
quartile	O
as	O
the	O
reference	O
category	O
for	O
comparison	O
.	O

In	O
the	O
case	O
of	O
a	O
cohort	O
appearing	O
in	O
the	O
literature	O
multiple	O
times	O
only	O
the	O
most	O
recent	O
version	O
was	O
included	O
since	O
it	O
provided	O
the	O
largest	O
number	O
of	O
cases	O
and	O
the	O
longest	O
follow	O
-	O
up	O
.	O

When	O
evidence	O
for	O
associations	O
persisted	O
,	O
we	O
considered	O
other	O
factors	O
which	O
can	B
be	O
considered	O
either	O
as	O
potential	B
confounders	O
or	O
potential	B
mediators	O
of	O
associations	O
between	O
maternal	O
free	O
sugar	O
intake	O
in	O
pregnancy	O
and	O
childhood	O
outcomes	O
,	O
i	O
.	O
e	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
Background	O
characteristics	O
of	O
the	O
participantsBackground	O
characteristics	O
Age	O
,	O
years	O
(	O
mean	O
±	O
SD	O
)	O
27	O
.	O
5	O
±	O
5	O
.	O
59Urban	O
environment	O
,	O
N	O
(%)	O
218	O
(	O
54	O
.	O
3	O
)	O
Formal	O
education	O
,	O
number	O
of	O
years	O
≤	O
8	O
(%)	O
25	O
.	O
5	O
9	O
-	O
12	O
(%)	O
40	O
.	O
5	O
>	O
12	O
(%)	O
34Married	O
,	O
N	O
(%)	O
323	O
(	O
80	O
.	O
8	O
)	O
Number	O
of	O
births	O
,	O
N	O
(%)	O
Primiparous198	O
(	O
49	O
.	O
5	O
)	O
Secundiparous129	O
(	O
32	O
.	O
3	O
)	O
Multiparous73	O
(	O
18	O
.	O
2	O
)	O
Wanted	O
pregnancy	O
,	O
N	O
(%)	O
360	O
(	O
90	O
)	O
Gestational	O
age	O
at	O
first	O
prenatal	O
visit	O
,	O
mean	O
±	O
SD2	O
.	O
59	O
±	O
1	O
.	O
23First	O
prenatal	O
visit	O
at	O
≤	O
4	O
months	O
of	O
pregnancy	O
,	O
N	O
(%)	O
364	O
(	O
91	O
)	O
Number	O
of	O
prenatal	O
visits	O
at	O
general	O
practitioner	O
,	O
mean	O
±	O
SD4	O
.	O
82	O
±	O
2	O
.	O
54Number	O
of	O
prenatal	O
visits	O
at	O
obstetrician	O
,	O
mean	O
±	O
SD4	O
.	O
76	O
±	O
3	O
.	O
07Total	O
number	O
of	O
prenatal	O
visits	O
,	O
mean	O
±	O
SD9	O
.	O
58	O
±	O
4	O
.	O
88Nutritional	O
knowledge	O
score	O
,	O
mean	O
±	O
SD11	O
±	O
4	O
.	O
8Advice	O
on	O
diet	O
,	O
YES	O
(	O
N	O
,%)	O
168	O
(	O
42	O
)	O
Advice	O
on	O
breastfeeding	O
,	O
YES	O
(	O
N	O
,%)	O
334	O
(	O
83	O
.	O
5	O
)	O
Use	O
of	O
folic	O
acid	O
(	O
N	O
,%)	O
192	O
(	O
48	O
)	O
Use	O
of	O
iron	O
(	O
N	O
,%)	O
181	O
(	O
45	O
.	O
3	O
)	O
Use	O
of	O
multivitamins	O
(	O
N	O
,%)	O
272	O
(	O
68	O
)	O
Statistical	O
analysis	O
Associations	O
between	O
socio	O
-	O
demographic	O
factors	O
,	O
prenatal	O
care	O
,	O
the	O
level	O
of	O
nutritional	O
knowledge	O
and	O
the	O
intake	O
of	O
nutritional	O
supplements	O
were	O
evaluated	O
using	O
the	O
Chi	O
-	O
square	O
test	O
(	O
χ2	O
)	O
and	O
binomial	O
logistical	O
regression	O
[	O
24	O
].	O

Statistical	O
analysis	O
Statistical	O
analysis	O
was	O
performed	O
using	O
SPSS11	O
.	O
5	O
software	O
.	O

Although	O
earlier	B
studies	I
have	O
mostly	B
examined	O
the	O
effects	O
of	O
particular	O
nutrients	O
or	O
foods	O
during	O
gestational	O
period	O
on	O
neonatal	O
anthropometric	O
measurements	O
,	O
there	O
are	O
few	B
studies	I
regarding	O
the	O
association	O
of	O
dietary	O
patterns	O
and	O
mentioned	O
measurements	O
.	O

Eligibility	O
criteria	O
included	O
nonsmoking	O
,	O
adults	O
(	O
age	O
>	O
18	O
years	O
),	O
fluency	O
in	O
English	O
,	O
access	O
to	O
telephone	O
,	O
gestational	O
age	O
between	O
10	O
and	O
16	O
weeks	O
,	O
singleton	O
pregnancy	O
,	O
no	O
current	O
or	O
history	O
of	O
eating	O
disorders	O
,	O
and	O
without	O
major	O
psychiatric	O
illness	O
(	O
i	O
.	O
e	O
.,	O
schizophrenia	O
,	O
bipolar	O
disorder	O
,	O
and	O
panic	O
/	O
anxiety	O
disorder	O
)	O
or	O
major	O
medical	O
problems	O
,	O
including	O
diabetes	O
,	O
stroke	O
,	O
and	O
cancer	O
.	O

This	O
fact	O
might	B
be	O
a	O
consequence	O
of	O
the	O
inadequate	O
fetal	O
programming	O
of	O
metabolic	O
systems	O
involved	O
in	O
energy	O
homeostasis	O
(	O
Hales	O
and	O
Barker	O
,	O
2001	O
;	O
Vaag	O
et	O
al	O
.,	O
2012	O
).	O

Given	O
that	O
73	O
%	O
of	O
children	O
had	O
vitamin	O
D	O
deficiency	O
in	O
the	O
study	O
region	O
in	O
2005	O
,	O
12and	O
that	O
the	O
incidence	O
of	O
pneumonia	O
was	O
ten	O
-	O
times	O
higher	O
in	O
vitamin	O
D	O
deficient	O
children	O
than	O
in	O
children	O
without	O
a	O
deficiency	O
in	O
case	O
-	O
control	O
studies1	O
,	O
2we	O
postulated	B
that	O
there	O
would	O
be	O
at	O
least	O
a	O
35	O
%	O
reduction	O
in	O
pneumonia	O
incidence	O
in	O
the	O
vitamin	O
D	O
compared	O
with	O
the	O
placebo	O
group	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
mean	O
AluYb8	O
levels	O
differed	O
significantly	O
by	O
maternal	O
tobacco	O
use	O
during	O
pregnancy	O
(	O
p	O
<	O
0	O
.	O
01	O
),	O
whereas	O
mean	O
LINE	O
-	O
1	O
levels	O
significantly	O
differed	O
only	O
by	O
maternal	O
alcohol	O
use	O
during	O
pregnancy	O
(	O
p	O
=	O
0	O
.	O
02	O
;	O
Table	O
2	O
).	O

It	O
will	O
be	O
valuable	O
to	O
utilise	O
our	O
clinical	O
and	O
biological	O
databases	O
to	O
explore	O
potential	B
pathways	O
whereby	O
maternal	O
obesity	O
contributes	O
to	O
childhood	O
outcomes	O
,	O
including	O
obesity	O
and	O
impaired	O
neurodevelopment	O
.	O

Collaboration	O
between	O
scientists	O
from	O
academia	O
,	O
industry	O
,	O
and	O
governmental	O
and	O
regulatory	O
bodies	O
will	O
promote	O
further	O
research	O
within	O
a	O
regulatory	O
context	O
,	O
and	O
drive	O
the	O
development	O
and	O
implementation	O
of	O
epigenetically	O
relevant	O
integrated	O
testing	O
strategies	O
or	O
policies	O
for	O
the	O
continued	O
protection	O
of	O
public	O
health	O
.	O

Review	O
of	O
Literature	O
Several	O
recent	B
studies	I
have	O
explored	O
season	O
of	O
birth	O
as	O
a	O
risk	O
factor	O
for	O
adult	O
glioma	O
,	O
but	O
results	O
have	B
been	I
mixed	O
(	O
Table	O
1	O
).	O

The	O
Avy	O
model	B
in	O
particular	O
has	B
been	I
put	B
forward	I
as	O
a	O
potential	B
epigenetic	O
toxicological	O
tool	O
(	O
Dolinoy2008	O
;	O
Rosenfeld2010	O
;	O
Faulk	O
et	O
al	O
.	O
2013	O
).	O

Its	O
indirect	O
effects	O
are	O
attributed	O
to	O
vitamin	O
D	O
’	O
s	O
effects	O
on	O
improvement	O
of	O
muscle	O
activities	O
.	O

Subjects	O
used	O
in	O
an	O
Australian	O
study	O
were	O
diagnosed	O
with	O
autism	O
spectrum	O
disorder	O
and	O
compared	O
to	O
control	O
subjects	O
.	O

Given	O
the	O
high	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
in	O
pregnant	O
women	O
in	O
Belgium	O
and	O
probably	O
in	O
many	O
European	O
countries	O
,	O
a	O
vitamin	O
D	O
nutrition	O
policy	O
is	O
needed	O
at	O
the	O
country	O
and	O
European	O
level	O
.	O

Smoking	O
has	O
not	O
been	O
found	B
to	O
have	O
a	O
direct	O
association	O
.	O

Cardiac	O
glycosides	O
in	O
the	O
venom	O
are	O
thought	B
to	I
inhibit	O
proteins	O
that	O
promote	O
cancer	O
cell	O
growth	O
,	O
thereby	O
causing	O
cancer	O
cell	O
death	O
.	O

Women	O
in	O
the	O
highest	O
quartile	O
of	O
adherence	O
to	O
traditional	O
dietary	O
pattern	O
were	O
20	O
%	O
less	O
likely	O
to	O
have	O
short	O
height	O
infant	O
compared	O
with	O
those	O
in	O
the	O
lowest	O
quartile	O
[	O
OR	O
0	O
.	O
80	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
34	O
-	O
1	O
.	O
85	O
),	O
P	O
<	O
0	O
.	O
93	O
]	O
in	O
the	O
final	O
adjusted	O
model	O
.	O

The	O
Center	O
for	O
the	O
Protection	O
of	O
Human	O
Subjects	O
at	O
Dartmouth	O
provided	O
institutional	O
review	O
board	O
approval	O
.	O

Ruth	O
et	O
al	O
.	O

Notably	O
,	O
investigators	O
have	B
reported	I
that	O
short	O
sleep	O
duration	O
and	O
other	O
parameters	O
of	O
sleep	O
disturbance	O
during	O
mid	O
and	O
late	O
pregnancy	O
are	O
associated	O
with	O
increased	O
systematic	O
inflammation	O
and	O
higher	O
stimulated	O
levels	O
of	O
IL	O
-	O
6	O
[	O
49	O
,	O
50	O
];	O
and	O
we	O
have	O
previously	B
reported	B
that	O
early	O
pregnancy	O
CRP	O
concentrations	O
are	O
predictive	O
of	O
incident	O
GDM	O
[	O
51	O
].	O

The	O
placenta	O
and	O
brain	O
,	O
in	O
particular	O
,	O
express	O
many	O
of	O
the	O
imprinted	O
genes	O
,	O
in	B
keeping	I
with	I
experimentally	O
identified	B
roles	O
for	O
imprinted	O
genes	O
in	O
prenatal	O
nutrient	O
acquisition	O
and	O
growth	O
regulation	O
,	O
neurodevelopment	O
,	O
and	O
postnatal	O
energy	O
homeostasis	O
and	O
behavior	O
.	O

There	O
was	O
no	O
difference	O
in	O
the	O
primary	O
outcome	O
between	O
the	O
two	O
groups	O
(	O
metformin	O
116	O
[	O
32	O
%]	O
events	O
,	O
insulin	O
119	O
events	O
[	O
32	O
.	O
2	O
%],	O
RR	O
1	O
.	O
0	O
[	O
0	O
.	O
9	O
–	O
1	O
.	O
1	O
],	O
p	O
=	O
0	O
.	O
95	O
).	O

Global	O
methylation	O
status	O
of	O
hypothalamic	O
genomic	O
DNA	O
was	O
determined	O
by	O
the	O
in	O
vitro	O
methyl	O
acceptance	O
assay	O
method	O
as	O
described	O
previously	O
.	O
18	O
,	O
19This	O
assay	O
involves3H	O
-	O
methyl	O
-	O
S	O
-	O
adenosylmethionine	O
(	O
New	O
England	O
Nuclear	O
,	O
Boston	O
,	O
MA	O
,	O
USA	O
)	O
as	O
a	O
methyl	O
donor	O
mediated	O
by	O
Sss1	O
DNA	O
methyltransferase	O
(	O
New	O
England	O
Biolabs	O
,	O
Pickering	O
,	O
ON	O
,	O
Canada	O
).	O

Conclusion	O
Most	O
of	O
the	O
patients	O
took	O
Vitamin	O
D	O
supplements	O
which	O
may	B
help	O
to	O
maintain	O
the	O
nutritional	O
balance	O
of	O
Vitamin	O
D	O
.	O
Background	O
Vitamin	O
D	O
promotes	O
calcium	O
absorption	O
in	O
the	O
gut	O
and	O
maintains	O
adequate	O
serum	O
calcium	O
and	O
phosphate	O
concentrations	O
to	O
ensure	O
normal	O
mineralization	O
of	O
the	O
bone	O
.	O

Even	O
in	O
adulthood	O
the	O
same	O
epigenetic	O
processes	O
drive	O
cell	O
proliferation	O
,	O
differentiation	O
,	O
function	O
and	O
adaptation	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
1	O
General	O
characteristics	O
of	O
study	O
subjectsGroupsNAge	O
(	O
Year	O
)	O
Gestational	O
weeks	O
(	O
Week	O
)	O
Pre	O
-	O
pregnancy	O
BMI	O
(	O
kg	O
/	O
m2	O
)	O
Control1434	O
.	O
3	O
±	O
4	O
.	O
928	O
.	O
9	O
±	O
4	O
.	O
124	O
.	O
7	O
±	O
4	O
.	O
5Intervention8433	O
.	O
3	O
±	O
3	O
.	O
828	O
.	O
9	O
±	O
3	O
.	O
322	O
.	O
8	O
±	O
3	O
.	O
5	O
Comparison	O
of	O
serum	O
25	O
-	O
OH	O
Vitamin	O
D	O
level	O
in	O
women	O
of	O
the	O
two	O
groups	O
As	O
shown	O
in	O
Table	O
2	O
,	O
the	O
serum	O
levels	O
of	O
total	O
25	O
-	O
OH	O
Vitamin	O
D	O
in	O
the	O
intervention	O
and	O
control	O
group	O
were	O
74	O
.	O

Thus	O
,	O
dietary	O
intake	O
of	O
vitamin	O
D	O
in	O
Thai	O
people	O
is	O
generally	O
low	O
.	O

The	O
MAS5	O
algorithm	O
was	O
used	O
to	O
skip	O
those	O
transcripts	O
which	O
were	O
expressed	O
in	O
less	O
than	O
50	O
%	O
of	O
the	O
animals	O
within	O
one	O
dietary	O
group	O
per	O
stage	O
.	O

Vasopressinase	O
is	O
a	O
cysteine	O
aminopeptidase	O
of	O
molecular	O
weight	O
330	O
kDa	O
,	O
and	O
is	O
produced	O
by	O
the	O
placental	O
trophoblasts	O
during	O
pregnancy	O
as	O
discussed	O
by	O
Gordge	O
et	O
al	O
.	O

Though	O
,	O
because	O
of	O
its	O
immediate	O
bioavailability	O
,	O
it	O
may	B
result	O
in	O
a	O
more	O
rapid	O
rise	O
in	O
haemoglobin	O
level	O
in	O
anaemic	O
patients	O
compared	O
with	O
oral	O
iron	O
;	O
but	O
it	O
probably	O
does	O
not	O
confer	O
an	O
advantage	O
in	O
preventing	O
anaemia	O
in	O
pregnancy	O
[	O
25	O
,	O
38	O
].	O

There	O
was	O
an	O
overall	O
significant	O
relationship	O
between	O
AluYb8	O
methylation	O
and	O
RPMM	O
class	O
methylation	O
(	O
p	O
=	O
0	O
.	O
01	O
);	O
no	O
association	O
was	O
observed	O
between	O
LINE	O
-	O
1	O
and	O
RPMM	O
class	O
methylation	O
.	O

Overall	O
,	O
findings	O
from	O
the	O
current	O
study	O
support	B
a	O
stronger	O
role	O
for	O
maternal	O
intake	O
than	O
expenditure	O
in	O
predicting	O
offspring	O
weight	O
outcomes	O
,	O
but	O
additional	O
studies	O
with	O
objective	O
measures	O
of	O
physical	O
activity	O
(	O
e	O
.	O
g	O
.,	O
accelerometry	O
)	O
are	O
clearly	O
needed	O
.	O

A	O
similar	O
question	O
was	O
asked	O
for	O
sleep	O
duration	O
before	O
pregnancy	O
.	O

In	O
two	O
community	O
clinics	O
,	O
we	O
conducted	O
an	O
hour	O
-	O
long	O
observation	O
to	O
understand	O
the	O
implementation	O
of	O
the	O
national	O
IFA	O
programme	O
.	O

To	O
verify	O
physical	O
presence	O
of	O
the	O
data	O
collectors	O
at	O
the	O
households	O
we	O
will	O
record	O
a	O
Geographic	O
Information	O
System	O
(	O
GIS	O
)	O
data	O
point	O
.	O

We	O
generated	O
the	O
following	O
four	O
experimental	O
groups	O
:	O
Male	O
offspring	O
from	O
control	O
diet	O
-	O
fed	O
dams	O
(	O
CC	O
male	O
;	O
n	O
=	O
15	O
);	O
Male	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
(	O
RC	O
male	O
;	O
n	O
=	O
23	O
);	O
Female	O
offspring	O
from	O
control	O
diet	O
-	O
fed	O
dams	O
(	O
CC	O
female	O
;	O
n	O
=	O
16	O
);	O
and	O
Female	O
offspring	O
from	O
calorie	O
-	O
restricted	O
dams	O
(	O
RC	O
female	O
;	O
n	O
=	O
23	O
).	O

Diagnostic	O
Tests	O
and	O
Clinical	O
Course	O
EKG	O
showed	O
a	O
sinus	O
rhythm	O
with	O
a	O
rate	O
of	O
75	O
and	O
no	O
signs	O
of	O
ischemic	O
changes	O
.	O

Studies	O
have	O
been	O
done	O
determining	O
the	O
effects	O
of	O
smoking	O
in	O
a	O
pregnant	O
patient	O
and	O
the	O
risk	O
of	O
autism	O
in	O
the	O
mother	O
'	O
s	O
offspring	O
.	O

In	O
women	O
belonging	O
to	O
the	O
high	O
level	O
symptoms	O
group	O
,	O
the	O
RRs	O
with	O
increasing	O
quartiles	O
of	O
omega	O
-	O
6	O
intake	O
were	O
:	O
0	O
.	O
67	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
55	O
-	O
0	O
.	O
82	O
),	O
0	O
.	O
66	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
54	O
-	O
0	O
.	O
81	O
),	O
0	O
.	O
78	O
(	O
95	O
%	O
CI	O
,	O
0	O
.	O
64	O
-	O
0	O
.	O
97	O
).	O

At	O
baseline	O
,	O
no	O
correlation	O
was	O
observed	O
between	O
25	O
-	O
hydroxyvitamin	O
D	O
concentration	O
and	O
depression	O
score	O
(	O
r	O
=	O
0	O
.	O
13	O
,	O
p	O
=	O
0	O
.	O
09	O
).	O

The	O
DVD	O
adult	O
rat	O
is	O
also	O
more	O
sensitive	O
to	O
haloperidol	O
,	O
a	O
dopamine	O
(	O
DA	O
)	O
D2	O
receptor	O
antagonist	O
[	O
10	O
],	O
that	O
is	O
a	O
widely	O
used	O
antipsychotic	O
medication	O
used	O
to	O
treat	O
schizophrenia	O
.	O

In	O
an	O
epidemiological	O
study	O
conducted	O
in	O
India	O
by	O
Mamidala	O
et	O
al	O
.,	O
maternal	O
hormonal	O
intervention	O
was	O
a	O
significant	O
risk	O
factor	O
for	O
ASD	O
,	O
possibly	B
due	O
to	O
maternal	O
hormone	O
disturbances	O
causing	O
obstetric	O
complications	O
,	O
which	O
in	O
turn	O
are	O
a	O
risk	O
for	O
ASD	O
[	O
42	O
].	O

At	O
6	O
months	O
,	O
no	O
significant	O
effects	O
were	O
seen	O
for	O
GWG	O
on	O
odds	O
of	O
WFA	O
>	O
90th	O
percentile	O
(	O
P	O
=	O
.	O
11	O
)	O
or	O
average	O
z	O
-	O
scores	O
(	O
P	O
=	O
.	O
16	O
)	O
at	O
6	O
months	O
.	O

Results	O
showed	B
that	O
in	O
the	O
vitamin	O
D	O
group	O
the	O
number	O
of	O
participants	O
with	O
depression	O
scores	O
of	O
<	O
9	O
were	O
more	O
than	O
the	O
control	O
group	O
at	O
38	O
–	O
40	O
weeks	O
of	O
gestation	O
also	O
,	O
at	O
4	O
and	O
8	O
weeks	O
after	O
birth	O
(	O
Table	O
3	O
).	O

The	O
activity	O
of	O
ATP	O
citrate	O
lyase	O
is	B
known	I
to	O
be	O
low	O
in	O
ruminants	O
[	O
87	O
];	O
thus	O
,	O
glucose	O
is	O
used	O
as	O
a	O
lipogenic	O
substrate	O
less	O
in	O
ruminants	O
than	O
in	O
monogastric	O
animals	O
[	O
87	O
].	O

Whether	O
“	O
brite	O
”	O
adipocytes	O
descend	O
from	O
unique	O
precursors	O
,	O
or	O
share	O
progenitors	O
with	O
either	O
white	O
or	O
classic	O
brown	O
adipocytes	O
still	O
remains	O
to	O
be	O
established	O
(	O
for	O
rev	O
.,	O
see	O
Chechi	O
et	O
al	O
.,	O
2013	O
).	O

1	O
,	O
25	O
-	O
Dihydroxyvitamin	O
D3	O
(	O
active	O
form	O
of	O
vitamin	O
D	O
)	O
inhibits	O
preadipocyte	O
differentiation	O
[	O
141	O
]	O
and	O
suppresses	O
adipogenic	O
PPARG	O
gene	O
expression	O
in	O
3T3	O
L1	O
cells	O
[	O
142	O
].	O

Experiments	O
with	O
animals	O
models	O
have	O
succeeded	O
in	O
simulate	O
metabolic	O
alterations	O
of	O
undernutrition	O
during	O
gestational	O
periods	O
in	O
humans	O
,	O
particularly	O
by	O
the	O
implementation	O
of	O
a	O
moderate	O
or	O
severe	O
calorie	O
restricted	O
diets	O
(	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
García	O
et	O
al	O
.,	O
2010	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Suzuki	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
).	O

If	O
glucose	O
targets	O
are	O
not	B
adequately	I
met	O
by	O
lifestyle	O
measures	O
,	O
and	O
perhaps	B
a	O
review	O
of	O
dietary	O
intake	O
,	O
then	O
pharmacotherapy	O
should	O
be	O
introduced	O
.	O

Several	O
biologic	O
mechanisms	O
underlying	O
the	O
nutritional	O
programming	O
,	O
which	O
become	O
altered	O
after	O
the	O
exposure	O
to	O
a	O
maternal	O
restricted	O
diet	O
during	O
pregnancy	O
,	O
have	B
been	I
identified	O
.	O

In	O
this	O
study	O
,	O
215	O
women	O
with	O
GDM	O
were	O
seen	O
at	O
sites	O
randomized	O
to	O
deliver	O
either	O
MNT	O
or	O
standard	O
care	O
.	O
27Fewer	O
subjects	O
in	O
the	O
MNT	O
group	O
required	O
insulin	O
(	O
24	O
.	O
6	O
%	O
vs	O
31	O
.	O
7	O
%,	O
p	O
=	O
0	O
.	O
05	O
)	O
and	O
there	O
was	O
a	O
trend	B
to	O
fewer	O
women	O
having	O
a	O
glycated	O
hemoglobin	O
(	O
HbA1c	O
)	O
>	O
6	O
%	O
(	O
8	O
.	O
1	O
%	O
vs	O
13	O
.	O
6	O
%,	O
p	O
=	O
0	O
.	O
25	O
).	O

In	O
retrospect	O
,	O
this	O
should	O
have	O
been	O
explicitly	O
stated	O
in	O
our	O
article	O
(	O
Martin	O
et	O
al	O
.	O

Handedness	O
Handedness	O
is	O
believed	B
to	O
be	O
determined	O
in	O
utero	O
[	O
179	O
],	O
possibly	B
through	O
hormonal	O
influences	O
[	O
180	O
–	O
183	O
],	O
and	O
has	B
been	I
linked	O
with	O
immune	O
disease	O
[	O
184	O
,	O
185	O
],	O
various	O
developmental	O
learning	O
disorders	O
[	O
184	O
],	O
epilepsy	O
[	O
186	O
],	O
and	O
breast	O
cancer	O
risk	O
in	O
both	O
pre	O
-	O
and	O
post	O
-	O
menopausal	O
women	O
[	O
187	O
–	O
190	O
].	O

Food	O
intake	O
over	O
72	O
hours	O
was	O
measured	O
every	O
2	O
weeks	O
from	O
0	O
–	O
29	O
weeks	O
post	O
-	O
weaning	O
.	O

Additionally	O
,	O
CC	O
and	O
RC	O
adolescent	O
females	O
showed	O
an	O
increase	O
in	O
chocolate	O
preference	O
than	O
the	O
respective	O
CC	O
and	O
RC	O
adolescent	O
males	O
(	O
days	O
1	O
,	O
2	O
,	O
and	O
4	O
;	O
Figure3A	O
).	O

1	O
,	O
25	O
(	O
OH	O
)	O
2D	O
may	B
interfere	O
with	O
many	O
functions	O
beyond	O
calcium	O
metabolism	O
,	O
such	O
as	O
foetal	O
"	O
imprinting	O
"	O
that	O
may	B
affect	O
neurodevelopment	O
,	O
immune	O
function	O
and	O
chronic	O
disease	O
susceptibility	O
later	O
in	O
life	O
,	O
as	O
well	O
as	O
soon	O
after	O
birth2425	O
.	O

Reproductive	O
Toxicity	O
:	O
Too	O
Much	O
of	O
a	O
Good	O
Thing	O
?	O

Plots	O
include	O
only	O
infants	O
delivered	O
vaginally	O
(	O
n	O
=	O
97	O
).	O

All	O
estimates	O
are	O
based	O
on	O
imputed	O
data	O
including	O
all	O
infants	O
who	O
were	O
eligible	O
for	O
the	O
follow	O
-	O
up	O
study	O
.	O

Exclusion	O
Criteria	O
were	O
:	O
the	O
participants	O
with	O
the	O
EPDS	O
baseline	O
scores	O
of	O
>	O
13	O
,	O
not	O
providing	O
blood	O
sample	O
at	O
the	O
onset	O
of	O
the	O
study	O
,	O
and	O
less	O
than	O
8	O
weeks	O
consumption	O
of	O
vitamin	O
D3supplementations	O
(	O
for	O
example	O
due	O
to	O
preterm	O
labor	O
or	O
stopping	O
consumption	O
),	O
irregular	O
consumption	O
(	O
for	O
example	O
every	O
two	O
/	O
three	O
days	O
instead	O
of	O
daily	O
consumption	O
).	O

PubMed	O
Central	O
:	O

Fieldworkers	O
allocated	O
children	O
to	O
randomisation	O
groups	O
during	O
recruitment	O
and	O
gave	O
vitamin	O
D	O
or	O
placebo	O
.	O

Such	O
an	O
approach	O
would	O
also	O
respect	O
the	O
3Rs	O
.	O

Proliferative	O
potential	O
is	O
lower	O
in	O
intramuscular	O
preadipocytes	O
than	O
in	O
subcutaneous	O
preadipocytes	O
[	O
97	O
].	O

The	O
expression	O
of	O
1	O
-	O
α	O
hydroxylase	O
is	O
increased	O
in	O
the	O
kidney	O
and	O
placenta	O
and	O
the	O
concentration	O
of	O
serum	O
1	O
,	O
25	O
-(	O
OH	O
)	O
2D	O
increases	O
in	O
normal	O
pregnancy	O
from	O
the	O
first	O
to	O
the	O
third	O
trimester	O
.	O

The	O
importance	O
of	O
an	O
exacerbation	O
of	O
eczema	O
and	O
dermatitis	O
during	O
pregnancy	O
should	O
not	O
be	O
underestimated	O
as	O
readout	O
of	O
the	O
atopic	O
state	O
,	O
being	O
of	O
interest	O
for	O
the	O
genetic	O
predisposition	O
of	O
the	O
newborn	O
[	O
42	O
].	O

It	O
is	O
also	O
indicated	B
in	O
pregnant	O
women	O
whose	O
hemoglobin	O
level	O
is	O
required	O
to	O
be	O
restored	O
rapidly	O
such	O
as	O
those	O
who	O
present	O
too	O
close	O
to	O
term	O
and	O
those	O
who	O
have	O
severe	O
anemia	O
[	O
40	O
].	O

Women	O
who	O
had	O
participated	O
in	O
the	O
NICHD	O
trial	O
provided	O
their	O
written	O
informed	O
consent	O
.	O

Nodes	O
in	O
the	O
jugular	O
chains	O
should	O
also	O
be	O
carefully	O
examined	O
with	O
US	O
before	O
surgery	O
and	O
,	O
when	O
suspicious	O
,	O
FNAB	O
should	O
be	O
obtained	O
.	O

Calcium	O
binding	O
proteins	O
are	O
central	O
to	O
a	O
wide	O
range	O
of	O
cellular	O
functions	O
,	O
of	O
which	O
calcium	O
sequestration	O
and	O
buffering	O
are	O
particularly	O
important	O
for	O
neurons	O
.	O

Such	O
tolerance	O
could	B
conceivably	B
develop	O
early	O
in	O
life	O
,	O
following	O
repeated	O
exposure	O
to	O
high	O
levels	O
of	O
allergens	O
such	O
as	O
organic	O
dusts	O
,	O
fungi	O
,	O
and	O
endotoxins	O
;	O
this	O
is	O
perhaps	B
the	O
result	O
of	O
component	O
lipopolysaccharides	O
that	O
excite	O
Th1	O
responses	O
and	O
suppress	O
the	O
development	O
of	O
immunoglobulin	O
-	O
E	O
(	O
IgE	O
)-	O
antibodies	O
[	O
109	O
,	O
116	O
].	O

At	O
6	O
months	O
,	O
no	O
significant	O
differences	O
in	O
WFA	O
z	O
-	O
scores	O
were	O
observed	O
between	O
offspring	O
of	O
normal	O
weight	O
and	O
overweight	O
/	O
obese	O
mothers	O
.	O

Points	O
are	O
colored	O
by	O
taxonomy	O
represented	O
heavily	O
in	O
top	O
results	O
,	O
for	O
p	O
<	O
0	O
.	O
10	O
.	O

In	O
infants	O
with	O
risk	O
of	O
allergy	O
,	O
introduction	O
of	O
solid	O
foods	O
in	O
general	O
should	O
be	O
postponed	O
until	O
6	O
months	O
of	O
age	O
,	O
milk	O
products	O
until	O
12	O
months	O
,	O
hen	O
'	O
s	O
egg	O
until	O
24	O
months	O
,	O
and	O
peanut	O
,	O
tree	O
nuts	O
,	O
fish	O
,	O
and	O
seafood	O
until	O
at	O
least	O
36	O
months	O
.	O

The	O
women	O
were	O
selected	O
according	O
to	O
a	O
multi	O
-	O
stage	O
proportionate	O
-	O
to	O
-	O
size	O
stratified	O
sampling	O
design	O
as	O
recommended	O
for	O
studies	O
assessing	O
iodine	O
deficiency	O
[	O
31	O
].	O

Examining	O
GWG	O
as	O
a	O
potential	B
mediator	O
,	O
the	O
effects	O
of	O
maternal	O
prenatal	O
behaviors	O
on	O
offspring	O
weight	O
outcomes	O
were	O
generally	O
attenuated	O
(	O
Table	O
4	O
).	O

2	O
.	O
2	O
.	O

The	O
potential	O
for	O
contamination	O
by	O
heavy	O
metals	O
,	O
as	O
well	O
as	O
risk	O
of	O
listeriosis	O
requires	O
careful	O
consideration	O
of	O
the	O
shaping	O
of	O
dietary	O
messages	O
related	O
to	O
fish	O
intake	O
during	O
pregnancy	O
.	O

Miscarriages	O
or	O
premature	O
birth	O
have	O
raised	O
concern	O
about	O
the	O
use	O
of	O
radioactive	O
iodine	O
in	O
a	O
childbearing	O
age	O
due	O
to	O
the	O
known	B
mutagenic	O
effect	O
of	O
radiation	O
and	O
the	O
theoretical	B
possibility	B
that	O
it	O
may	B
affect	O
germ	O
cells	O
,	O
thereby	O
causing	O
genetic	O
damage	O
,	O
congenital	O
abnormalities	O
and	O
malignancy	O
in	O
offspring	O
.	O

Study	O
eligibility	O
criteria	O
for	O
mothers	O
included	O
healthy	O
mothers	O
ranging	O
from	O
18	O
to	O
40	O
years	O
of	O
age	O
,	O
with	O
no	O
history	O
of	O
gestational	O
diabetes	O
,	O
psychological	O
disorders	O
,	O
or	O
genetic	O
disorders	O
.	O

We	O
also	O
found	B
that	O
lower	O
vitamin	O
D	O
status	O
in	O
early	O
pregnancy	O
was	O
related	O
to	O
pregnancy	O
loss	O
.	O

The	O
results	O
of	O
several	O
meta	O
-	O
analyses	O
reinforce	B
the	O
beneficial	O
role	O
of	O
iron	O
and	O
folic	O
acid	O
supplements	O
during	O
pregnancy	O
in	O
reducing	O
the	O
prevalence	O
of	O
neural	O
tube	O
defects	O
,	O
low	O
-	O
birth	O
weight	O
babies	O
,	O
small	O
for	O
gestational	O
age	O
newborns	O
and	O
maternal	O
anaemia	O
[	O
7	O
-	O
9	O
].	O

Statistics	O
Both	O
R	O
(	O
version	O
2	O
.	O
11	O
.	O
1	O
)	O
and	O
SPSS	O
(	O
PASW	O
version	O
18	O
.	O
0	O
.	O
1	O
)	O
statistical	O
packages	O
were	O
used	O
.	O

b	O
.	O

Further	O
study	O
is	O
needed	O
to	O
clarify	O
the	O
effects	O
of	O
dietary	O
vitamin	O
D	O
on	O
MS	O
and	O
QG	O
in	O
beef	O
cattle	O
.	O

Sample	O
size	O
The	O
available	O
sample	O
size	O
for	O
follow	O
-	O
up	O
assessment	O
at	O
6	O
-	O
months	O
of	O
age	O
was	O
predetermined	O
by	O
the	O
LIMIT	O
trial	O
,	O
which	O
was	O
powered	O
on	O
the	O
primary	O
outcome	O
of	O
large	O
for	O
gestational	O
age	O
,	O
with	O
2212	O
women	O
randomised	O
[	O
22	O
].	O

PubMed	O
Central	O
:	O

Notably	O
,	O
high	O
sympathetic	O
nervous	O
system	O
activity	O
,	O
intermittent	O
hypoxemia	O
,	O
dysregulation	O
of	O
the	O
HPA	O
axis	O
,	O
endothelial	O
dysfunction	O
and	O
alterations	O
in	O
cytokine	O
and	O
adipokine	O
synthesis	O
and	O
release	O
have	B
all	O-
been	I
proposed	B
mechanisms	O
for	O
these	O
consistently	O
observed	B
epidemiological	O
observations	B
.	O

Vinter	O
and	O
colleagues	O
[	O
18	O
]	O
conducted	O
a	O
follow	O
-	O
up	O
assessment	O
of	O
participants	O
6	O
-	O
months	O
after	O
birth	O
,	O
in	O
which	O
an	O
antenatal	O
dietary	O
and	O
lifestyle	O
intervention	O
was	O
provided	O
to	O
overweight	O
and	O
obese	O
women	O
[	O
15	O
].	O

Yet	O
,	O
visfatin	O
’	O
s	O
regulatory	O
and	O
release	O
mechanisms	O
in	O
the	O
fetus	O
and	O
neonate	O
are	O
still	O
unclear	O
(	O
5	O
).	O

Bonferrroni	O
analysis	O
indicated	B
that	O
RC	O
male	O
exhibited	O
an	O
increase	O
in	O
the	O
perirenal	O
,	O
perigonadal	O
,	O
and	O
abdominal	O
fat	O
weights	O
,	O
and	O
in	O
the	O
percentage	O
of	O
perirenal	O
fat	O
compared	O
to	O
those	O
of	O
the	O
CC	O
males	O
.	O

Results	O
from	O
an	O
international	O
case	O
-	O
control	O
study	O
of	O
childhood	O
brain	O
tumors	O
:	O
the	O
role	O
of	O
prenatal	O
vitamin	O
supplementation	O
.	O

Individuals	O
with	O
a	O
BMI	O
above	O
30	O
kg	O
/	O
m2are	O
classified	O
as	O
obese	O
;	O
those	O
with	O
a	O
BMI	O
between	O
25	O
and	O
30	O
kg	O
/	O
m2are	O
considered	O
to	O
be	O
overweight	O
.	O

While	O
there	O
is	O
still	O
room	O
for	O
much	O
further	O
research	O
,	O
current	O
understanding	O
suggests	B
that	O
length	O
of	O
labor	O
is	O
possibly	B
associated	O
with	O
autism	O
.	O

A	O
non	O
parametric	O
test	O
(	O
Mann	O
Whitney	O
U	O
test	O
)	O
was	O
used	O
whenever	O
the	O
continuous	O
measures	O
were	O
not	O
normally	O
distributed	O
.	O

The	O
primer	O
sequences	O
used	O
for	O
miRNAs	O
analysis	O
are	O
listed	O
inTable	O
1	O
.	O
The	O
fold	O
change	O
was	O
calculated	O
using	O
the	O
2	O
-△△	O
Ct	O
method	O
.	O

High	O
Prevalence	O
of	O
Vitamin	O
D	O
Deficiency	O
in	O
Pregnant	O
Women	O
:	O
A	O
National	O
Cross	O
-	O
Sectional	O
Survey	O
Abstract	O
An	O
increasing	O
number	B
of	I
studies	I
suggest	B
that	O
vitamin	O
D	O
deficiency	O
during	O
pregnancy	O
is	O
associated	O
with	O
multiple	O
adverse	O
health	O
outcomes	O
in	O
mothers	O
,	O
neonates	O
and	O
children	O
.	O

The	O
greatest	O
risk	O
reduction	O
was	O
among	O
children	O
diagnosed	O
under	O
5	O
years	O
of	O
age	O
whose	O
mothers	O
used	O
supplements	O
during	O
all	O
three	O
trimesters	O
(	O
OR	O
0	O
.	O
5	O
,	O
CI	O
0	O
.	O
3	O
-	O
0	O
.	O
8	O
).	O

The	O
responses	O
in	O
the	O
questionnaires	O
were	O
transcribed	O
into	O
EPIInfo	O
version	O
3	O
.	O
5	O
.	O
1	O
database	O
(	O
CDC	O
/	O
WHO	O
,	O
Atlanta	O
,	O
USA	O
).	O

A	O
number	O
of	O
410	O
women	O
was	O
invited	O
to	O
participate	O
at	O
the	O
study	O
.	O

Considering	O
type	O
of	O
pet	O
,	O
the	O
relationship	O
for	O
no	O
pet	O
compared	O
to	O
1	O
or	O
>	O
1	O
dog	O
(	O
37	O
.	O
7	O
,	O
46	O
.	O
1	O
,	O
49	O
.	O
9	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
001	O
)	O
was	O
similar	O
to	O
that	O
for	O
no	O
pet	O
versus	O
1	O
or	O
>	O
1	O
cat	O
(	O
37	O
.	O
7	O
,	O
43	O
.	O
0	O
,	O
46	O
.	O
5	O
nmol	O
/	O
L	O
,	O
respectively	O
,	O
P	O
=	O
0	O
.	O
065	O
).	O

Women	O
who	O
stated	O
that	O
they	O
had	O
received	O
dietary	O
or	O
breastfeeding	O
advice	O
had	O
a	O
higher	O
probability	O
of	O
using	O
folic	O
acid	O
or	O
multivitamins	O
regardless	O
of	O
the	O
number	O
of	O
prenatal	O
visits	O
.	O

One	O
ecological	O
study	O
reported	O
a	O
correlation	O
between	O
perinatal	O
consumption	O
of	O
sugar	O
and	O
severe	O
childhood	O
asthma	O
symptoms	O
[	O
9	O
],	O
but	O
could	O
not	B
specifically	I
address	O
maternal	O
sugar	O
intake	O
in	O
pregnancy	O
.	O

In	O
adults	O
,	O
Toxoplasma	O
gondii	O
infection	O
has	B
been	I
associated	O
with	O
a	O
greater	O
prevalence	O
of	O
astrocytomas	O
[	O
134	O
],	O
while	O
decreased	O
glioma	O
risk	O
has	B
been	I
associated	O
with	O
a	O
history	O
of	O
infections	O
/	O
colds	O
[	O
88	O
],	O
and	O
chicken	O
pox	O
[	O
135	O
,	O
136	O
].	O

Materials	O
and	O
methods	O
The	O
planned	O
implementation	O
consisted	O
of	O
a	O
9	O
-	O
month	O
pre	O
(	O
usual	O
care	O
)/	O
post	O
(	O
new	O
model	O
of	O
care	O
)	O
design	O
with	O
a	O
month	O
for	O
‘	O
integration	O
’	O
across	O
2012	O
-	O
2013	O
.	O

(	O
2014b	O
)*/†	O
Vinyl	O
carbamateMouseInjection	O
(	O
ip	O
)	O
(	O
0	O
.	O
32	O
mg	O
/	O
mouse	O
)	O
Adolescence	O
/	O
early	O
adulthoodAdulthoodPulmonary	O
carcinogenesismiRNAsKassie	O
et	O
al	O
.	O

Generally	O
,	O
there	O
is	O
a	O
lack	B
of	I
evidence	I
for	O
maternal	O
pregnancy	O
restriction	O
diets	O
.	O

47	O
859	O
women	O
were	O
invited	O
to	O
complete	O
a	O
web	O
-	O
based	O
questionnaire	O
,	O
and	O
non	O
-	O
responders	O
received	O
a	O
paper	O
questionnaire	O
.	O

Within	O
developmental	O
period	O
III	O
,	O
AP	O
offspring	O
showed	O
a	O
decreased	O
expression	O
of	O
genes	O
associated	O
with	O
Polo	O
-	O
like	O
kinases	O
,	O
which	O
is	O
in	B
line	I
with	I
the	O
assumption	O
that	O
LP	O
pigs	O
have	O
not	O
terminated	O
their	O
growth	O
at	O
stage	O
188	O
dpn	O
;	O
in	O
particular	O
their	O
liver	O
has	O
not	O
attained	O
a	O
steady	O
-	O
state	O
and	O
that	O
there	O
is	O
persistent	O
functional	O
demand	O
towards	O
cell	O
proliferation	O
potentially	B
to	O
respond	O
to	O
an	O
elevated	O
metabolic	O
burden	O
,	O
including	O
a	O
higher	O
turn	O
over	O
of	O
lipids	O
and	O
ketone	O
bodies	O
.	O

Background	O
Gestational	O
diabetes	O
(	O
GDM	O
)	O
is	O
defined	O
as	O
“	O
carbohydrate	O
intolerance	O
with	O
onset	O
or	O
first	O
recognition	O
during	O
pregnancy	O
”.	O
1Large	O
studies	O
have	O
found	B
that	O
GDM	O
occurs	O
in	O
2	O
.	O
2	O
%–	O
8	O
.	O
8	O
%	O
of	O
pregnancies	O
,	O
depending	O
on	O
the	O
ethnic	O
mix	O
of	O
the	O
population	O
and	O
the	O
criteria	O
used	O
for	O
diagnosis	O
.	O
2In	O
some	B
specific	O
populations	O
however	O
,	O
the	O
incidence	O
can	B
be	O
considerably	O
higher	O
.	O

Antiepileptic	O
drugs	O
and	O
oral	O
supplements	O
may	B
play	O
a	O
role	O
in	O
later	O
onset	O
.	O

It	O
has	B
been	I
shown	O
that	O
fetal	O
growth	O
retardation	O
is	O
accompanied	O
by	O
alterations	O
in	O
cell	O
cycle	O
regulating	O
molecules	O
at	O
both	O
transcriptome	O
[	O
25	O
]	O
and	O
proteome	O
level	O
[	O
26	O
].	O

Although	O
this	O
is	O
probably	O
true	O
,	O
a	O
sufficient	O
serum	O
concentrations	O
for	O
the	O
immunological	O
effects	O
of	O
vitamin	O
D	O
is	O
unknown	O
and	O
could	B
be	I
higher	O
or	O
lower	O
than	O
that	O
of	O
the	O
skeletal	O
system	O
accepted	O
concentrations	O
.	O
6The	B
need	I
for	O
a	O
steady	O
state	O
is	O
currently	O
highly	O
speculative	B
and	O
relates	O
to	O
vitamin	O
D2supplementation	O
for	O
negative	O
cancer22and	O
bone	O
outcomes	O
.	O
23	O
Our	O
findings	O
are	O
at	O
odds	O
with	O
smaller	B
case	O-
-	O-
control	O-
hospital	O-
studies	I
that	O
show	O
an	O
enhanced	O
rate	O
of	O
vitamin	O
D	O
deficiency	O
or	O
rickets	O
in	O
children	O
with	O
pneumonia	O
and	O
the	O
increasing	B
evidence	I
suggesting	B
that	O
calcitriol	O
,	O
the	O
biologically	O
active	O
metabolite	O
of	O
vitamin	O
D	O
,	O
has	O
an	O
important	O
role	O
in	O
the	O
human	O
immune	O
system	O
.	O
4A	O
systematic	O
review	O
of	O
the	O
role	O
of	O
vitamin	O
D	O
supplementation	O
in	O
infectious	O
diseases	O
had	O
mixed	O
findings	O
,	O
concluding	O
that	O
more	O
rigorously	O
designed	O
clinical	O
trials	O
are	O
needed	O
(	O
panel	O
).	O
25No	B
studies	I
report	O
the	O
effect	O
of	O
vitamin	O
D	O
on	O
radiologically	O
confirmed	O
pneumonias	O
.	O

The	O
measurement	O
is	O
taken	O
with	O
the	O
infant	O
lying	O
on	O
his	O
/	O
her	O
back	O
on	O
the	O
infantometer	O
,	O
legs	O
extended	O
with	O
the	O
head	O
and	O
foot	O
board	O
making	O
contact	O
with	O
the	O
infant	O
.	O

The	O
questionnaire	O
is	O
designed	O
to	O
assess	O
rhinitis	O
,	O
asthma	O
and	O
eczema	O
in	O
children	O
and	O
has	O
been	O
used	O
successfully	O
in	O
an	O
older	O
black	O
population	O
in	O
South	O
Africa	O
[	O
50	O
].	O

However	O
,	O
the	O
models	O
were	O
adjusted	O
for	O
gestational	O
age	O
at	O
registration	O
for	O
antenatal	O
care	O
.	O

When	O
analyzing	O
maternal	O
GWG	O
as	O
a	O
continuous	O
measure	O
,	O
similar	O
results	O
were	O
observed	O
.	O

The	O
Cronbach	O
’	O
s	O
α	O
coefficient	O
was	O
acceptable	O
for	O
all	O
sections	O
(	O
general	O
recommendations	O
,	O
0	O
.	O
66	O
;	O
sources	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
;	O
the	O
role	O
of	O
nutrients	O
,	O
0	O
.	O
77	O
),	O
except	O
for	O
breastfeeding	O
(	O
0	O
.	O
60	O
),	O
which	O
was	O
therefore	O
eliminated	O
.	O

The	O
topics	O
focused	O
mainly	O
on	O
care	O
in	O
pregnancy	O
(	O
diet	O
,	O
exercise	O
and	O
importance	O
of	O
ANC	O
)	O
and	O
for	O
the	O
newborn	O
(	O
diet	O
and	O
breastfeeding	O
).	O

A	O
study	O
of	O
15	O
,	O
390	O
Brazilian	O
students	O
was	O
unable	O
to	O
detect	O
a	O
difference	O
in	O
the	O
season	O
of	O
birth	O
between	O
right	O
-	O
and	O
left	O
-	O
handers	O
.	O

1	O
).	O

To	O
visualize	O
the	O
results	O
,	O
we	O
performed	O
principal	O
coordinates	O
analysis	O
(	O
PCoA	O
)	O
on	O
generalized	O
UniFrac	O
distances	O
using	O
the	O
cmdscale	O
function	O
in	O
R	O
[	O
42	O
]	O
and	O
plotted	O
the	O
samples	O
by	O
the	O
first	O
two	O
coordinates	O
,	O
colored	O
by	O
each	O
dietary	O
variable	O
tertile	O
to	O
aid	O
in	O
visualization	O
.	O

Although	O
maternal	O
obesity	O
and	O
excessive	O
GWG	O
are	O
both	O
the	O
result	O
of	O
energy	O
intake	O
exceeding	O
energy	O
expenditure	O
,	O
few	B
studies	I
have	O
examined	O
the	O
specific	O
influences	O
of	O
maternal	O
dietary	O
and	O
exercise	O
behaviors	O
during	O
pregnancy	O
on	O
offspring	O
obesity	O
risk	O
.	O

Maternal	O
diet	O
may	B
influence	O
the	O
infant	O
gut	O
microbiome	O
through	O
vertical	O
transfer	O
of	O
maternal	O
microbes	O
to	O
infants	O
during	O
vaginal	O
delivery	O
and	O
breastfeeding	O
.	O

We	O
found	B
that	O
48	O
.	O
0	O
%	O
of	O
women	O
took	O
folic	O
acid	O
at	O
some	O
stage	O
during	O
pregnancy	O
,	O
compared	O
with	O
27	O
.	O
0	O
%	O
in	O
the	O
IOMC	O
study	O
.	O

The	O
mortality	O
rate	O
in	O
our	O
study	O
cohort	O
was	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
95	O
%	O
CI	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
):	O
4	O
·	O
2	O
per	O
1000	O
child	O
years	O
(	O
2	O
·	O
4	O
–	O
6	O
·	O
7	O
;	O
ten	O
cases	O
)	O
in	O
our	O
vitamin	O
D	O
group	O
and	O
3	O
·	O
4	O
per	O
1000	O
child	O
years	O
(	O
1	O
·	O
3	O
–	O
7	O
·	O
1	O
;	O
seven	O
cases	O
)	O
in	O
our	O
placebo	O
group	O
.	O

Values	O
are	O
expressed	O
as	O
means	O
±	O
S	O
.	O
E	O
.	O
M	O
.	O

A	O
continuous	O
supply	O
of	O
normal	O
levels	O
of	O
dietary	O
vitamin	O
A	O
during	O
the	O
entire	O
growth	O
period	O
may	B
also	O
result	O
in	O
poor	O
marbling	O
and	O
QG	O
,	O
even	O
if	O
the	O
growth	O
rate	O
were	O
normal	O
and	O
no	O
health	O
problems	O
occurred	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
without	O
wheezes	O
,	O
rhonchi	O
,	O
or	O
rales	O
.	O

Fatty	O
acids	O
in	O
red	O
blood	O
cell	O
total	O
phospholipids	O
are	O
determined	O
using	O
gas	O
chromatography	O
tandem	O
mass	O
spectrometry	O
(	O
GCMSMS	O
)	O
[	O
73	O
].	O

A	O
high	B
index	I
of	I
suspicion	I
of	O
gestational	O
diabetes	O
insipidus	O
is	O
required	O
in	O
a	O
correct	O
clinical	O
setting	O
especially	O
in	O
the	O
presence	O
of	O
other	O
risk	O
factors	O
such	O
as	O
preeclampsia	O
,	O
HELLP	O
syndrome	O
,	O
and	O
twin	O
pregnancies	O
.	O

However	O
,	O
we	O
plan	O
to	O
re	O
-	O
examine	O
this	O
hypothesis	B
in	O
another	O
birth	O
cohort	O
to	O
see	O
if	O
we	O
can	B
replicate	O
the	O
main	O
findings	O
.	O

Nutrition	O
during	O
pregnancy	O
and	O
early	O
development	O
(	O
NuPED	O
)	O
in	O
urban	O
South	O
Africa	O
:	O
a	O
study	O
protocol	O
for	O
a	O
prospective	O
cohort	O
Abstract	O
Background	O
Adequate	O
nutrition	O
during	O
pregnancy	O
is	O
important	O
to	O
ensure	O
optimal	O
birth	O
outcomes	O
,	O
maternal	O
health	O
and	O
offspring	O
development	O
.	O

miRNAs	O
targeting	O
GR	O
were	O
predicted	O
using	O
the	O
PITA	O
algorithm	O
.	O

All	O
supplement	O
use	O
,	O
as	O
well	O
as	O
food	O
cravings	O
and	O
aversions	O
,	O
are	O
additionally	O
recorded	O
daily	O
by	O
participants	O
on	O
a	O
calendar	O
.	O

Mothers	O
also	O
took	O
individual	O
micronutrient	O
supplements	O
(	O
e	O
.	O
g	O
.,	O
vitamin	O
C	O
tablets	O
),	O
but	O
most	O
mothers	O
who	O
took	O
these	O
also	O
took	O
multivitamins	O
,	O
making	O
it	O
impossible	O
to	O
determine	O
potential	B
independent	O
effects	O
of	O
these	O
micronutrients	O
.	O

Therefore	O
,	O
a	O
decreased	O
perinatal	O
depression	O
level	O
is	O
justifiable	O
.	O

Furthermore	O
,	O
the	O
gestation	O
at	O
which	O
vitamin	O
D	O
was	O
measured	O
is	O
also	O
important	O
.	O

The	O
pathophysiology	O
is	O
not	O
well	O
understood	O
but	O
has	B
been	I
hypothesized	B
to	O
result	O
from	O
excessive	O
stimulation	O
of	O
V1	O
receptors	O
by	O
vasopressinase	O
-	O
altered	O
AVP	O
leading	O
to	O
platelet	O
aggregation	O
,	O
vasospasm	O
,	O
endothelial	O
constriction	O
,	O
and	O
brain	O
stimulation	O
as	O
discussed	O
by	O
Krege	O
and	O
Katz	O
[	O
6	O
].	O

The	O
high	O
frequency	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
the	O
developing	O
countries	O
has	O
substantial	O
health	O
and	O
economic	O
cost	O
implications	O
.	O

Our	O
aim	O
was	O
to	O
assess	O
whether	O
oral	O
supplementation	O
of	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
will	O
reduce	O
the	O
incidence	O
and	O
severity	O
of	O
pneumonia	O
in	O
a	O
high	O
-	O
risk	O
infant	O
population	O
.	O

Follow	O
-	O
up	O
of	O
a	O
smaller	O
proportion	O
of	O
child	O
participants	O
at	O
2	O
to	O
3	O
years	O
of	O
age	O
[	O
42	O
,	O
43	O
]	O
demonstrated	O
no	O
significant	O
differences	O
in	O
the	O
metabolic	O
profile	O
of	O
children	O
[	O
42	O
],	O
or	O
on	O
measures	O
of	O
growth	O
and	O
adiposity	O
[	O
43	O
].	O

Of	O
these	O
,	O
78	O
.	O
5	O
%	O
(	O
n	O
=	O
285	O
/	O
363	O
;	O
132	O
overweight	O
/	O
obese	O
and	O
153	O
normal	O
weight	O
)	O
had	O
pediatrician	O
records	O
at	O
birth	O
and	O
68	O
.	O
6	O
%	O
(	O
n	O
=	O
249	O
/	O
363	O
;	O
121	O
overweight	O
/	O
obese	O
and	O
128	O
normal	O
weight	O
)	O
had	O
pediatrician	O
information	O
at	O
6	O
months	O
.	O

Cathelicidin	O
(	O
ng	O
/	O
mL	O
)	O
CharacteristicMedian	O
(	O
IQR	O
)	O
1p	O
-	O
valueRace	O
/	O
Ethnicity0	O
.	O
999	O
Black26	O
.	O
8	O
(	O
23	O
.	O
3	O
,	O
41	O
.	O
6	O
)	O
White27	O
.	O
7	O
(	O
18	O
.	O
0	O
,	O
51	O
.	O
9	O
)	O
Hispanic30	O
.	O
2	O
(	O
20	O
.	O
2	O
,	O
39	O
.	O
0	O
)	O
Vitamin	O
D	O
status	O
at	O
Follow	O
-	O
up	O
Visit0	O
.	O
78	O
Deficient	O
(<	O
20	O
ng	O
/	O
mL	O
)	O
27	O
.	O
4	O
(	O
19	O
.	O
8	O
,	O
35	O
.	O
9	O
)	O
Sufficient	O
(≥	O
20	O
ng	O
/	O
mL	O
)	O
29	O
.	O
6	O
(	O
20	O
.	O
2	O
,	O
43	O
.	O
2	O
)	O
1IQR	O
represents	O
25th	O
and	O
75th	O
percentile	O
No	O
significant	O
overall	O
correlation	O
existed	O
between	O
the	O
children	O
’	O
s	O
cathelicidin	O
concentration	O
and	O
the	O
children	O
’	O
s	O
25	O
(	O
OH	O
)	O
D	O
concentration	O
at	O
the	O
time	O
of	O
follow	O
-	O
up	O
visit	O
,	O
nor	O
did	O
one	O
exist	O
when	O
the	O
cohort	O
was	O
stratified	O
by	O
race	O
/	O
ethnicity	O
.	O

There	O
are	O
two	O
major	O
forms	O
of	O
active	O
Vitamin	O
D	O
,	O
Vitamin	O
D2	O
(	O
ergocalciferol	O
)	O
and	O
Vitamin	O
D3	O
(	O
cholecalciferol	O
).	O

The	O
majority	O
of	O
these	O
have	B
been	I
in	O
patients	O
with	O
type	O
1	O
diabetes	O
.	O

Multivariable	O
logistic	O
regression	O
analyses	O
of	O
the	O
outcome	O
variables	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
were	O
performed	O
with	O
25OHD	O
at	O
T1	O
,	O
T3	O
and	O
change	O
in	O
25OHD	O
during	O
pregnancy	O
as	O
the	O
independent	O
variables	O
.	O

Stress	O
was	O
assessed	O
using	O
the	O
short	O
form	O
of	O
the	O
Perceived	O
Stress	O
Scale	O
[	O
29	O
].	O

The	O
porcine	O
expression	O
patterns	O
in	O
this	O
study	O
showed	O
a	O
decreased	O
mRNA	O
expression	O
of	O
genes	O
associated	O
with	O
the	O
control	O
of	O
mitosis	O
and	O
cell	O
cycle	O
checkpoint	O
regulation	O
at	O
stage	O
94	O
dpc	O
in	O
LP	O
fetuses	O
.	O

Using	O
a	O
new	O
assessment	O
technique	O
,	O
we	O
investigated	O
Vitamin	O
D	O
nutritional	O
status	O
among	O
outpatients	O
with	O
GDM	O
in	O
our	O
hospital	O
,	O
and	O
analyzed	O
Vitamin	O
D	O
sources	O
and	O
its	O
association	O
with	O
dietary	O
pattern	O
.	O

Women	O
who	O
were	O
prescribed	O
increased	O
doses	O
of	O
valproic	O
acid	O
showed	O
a	O
twofold	O
increase	O
in	O
risk	O
of	O
developmental	O
malformations	O
and	O
significantly	O
reduced	O
intelligence	O
[	O
30	O
].	O

While	O
the	O
use	O
of	O
a	O
more	O
sensitive	O
test	O
would	O
provide	O
more	O
detailed	O
and	O
accurate	O
estimates	O
of	O
early	O
neurodevelopmental	O
achievement	O
,	O
the	O
ASQ	O
has	B
been	I
validated	O
against	O
robust	O
assessment	O
tools	O
[	O
32	O
],	O
and	O
in	O
a	O
paediatric	O
population	O
[	O
33	O
].	O

Moreover	O
,	O
up	O
to	O
70	O
%	O
of	O
small	O
-	O
for	O
-	O
gestational	O
-	O
age	O
(	O
SGA	O
)	O
infants	O
are	O
constitutionally	O
small	O
(“	O
small	O
but	O
healthy	O
”),	O
which	O
make	O
SGA	O
birth	O
a	O
poor	O
surrogate	O
for	O
intrauterine	O
growth	O
restriction	O
[	O
29	O
].	O

The	O
absorption	O
of	O
dietary	O
vitamin	O
D	O
is	O
generally	O
high	O
at	O
all	O
stages	O
of	O
life	O
[	O
34	O
],	O
but	O
serum	O
levels	O
also	O
depend	O
on	O
the	O
endogenous	O
production	O
of	O
vitamin	O
D	O
due	O
to	O
sun	O
exposure	O
which	O
is	O
subject	O
to	O
seasonal	O
variations	O
.	O

Both	O
histone	O
modifications	O
and	O
DNA	O
methylation	O
changes	O
can	O
inhibit	O
or	O
promote	O
transcription	O
of	O
mRNAs	O
and	O
ncRNAs	O
.	O

The	O
services	O
offered	O
were	O
acceptable	O
in	O
contrast	O
with	O
observations	O
from	O
other	O
studies	O
in	O
Sub	O
-	O
Saharan	O
countries	O
such	O
as	O
in	O
Uganda	O
by	O
Cham	O
et	O
al	O
[	O
27	O
]	O
and	O
that	O
by	O
van	O
Eijket	O
al	O
[	O
4	O
]	O
in	O
Kenya	O
where	O
for	O
example	O
,	O
urine	O
and	O
serological	O
tests	O
are	O
not	O
routinely	O
done	O
.	O

Researchers	O
have	O
studied	O
the	O
relationship	O
between	O
low	O
serum	O
vitamin	O
D	O
concentration	O
and	O
perinatal	O
depression	O
,	O
although	O
no	B
clinical	O-
trial	O-
has	I
been	I
conducted	I
on	O
vitamin	O
D	O
’	O
s	O
effects	O
on	O
depression	O
related	O
to	O
childbirth	O
.	O

The	O
ALSPAC	O
study	O
reports	O
by	O
Daniels	O
et	O
al	O
.	O

In	O
addition	O
,	O
not	O
all	O
of	O
the	O
spermatozoal	O
histones	O
are	O
replaced	O
with	O
protamines	O
during	O
spermiogenesis	O
,	O
up	O
to	O
15	O
%	O
of	O
histones	O
within	O
human	O
spermatozoa	O
and	O
1	O
%	O
in	O
mouse	O
spermatozoa	O
are	O
retained	O
(	O
Miller	O
et	O
al	O
.	O
2010	O
;	O
Carrell2012	O
).	O

A	O
unique	O
form	O
of	O
urticaria	O
associated	O
with	O
pregnancy	O
,	O
which	O
tends	O
to	O
recur	O
in	O
subsequent	O
pregnancies	O
(	O
pregnancy	O
urticaria	O
),	O
has	B
been	I
reported	O
[	O
45	O
].	O

Differences	O
were	O
considered	O
significant	O
at	O
P	O
≤	O
0	O
.	O
05	O
.	O

The	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
(	O
25	O
-(	O
OH	O
)	O
D	O
<	O
20	O
ng	O
/	O
ml	O
)	O
increased	O
significantly	O
with	O
BMI	O
and	O
was	O
significantly	O
higher	O
for	O
women	O
who	O
reported	O
not	O
taking	O
vitamin	O
D	O
-	O
containing	O
multivitamins	O
(	O
Table	O
4	O
).	O

Interaction	O
between	O
time	O
and	O
diet	O
,	O
time	O
and	O
sex	O
,	O
and	O
time	O
,	O
diet	O
,	O
and	O
sex	O
were	O
also	O
significant	O
[	O
F	O
(	O
16	O
,	O
58	O
)=	O
1	O
.	O
83	O
,	O
P	O
<	O
0	O
.	O
05	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
72	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
001	O
;	O
F	O
(	O
16	O
,	O
58	O
)=	O
2	O
.	O
72	O
,	O
P	O
<	O
0	O
.	O
01	O
,	O
respectively	O
].	O

Appropriate	O
sized	O
cuffs	O
are	O
used	O
for	O
obese	O
participants	O
.	O

45	O
.	O
2	O
%	O
of	O
respondents	O
received	O
information	O
on	O
the	O
detection	O
or	O
management	O
of	O
pregnancy	O
danger	O
signs	O
,	O
an	O
observation	O
similar	B
to	I
the	O
42	O
%	O
in	O
Pembe	O
'	O
s	O
study	O
in	O
Tanzania	O
[	O
23	O
].	O

As	B
with	I
the	O
trials	O
in	O
the	O
older	O
children	O
,	O
giving	O
higher	O
doses	O
of	O
vitamin	O
D	O
,	O
25	O
,	O
34we	O
too	O
did	O
not	O
record	O
any	O
adverse	O
effects	O
associated	O
with	O
vitamin	O
D	O
supplementation	O
.	O

Furthermore	O
,	O
the	O
study	O
field	O
-	O
supervisors	O
mapped	O
the	O
region	O
independently	O
to	O
verify	O
the	O
accuracy	O
of	O
the	O
maps	O
of	O
the	O
Agha	O
Khan	O
Trust	O
for	O
Culture	O
,	O
and	O
during	O
recruitment	O
they	O
visited	O
every	O
house	O
in	O
the	O
mapped	O
region	O
to	O
identify	O
families	O
with	O
young	O
children	O
.	O

Same	O
result	O
was	O
obtained	O
about	O
healthy	O
dietary	O
pattern	O
[	O
OR	O
3	O
.	O
70	O
,	O
95	O
%	O
(	O
CI	O
)	O
(	O
0	O
.	O
72	O
-	O
17	O
.	O
86	O
),	O
P	O
=	O
0	O
.	O
52	O
].	O

Averaging	O
parameters	O
were	O
set	O
at	O
70	O
%,	O
therefore	O
for	O
a	O
protein	O
spot	O
to	O
appear	O
in	O
the	O
averaged	O
gel	O
it	O
must	O
be	O
present	O
in	O
70	O
%	O
of	O
all	O
gels	O
within	O
a	O
group	O
.	O

In	O
contrast	O
,	O
in	O
another	B
study	I
40	O
,	O
000	O
IU	O
vitamin	O
D	O
per	O
week	O
was	O
used	O
for	O
6	O
months	O
,	O
but	O
vitamin	O
D	O
was	O
not	O
effective	O
in	O
decreasing	O
depression	O
level	O
compared	O
to	O
the	O
control	O
group	O
[	O
68	O
].	O

Some	B
clinical	O
trials	O
in	O
non	O
-	O
pregnant	O
people	O
showed	B
that	O
vitamin	O
D	O
was	O
effective	O
in	O
decreasing	O
depression	O
level	O
.	O

The	O
rate	O
of	O
neonatal	O
hypoglycemia	O
(	O
5	O
.	O
3	O
%)	O
was	O
similar	O
to	O
insulin	O
(	O
3	O
.	O
7	O
%),	O
but	O
lower	O
than	O
glyburide	O
(	O
33	O
%)	O
(	O
p	O
=	O
0	O
.	O
006	O
).	O

We	O
have	O
previously	B
shown	I
that	O
higher	O
vitamin	O
D	O
status	O
in	O
late	O
pregnancy	O
and	O
larger	O
increase	O
in	O
vitamin	O
D	O
status	O
during	O
pregnancy	O
is	O
associated	O
with	O
lower	O
risk	O
of	O
preeclampsia	O
[	O
3	O
].	O

Accumulation	O
of	O
Vitamin	O
D2	O
in	O
food	O
chain	O
,	O
such	O
as	O
from	O
poultry	O
fed	O
with	O
Vitamin	O
D2	O
fortified	O
feeds	O
and	O
their	O
eggs	O
,	O
also	O
contribute	O
to	O
elevated	O
Vitamin	O
D2	O
levels	O
in	O
human	O
bodies	O
.	O

Furthermore	O
,	O
epigenetic	O
changes	O
may	B
themselves	O
have	O
no	O
consequences	O
on	O
gene	O
expression	O
(	O
as	O
demonstrated	B
in	O
a	O
recent	B
in	O-
vitro	O-
study	I
by	O
Ramos	O
et	O
al	O
.	O

Cross	O
-	O
linking	O
is	O
more	O
likely	O
if	O
the	O
allergen	O
occurs	O
in	O
dimerized	O
or	O
multimerized	O
form	O
[	O
3	O
].	O

Both	O
hypotheses	O
can	B
be	O
valid	O
and	O
coexist	O
,	O
and	O
the	O
second	O
(	O
foetal	O
-	O
cell	O
carcinogenesis	O
)	O
could	B
explain	O
some	B
cases	O
of	O
unusual	B
,	O
rapidly	O
growing	O
DTC	O
.	O

Slaughter	O
weight	O
IMF	O
content	O
or	O
MS	O
generally	O
increases	O
with	O
slaughter	O
weight	O
in	O
several	O
cattle	O
breeds	O
.	O

Comparing	O
perinatal	O
and	O
juvenile	O
piglets	O
(	O
period	O
II	O
)	O
991	O
probe	O
-	O
sets	O
were	O
regulated	O
in	O
a	O
different	O
manner	O
in	O
AP	O
offspring	O
and	O
in	O
LP	O
offspring	O
.	O

A	O
recent	B
case	O-
control	O-
study	I
done	O
in	O
New	O
South	O
Wales	O
,	O
Australia	O
,	O
focused	O
on	O
determining	O
risk	O
factors	O
for	O
autism	O
.	O

In	O
clinical	O
studies	O
,	O
researchers	O
from	O
Kaiser	O
Permanente	O
Northern	O
California	O
Hospitals	O
examined	O
291	O
children	O
born	O
from	O
1995	O
to	O
1999	O
,	O
compared	O
to	O
284	O
controls	O
.	O

Surely	O
,	O
it	O
is	O
better	B
for	O
both	O
society	O
and	O
public	O
health	O
to	O
fully	O
assess	O
the	O
potential	B
epigenetic	O
effects	O
of	O
environmental	O
exposures	O
and	O
introduce	O
regulations	O
and	O
TGs	O
based	O
on	O
relevant	O
data	O
and	O
proven	O
mechanisms	O
of	O
toxicity	O
.	O

However	O
,	O
Burgaz	O
et	O
al	O
.	O

First	O
,	O
our	O
determination	O
of	O
maternal	O
sleep	O
duration	O
and	O
snoring	O
was	O
based	B
on	I
reports	O
made	O
early	O
during	O
pregnancy	O
,	O
so	O
reporting	O
was	B
not	I
conditional	O
on	O
pregnancy	O
outcomes	O
or	O
on	O
signs	O
and	O
symptoms	O
of	O
GDM	O
.	O

Conclusion	O
The	O
obesogenic	O
phenotype	O
in	O
offspring	O
from	O
HV	O
fed	O
dams	O
is	O
prevented	O
by	O
feeding	O
HV	O
or	O
HFol	O
pup	O
diets	O
,	O
possibly	B
due	O
to	O
post	O
-	O
weaning	O
modulation	O
of	O
food	O
intake	O
regulatory	O
mechanisms	O
.	O

Besides	O
,	O
activated	O
lymphocytes	O
can	O
cross	O
the	O
blood	O
–	O
brain	O
barrier	O
and	O
secrete	O
cytokines	O
in	O
the	O
brain	O
[	O
72	O
].	O

The	O
authors	O
suggested	B
that	O
metabolic	O
imprinting	O
by	O
early	O
weaning	O
and	O
a	O
high	O
concentrate	O
feeding	O
before	O
grazing	O
is	O
a	O
feasible	O
method	O
to	O
improve	O
MS	O
and	O
carcass	O
weight	O
.	O

2007	O
).	O

This	O
includes	O
changes	O
in	O
raphe	O
and	O
callosal	O
connections	O
,	O
sensory	O
processing	O
,	O
myelin	O
sheath	O
formation	O
,	O
neophobia	O
,	O
and	O
disrupted	O
juvenile	O
play	O
behavior	O
.	O

This	O
so	O
-	O
called	O
transgenerational	O
epigenetic	O
inheritance	O
is	O
a	O
hotly	O
debated	O
topic	O
.	O

Excess	O
weight	O
is	O
usually	B
defined	O
by	O
the	O
body	O
mass	O
index	O
or	O
BMI	O
.	O

To	O
determine	O
the	O
most	O
robust	O
set	O
of	O
predictors	O
and	O
correlates	O
of	O
infant	O
outcomes	O
,	O
multiple	O
regression	O
analyses	O
were	O
used	O
.	O

However	O
,	O
studies	O
during	O
postnatal	O
periods	O
(	O
after	O
weaning	O
or	O
finishing	O
period	O
)	O
show	O
that	O
feeding	O
a	O
high	O
starch	O
diet	O
along	O
with	O
early	O
weaning	O
in	O
steers	O
generally	O
increased	O
marbling	O
,	O
as	O
described	O
above	O
[	O
51	O
,	O
53	O
,	O
157	O
].	O

Effect	O
on	O
the	O
incidence	O
of	O
pneumonia	O
of	O
vitamin	O
D	O
supplementation	O
by	O
quarterly	O
bolus	O
dose	O
to	O
infants	O
in	O
Kabul	O
:	O
a	O
randomised	O
controlled	O
superiority	O
trial	O
AbstractSummary	O
Background	O
Vitamin	O
D	O
has	O
a	O
role	O
in	O
regulating	O
immune	O
function	O
,	O
and	O
its	O
deficiency	O
is	O
a	O
suggested	B
risk	O
factor	O
for	O
childhood	O
pneumonia	O
.	O

Most	O
women	O
(	O
96	O
.	O
0	O
%)	O
registered	O
their	O
pregnancy	O
with	O
their	O
general	O
practitioner	O
and	O
had	O
the	O
first	O
prenatal	O
visit	O
in	O
the	O
second	O
(	O
61	O
.	O
0	O
%)	O
or	O
the	O
third	O
(	O
19	O
.	O
0	O
%)	O
month	O
;	O
only	O
9	O
.	O
0	O
%	O
of	O
women	O
had	O
the	O
first	O
visit	O
in	O
the	O
fifth	O
month	O
.	O

However	O
,	O
some	B
recent	O
insights	B
are	O
presented	O
and	O
discussed	O
in	O
Hatanaka	O
et	O
al	O
.	O

Histopathologic	O
examination	O
found	O
an	O
inflammatory	O
crust	O
covering	O
an	O
ulceration	O
that	O
consisted	O
of	O
a	O
dense	O
proliferation	O
of	O
capillaries	O
and	O
endothelial	O
cells	O
in	O
the	O
dermis	O
(	O
Fig	O
2	O
).	O

Ancient	O
Chinese	O
Cancer	O
Secret	O
?	O

Methods	O
Study	O
objects	O
Pregnant	O
women	O
in	O
middle	O
and	O
late	O
pregnancy	O
who	O
were	O
diagnosed	O
with	O
GDM	O
by	O
75	O
-	O
g	O
oral	O
glucose	O
tolerance	O
test	O
(	O
OGTT	O
)	O
at	O
the	O
outpatient	O
nutrition	O
clinic	O
in	O
Peking	O
Union	O
Medical	O
College	O
Hospital	O
from	O
October	O
2013	O
to	O
July	O
2015	O
were	O
enrolled	O
in	O
this	O
study	O
.	O

Overall	O
,	O
severe	O
temperature	O
stress	O
may	B
have	O
significant	O
negative	O
effects	O
on	O
animal	O
production	O
,	O
including	O
growth	O
performance	O
and	O
product	O
quality	O
,	O
although	O
mild	O
temperature	O
stress	O
may	B
differentially	O
affect	O
production	O
.	O

We	O
conducted	O
a	O
review	O
of	O
effectiveness	O
of	O
preventive	O
treatments	O
of	O
iron	O
deficiency	O
anaemia	O
in	O
pregnancy	O
in	O
developing	O
countries	O
and	O
highlighted	B
their	O
constraints	O
as	O
well	O
as	O
interventions	O
required	O
to	O
strengthen	O
the	O
health	O
services	O
.	O

Her	O
serum	O
antidiuretic	O
hormone	O
level	O
,	O
at	O
the	O
time	O
of	O
birth	O
,	O
was	O
<	O
0	O
.	O
5	O
pg	O
/	O
mL	O
(	O
Normal	O
0	O
.	O
0	O
–	O
4	O
.	O
7	O
pg	O
/	O
mL	O
).	O

Body	O
weight	O
and	O
cumulative	O
caloric	O
intake	O
relative	O
to	O
body	O
weight	O
in	O
offspring	O
were	O
evaluated	O
during	O
the	O
lactation	O
and	O
/	O
or	O
post	O
-	O
weaning	O
periods	O
(	O
Figures2B	O
,	O
C	O
).	O

So	O
,	O
the	O
purpose	O
of	O
the	O
current	O
study	O
was	O
to	O
investigate	O
the	O
association	O
between	O
major	O
maternal	O
dietary	O
patterns	O
during	O
the	O
first	O
-	O
trimester	O
period	O
and	O
neonatal	O
anthropometric	O
measurements	O
including	O
body	O
weight	O
,	O
head	O
circumference	O
,	O
and	O
height	O
.	O

Conclusions	O
Antenatal	O
dietary	O
and	O
lifestyle	O
advice	O
did	O
not	O
alter	O
infant	O
growth	O
and	O
adiposity	O
at	O
6	O
-	O
months	O
of	O
age	O
.	O

3	O
.	O
3	O
.	O
2	O
.	O

Venous	O
blood	O
is	O
processed	O
within	O
1	O
h	O
after	O
blood	O
draw	O
;	O
plasma	O
/	O
serum	O
separated	O
and	O
red	O
blood	O
cells	O
washed	O
twice	O
with	O
normal	O
saline	O
.	O

In	O
this	O
issue	O
of	O
Journal	O
of	O
Clinical	O
and	O
Translational	O
Endocrinology	O
,	O
Alissa	O
et	O
al	O
.	O

A	O
previous	O
small	O
study	O
in	O
Brussels	O
suggested	B
that	O
the	O
prevalence	O
of	O
vitamin	O
D	O
deficiency	O
was	O
high	O
among	O
the	O
adult	O
population	O
and	O
that	O
immigrants	O
were	O
at	O
greater	O
risk	O
of	O
vitamin	O
D	O
deficiency	O
[	O
32	O
].	O

In	O
univariate	O
analyses	O
,	O
thyroxine	O
therapy	O
apparently	O
helps	O
decrease	O
cancer	O
-	O
related	O
death	O
rates	O
among	O
patients	O
with	O
PTC	O
.	O

Summary	O
Based	O
on	O
currently	O
available	B
evidence	I
,	O
guidelines	O
for	O
primary	O
and	O
secondary	O
prevention	O
of	O
allergic	O
disease	O
can	O
be	O
summarized	O
as	O
follows	O
(	O
Table3	O
).	O

Weaning	O
age	O
Weaning	O
age	O
is	O
known	O
to	O
affect	O
IMF	O
deposition	O
and	O
MS	O
in	O
beef	O
.	O

Despite	O
this	O
,	O
it	O
remains	B
important	O
to	O
continue	O
to	O
follow	O
-	O
up	O
the	O
children	O
whose	O
mothers	O
participated	O
in	O
this	O
intervention	O
trial	O
,	O
particularly	O
in	O
view	B
of	O
the	O
well	O
recognised	O
association	O
between	O
high	O
-	O
infant	O
birth	O
weight	O
and	O
subsequent	O
childhood	O
obesity	O
[	O
48	O
],	O
and	O
the	O
emerging	B
associations	O
between	O
maternal	O
obesity	O
and	O
impaired	O
childhood	O
neurodevelopmental	O
function	O
[	O
46	O
].	O

Not	O
only	O
is	O
it	O
unlikely	O
that	O
a	O
human	O
would	O
receive	O
this	O
,	O
or	O
any	O
,	O
environmental	O
exposure	O
via	O
the	O
same	O
route	O
of	O
administration	O
,	O
but	O
also	O
the	O
way	O
in	O
which	O
an	O
exposure	O
is	O
administered	O
determines	O
its	O
overall	O
effect	O
.	O

Although	O
vitamin	O
D	O
overload	O
is	O
a	O
theoretical	O
possibility	B
,	O
100	O
000	O
IU	O
of	O
vitamin	O
D3has	B
been	I
shown	O
to	O
provide	O
the	O
best	O
protection	O
against	O
vitamin	O
D	O
deficiency	O
without	O
overload	O
or	O
side	O
-	O
effects	O
in	O
high	O
-	O
risk	O
infants	O
aged	O
0	O
–	O
9	O
months	O
with	O
normal	O
baseline	O
ranges	O
of	O
vitamin	O
D	O
.	O
16Furthermore	O
,	O
single	O
intramuscular	O
injection	O
of	O
three	O
times	O
this	O
dose	O
(	O
300	O
000	O
IU	O
)	O
was	O
safe	O
in	O
treating	O
nutritional	O
rickets	O
in	O
6	O
–	O
30	O
-	O
month	O
-	O
old	O
children	O
residing	O
in	O
lower	O
socioeconomic	O
regions	O
of	O
sunny	O
Istanbul	O
.	O
35Higher	O
than	O
recommended	O
doses	O
of	O
daily	O
supplementation	O
of	O
vitamin	O
D	O
(	O
500	O
–	O
1000	O
IU	O
per	O
day	O
,	O
adding	O
up	O
to	O
120	O
000	O
IU	O
over	O
3	O
months	O
)	O
plus	O
additional	O
milk	O
fortified	O
with	O
vitamin	O
D	O
,	O
has	B
been	I
shown	O
not	O
to	O
induce	O
an	O
overload	O
,	O
13including	O
in	O
infants	O
starting	O
with	O
normal	O
ranges	O
of	O
vitamin	O
D	O
,	O
even	O
when	O
supplementation	O
continued	O
during	O
the	O
summer	O
(	O
in	O
France	O
)	O
and	O
when	O
mothers	O
had	O
antenatal	O
vitamin	O
D	O
supplementation	O
.	O
36It	O
is	O
important	O
to	O
note	O
that	O
in	O
our	O
study	O
,	O
where	O
community	O
supplementation	O
was	O
in	O
a	O
population	O
with	O
known	O
high	O
rates	O
of	O
vitamin	O
D	O
deficiency	O
,	O
1	O
%	O
of	O
children	O
tested	O
had	O
a	O
calcifediol	O
concentration	O
greater	O
than	O
375	O
nmol	O
/	O
L	O
—	O
thought	B
undesirably	O
high	O
.	O
6Although	O
these	O
did	O
not	O
produce	O
any	O
clinical	O
signs	O
and	O
symptoms	O
,	O
these	O
measurements	O
raise	O
a	O
need	O
for	O
caution	O
with	O
doses	O
for	O
population	O
supplementation	O
.	O

Particularly	O
,	O
Bonferroni	O
analysis	O
indicated	B
that	O
RC	O
males	O
and	O
RC	O
females	O
did	O
not	O
displayed	O
higher	O
caloric	O
intake	O
compared	O
to	O
the	O
respective	O
CC	O
males	O
and	O
CC	O
females	O
.	O

OR	O
Odds	O
ratio	O
.	O

We	O
will	O
publish	O
the	O
analysis	O
of	O
the	O
outcomes	O
in	O
the	O
form	O
of	O
internal	O
documents	O
,	O
working	O
papers	O
,	O
and	O
in	O
international	O
peer	O
-	O
reviewed	O
journals	O
.	O

In	O
addition	O
the	O
odds	O
of	O
having	O
a	O
serum	O
25	O
-(	O
OH	O
)	O
D	O
concentration	O
lower	O
than	O
10	O
ng	O
/	O
ml	O
(	O
severe	O
vitamin	O
D	O
deficiency	O
)	O
versus	O
a	O
non	O
severe	O
deficient	O
vitamin	O
D	O
status	O
were	O
estimated	O
through	O
multiple	O
logistic	O
regressions	O
while	O
entering	O
the	O
same	O
predictors	O
in	O
the	O
model	O
.	O

Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
I	O
.	O
Physiological	O
changes	O
in	O
thyroid	O
function	O
during	O
pregnancy	O
.	O
IncreaseDecreaseHCG	O
(	O
TSH	O
–	O
like	O
effect	O
)	O
TSHTBG	O
,	O
serum	O
total	O
T	O
4	O
and	O
T3	O
,	O
T3	O
and	O
T4	O
pool	O
sizeHTGType	O
III	O
5	O
-	O
deiodinase	O
,	O
iodine	O
clearance	O
,	O
T3	O
and	O
T4	O
degradationThyroid	O
volume	O
Besides	O
the	O
well	O
-	O
known	O
association	O
between	O
gestational	O
hypothyroidism	O
and	O
impaired	O
intellectual	O
and	O
cognitive	O
development	O
in	O
offspring	O
,	O
untreated	O
or	O
inadequately	O
treated	O
and	O
subclinical	O
hypothyroidism	O
is	O
associated	O
with	O
foetal	O
loss	O
,	O
anaemia	O
,	O
gestational	O
hypertension	O
and	O
preeclampsia	O
,	O
abruption	O
placentae	O
,	O
increased	O
risk	O
of	O
miscarriage	O
,	O
foetal	O
growth	O
retardation	O
,	O
perinatal	O
mortality	O
and	O
neonatal	O
morbidity91315	O
-	O
172122	O
.	O

However	O
,	O
the	O
fetal	O
programming	O
did	O
not	O
significantly	O
affect	O
beef	O
quality	O
characteristics	O
at	O
30	O
mo	O
of	O
age	O
.	O

Concerning	O
hyperphagia	O
,	O
several	B
studies	I
have	B
reported	I
this	O
feeding	O
alteration	O
after	O
the	O
exposure	O
to	O
undernutrition	O
in	O
critical	O
windows	O
of	O
development	O
(	O
Vickers	O
et	O
al	O
.,	O
2000	O
;	O
Desai	O
et	O
al	O
.,	O
2005	O
;	O
Breton	O
et	O
al	O
.,	O
2009	O
;	O
Palou	O
et	O
al	O
.,	O
2010	O
;	O
Lukaszewski	O
et	O
al	O
.,	O
2011	O
;	O
Manuel	O
-	O
Apolinar	O
et	O
al	O
.,	O
2014	O
),	O
so	O
it	O
has	B
been	I
proposed	B
as	O
an	O
important	O
contributor	O
of	O
the	O
excessive	O
body	O
weight	O
.	O

Caption	O
(	O
FIG	O
):	O
FIGURE	O
3	O
.	O

After	O
adjusting	O
for	O
maternal	O
age	O
and	O
race	O
/	O
ethnicity	O
,	O
women	O
who	O
reported	O
sleeping	O
≤	O
4	O
hours	O
per	O
night	O
during	O
early	O
pregnancy	O
had	O
a	O
5	O
.	O
56	O
-	O
fold	O
increased	O
risk	O
of	O
GDM	O
as	O
compared	O
with	O
those	O
women	O
who	O
reported	O
sleeping	O
9	O
hours	O
per	O
night	O
(	O
the	O
reference	O
group	O
)	O
(	O
RR	O
=	O
5	O
.	O
56	O
;	O
95	O
%	O
CI	O
1	O
.	O
31	O
-	O
23	O
.	O
69	O
).	O

SIRTs	O
have	O
an	O
important	O
role	O
in	O
the	O
process	O
of	O
synapse	O
promotion	O
and	O
modulation	O
of	O
their	O
strength	O
,	O
which	O
is	O
important	O
for	O
memory	O
formation	O
.	O

Genes	O
associated	O
with	O
the	O
'	O
complement	O
system	O
'	O
showed	O
increased	O
mRNA	O
expression	O
levels	O
,	O
whereas	O
the	O
canonical	O
pathway	O
'	O
G1	O
/	O
S	O
checkpoint	O
regulation	O
'	O
was	O
found	O
to	O
be	O
decreased	O
in	O
LP	O
offspring	O
.	O

Urinary	O
iodine	O
concentrations	O
are	O
determined	O
in	O
spot	O
urine	O
samples	O
using	O
a	O
modification	O
of	O
the	O
Sandell	O
-	O
Kolthoff	O
reaction	O
with	O
spectrophotometric	O
detection	O
[	O
70	O
].	O

Generalized	O
linear	O
models	O
were	O
fitted	O
to	O
derive	O
relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
intervals	O
(	O
95	O
%	O
CIs	O
)	O
of	O
GDM	O
associated	O
with	O
sleep	O
duration	O
and	O
snoring	O
,	O
respectively	O
.	O

The	O
validity	O
of	O
PUFA	O
estimated	O
by	O
means	O
of	O
the	O
FFQ	O
was	O
r	O
=	O
0	O
.	O
5	O
in	O
comparison	O
to	O
adipose	O
tissue	O
composition	O
[	O
26	O
].	O

Repetitive	O
element	O
DNA	O
methylation	O
was	O
determined	O
by	O
bisulfite	O
pyrosequencing	O
of	O
the	O
LINE	O
-	O
1	O
and	O
the	O
AluYb8	O
repetitive	O
elements	O
as	O
previously	O
described	O
(	O
Bollati	O
et	O
al	O
.	O

However	O
,	O
none	B
of	O
these	O
covariates	O
change	O
the	O
estimates	B
substantially	O
,	O
and	O
was	O
therefore	O
not	O
included	O
in	O
the	O
final	O
multivariate	O
model	B
cAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
cod	O
-	O
type	O
fish	O
and	O
shellfish	O
dAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
salmon	O
-	O
type	O
fish	O
and	O
shellfish	O
eAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
,	O
alcohol	O
,	O
salmon	O
-	O
type	O
fish	O
and	O
cod	O
-	O
type	O
fish	O
fAdjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
and	O
alcohol	O
Caption	O
(	O
FIG	O
):	O
FIGURE	O
1	O
Relative	O
risk	O
of	O
positive	O
psychotic	O
-	O
like	O
symptoms	O
in	O
relation	O
to	O
estimated	O
dietary	O
intake	O
of	O
all	O
fish	O
and	O
seafood4	O
.	O
1Relative	O
risk	O
(	O
RR	O
)	O
and	O
95	O
%	O
confidence	O
interval	O
evaluated	O
by	O
multinomial	O
logistic	O
regression	O
,	O
adjusted	O
for	O
age	O
,	O
total	O
energy	O
intake	O
and	O
dietary	O
intake	O
of	O
vegetables	O
,	O
vitamin	O
B12	O
and	O
alcohol	O
.	O
2The	O
group	O
with	O
no	O
or	O
low	O
level	O
of	O
psychotic	O
symptoms	O
was	O
used	O
as	O
reference	O
group	O
.	O
3Participants	O
categorized	O
into	O
levels	O
;	O
no	O
/	O
low	O
,	O
middle	O
,	O
high	O
frequency	O
of	O
psychotic	O
-	O
like	O
symptoms	O
.	O
4Total	O
intake	O
of	O
all	O
fish	O
and	O
seafood	O
were	O
grouped	O
into	O
six	O
categories	O
;	O
none	O
,	O
1	O
-	O
3	O
times	O
per	O
month	O
,	O
once	O
per	O
week	O
,	O
twice	O
per	O
week	O
,	O
3	O
-	O
4	O
times	O
per	O
week	O
and	O
5	O
times	O
per	O
week	O
or	O
more	O
.	O

A	O
summary	O
of	O
these	O
articles	O
and	O
their	O
quality	O
rating	O
is	O
presented	O
inTable	O
2	O
.	O
nutrients	O
-	O
07	O
-	O
02001	O
-	O
t002_Table	O
2	O
Caption	O
(	O
TABLE	O
-	O
WRAP	O
):	O
TABLE	O
2	O
Summary	O
and	O
quality	O
rating	O
for	O
reviewed	O
articles	O
.	O
ReferenceDaniels	O
et	O
al	O
.	O

In	O
addition	O
,	O
treating	O
the	O
infant	O
with	O
DDAVP	O
besides	O
intravenous	O
fluids	O
may	B
also	O
be	O
beneficial	O
.	O

indicates	O
the	O
existence	O
of	O
conflicting	O
data	O
in	O
the	O
literature	O
with	O
regard	O
to	O
the	O
impact	O
of	O
the	O
factor	O
on	O
UCP1	O
activity	O
.	O

More	O
studies	O
that	O
incorporate	O
some	B
form	O
of	O
inhibition	O
/	O
treatment	O
/	O
cessation	O
into	O
the	O
experimental	O
design	O
are	O
vital	O
for	O
establishing	O
whether	O
or	O
not	O
an	O
exposure	O
truly	O
represents	O
an	O
epigenetic	O
toxicant	O
.	O

Results	O
Cohort	O
While	O
194	O
children	O
had	O
participated	O
in	O
the	O
follow	O
-	O
up	O
study	O
(	O
55	O
%	O
of	O
the	O
original	O
cohort	O
participating	O
in	O
the	O
vitamin	O
D	O
pregnancy	O
study	O
),	O
133	O
(	O
38	O
%)	O
had	O
a	O
blood	O
sample	O
obtained	O
at	O
the	O
time	O
of	O
the	O
study	O
visit	O
and	O
thus	O
,	O
were	O
able	O
to	O
have	O
cathelicidin	O
measured	O
.	O

Obesity	O
was	O
defined	O
as	O
BMI	O
≥	O
30	O
kg	O
/	O
m2	O
,	O
overweight	O
as	O
BMI	O
≥	O
25	O
and	O
<	O
30	O
kg	O
/	O
m2	O
,	O
normal	O
weight	O
as	O
BMI	O
>	O
20	O
and	O
<	O
25	O
kg	O
/	O
m2and	O
underweight	O
as	O
BMI	O
≤	O
20	O
kg	O
/	O
m2	O
.	O

Higher	O
IMF	O
deposition	O
with	O
higher	O
concentrate	O
feeding	O
may	B
occur	O
if	O
IMF	O
preferentially	O
uses	O
glucose	O
as	O
a	O
substrate	O
for	O
FA	O
synthesis	O
,	O
while	O
subcutaneous	O
fat	O
uses	O
acetate	O
,	O
as	O
described	O
by	O
Smith	O
and	O
Crouse	O
[	O
88	O
].	O

The	O
questionnaire	O
asked	O
about	O
76	O
food	O
items	O
,	O
plus	O
use	O
of	O
vitamins	O
,	O
certain	O
reduced	O
-	O
fat	O
foods	O
,	O
and	O
cooking	O
fat	O
.	O

The	O
CB1	O
receptor	O
inverse	O
agonist	O
AM251	O
was	O
able	O
to	O
decrease	O
the	O
motivation	O
to	O
obtain	O
highly	O
palatable	O
food	O
in	O
a	O
free	O
choice	O
test	O
(	O
Mathes	O
et	O
al	O
.,	O
2008	O
;	O
Droste	O
et	O
al	O
.,	O
2010	O
;	O
Deshmukh	O
and	O
Sharma	O
,	O
2012	O
).	O

These	O
spots	O
were	O
mapped	O
to	O
33	O
unique	O
proteins	O
.	O

As	O
expected	O
,	O
a	O
greater	O
proportion	O
of	O
CpGs	O
in	O
the	O
relatively	O
methylated	O
(	O
rightmost	O
)	O
classes	O
9	O
–	O
12	O
are	O
localized	O
in	O
repetitive	O
elements	O
(	O
Figure	O
2A	O
–	O
D	O
).	O

The	O
disorder	O
is	O
debilitating	O
for	O
the	O
patient	O
and	O
immensely	O
challenging	O
for	O
his	O
/	O
her	O
family	O
.	O

suggested	B
that	O
more	O
accurate	O
clinical	O
trials	O
are	O
required	O
to	O
reach	O
a	O
conclusion	B
about	O
the	O
effectiveness	O
of	O
vitamin	O
D	O
on	O
depression	O
[	O
31	O
].	O

Full	O
adherence	O
may	B
have	O
resulted	O
in	O
even	O
greater	O
changes	O
.	O

These	O
concerns	O
had	O
been	O
attributed	O
to	O
inadequate	B
infrastructure	O
and	O
poor	O
compliance	O
with	O
preventive	O
treatment	O
,	O
among	O
others	O
[	O
34	O
].	O

2	O
.	O
2	O
.	O
2	O
.	O

As	O
the	O
main	O
endogenous	O
agonists	O
(	O
anandamide	O
and	O
2	O
-	O
arachidonoyl	O
glycerol	O
)	O
of	O
the	O
cannabinoid	O
receptors	O
CB1	O
and	O
CB2	O
are	O
derivatives	O
of	O
fatty	O
acids	O
,	O
it	O
has	B
been	I
demonstrated	I
that	O
the	O
lipid	O
profile	O
of	O
the	O
diet	O
could	B
modify	O
the	O
endocannabinoid	O
levels	O
(	O
Artmann	O
et	O
al	O
.,	O
2008	O
)	O
in	O
some	B
tissues	O
,	O
including	O
the	O
early	O
developing	O
brain	O
(	O
Berger	O
et	O
al	O
.,	O
2001	O
).	O

The	O
average	O
number	O
of	O
visits	O
to	O
the	O
general	O
practitioner	O
was	O
4	O
.	O
8	O
±	O
2	O
.	O
54	O
.	O

Infant	O
anthropometric	O
measurements	O
Infant	O
growth	O
is	O
assessed	O
at	O
each	O
postnatal	O
visit	O
.	O

The	O
methylation	O
status	O
for	O
each	O
individual	O
CpG	O
locus	O
was	O
calculated	O
as	O
the	O
ratio	O
of	O
fluorescent	O
signals	O
:	O
β	O
=	O
max	O
(	O
M	O
,	O
0	O
)/[	O
max	O
(	O
M	O
,	O
0	O
)	O
+	O
max	O
(	O
U	O
,	O
0	O
)	O
+	O
100	O
],	O
using	O
the	O
average	O
probe	O
intensity	O
for	O
the	O
methylated	O
(	O
M	O
)	O
and	O
unmethylated	O
(	O
U	O
)	O
alleles	O
.	O

In	O
view	B
of	O
the	O
multiple	O
analyses	O
carried	O
out	O
and	O
the	O
post	O
hoc	O
nature	O
of	O
the	O
findings	O
for	O
atopic	O
asthma	O
,	O
we	O
cannot	B
exclude	I
the	O
possibility	B
that	O
the	O
main	O
findings	O
occurred	O
by	O
chance	O
;	O
hence	O
,	O
they	O
should	O
be	O
interpreted	O
with	O
caution	B
.	O

The	O
different	O
dietary	O
exposure	O
of	O
the	O
offspring	O
during	O
prenatal	O
development	O
can	O
be	O
expected	O
to	O
cause	O
slight	O
shifts	O
of	O
the	O
developmental	O
age	O
of	O
the	O
offspring	O
that	O
may	B
be	I
reflected	O
by	O
subtle	O
changes	O
of	O
the	O
transcriptome	O
and	O
could	B
hamper	O
the	O
identification	O
of	O
direct	O
effects	O
of	O
the	O
gestational	O
diets	O
on	O
the	O
hepatic	O
expression	O
.	O

It	O
is	O
worth	O
noting	O
,	O
however	O
,	O
that	O
establishing	O
the	O
actual	O
level	O
of	O
human	O
exposure	O
to	O
a	O
particular	O
factor	O
and	O
mimicking	O
it	O
in	O
experimental	O
models	B
is	O
not	O
always	O
easy	O
.	O

Similar	B
studies	I
using	O
a	O
Swedish	O
medical	O
birth	O
registry	O
observed	O
different	O
factors	O
that	O
affected	O
autism	O
spectrum	O
disorders	O
.	O

Analyzed	O
the	O
data	O
:	O
MO	O
EM	O
SP	O
KW	O
.	O

The	O
general	O
principles	O
of	O
treatment	O
of	O
pregnant	O
women	O
with	O
asthma	O
[	O
21	O
,	O
22	O
,	O
28	O
]	O
and	O
AR	O
[	O
29	O
]	O
do	O
not	O
differ	O
from	O
the	O
stepwise	O
approach	O
recommended	O
for	O
treatment	O
of	O
nonpregnant	O
women	O
.	O

Over	O
the	O
past	O
several	O
decades	O
,	O
continuing	B
research	I
has	B
been	I
conducted	O
,	O
and	O
much	B
literature	I
has	B
been	I
published	O
that	O
has	O
supported	B
the	O
existence	O
of	O
the	O
links	O
between	O
autism	O
and	O
factors	O
that	O
relate	O
to	O
pre	O
-,	O
peri	O
-,	O
and	O
neonatal	O
care	O
.	O

As	O
indicated	B
by	O
the	O
seasonal	O
variation	O
in	O
serum	O
25	O
(	O
OH	O
)	O
D	O
,	O
amongst	O
women	O
recruited	O
in	O
Adelaide	O
,	O
vitamin	O
D	O
status	O
declined	O
significantly	O
from	O
February	O
to	O
April	O
whilst	O
in	O
the	O
women	O
recruited	O
in	O
Auckland	O
,	O
serum	O
25	O
(	O
OH	O
)	O
D	O
in	O
March	O
and	O
April	O
remained	O
elevated	O
before	O
declining	O
.	O

Are	O
Attributes	O
of	O
Pregnancy	O
and	O
the	O
Delivery	O
Room	O
Experience	O
Related	O
to	O
Development	O
of	O
Autism	O
?	O

On	O
the	O
other	O
hand	O
,	O
increased	O
risk	O
for	O
childhood	O
brain	O
tumors	O
has	B
been	I
associated	O
in	O
some	B
studies	O
with	O
a	O
history	O
of	O
chicken	O
pox	O
[	O
137	O
],	O
influenza	O
[	O
138	O
,	O
139	O
],	O
measles	O
[	O
138	O
],	O
general	O
viral	O
infections	O
[	O
140	O
,	O
141	O
],	O
and	O
neonatal	O
urinary	O
tract	O
infections	O
[	O
141	O
].	O

But	O
neither	O
body	O
weight	O
at	O
weaning	O
nor	O
body	O
weight	O
at	O
188	O
dpn	O
differed	O
significantly	O
among	O
offspring	O
of	O
the	O
LP	O
and	O
the	O
AP	O
group	O
,	O
whereas	O
visceral	O
and	O
subcutaneous	O
fat	O
content	O
remained	O
higher	O
in	O
LP	O
than	O
in	O
AP	O
during	O
postnatal	O
life	O
[	O
15	O
-	O
17	O
].	O

Nulliparous	O
and	O
multiparous	O
mothers	O
were	O
considered	O
as	O
the	O
strata	O
.	O

Season	O
was	O
coded	O
as	O
a	O
binary	O
variable	O
,	O
since	O
this	O
explained	O
30	O
%	O
of	O
vitamin	O
D	O
status	O
in	O
a	O
previous	B
study	I
in	O
pregnant	O
women	O
at	O
the	O
same	O
latitude	O
[	O
16	O
].	O

Low	O
maternal	O
fish	O
and	O
seafood	O
consumption	O
during	O
pregnancy	O
is	O
reported	B
to	O
increase	O
the	O
risk	O
for	O
a	O
low	O
IQ	O
and	O
suboptimal	O
neuro	O
-	O
developmental	O
outcomes	O
in	O
childhood	O
[	O
10	O
],	O
factors	O
that	O
in	O
turn	O
are	O
associated	O
with	O
an	O
increased	O
risk	O
for	O
adult	O
mental	O
disorders	O
like	O
schizophrenia	O
[	O
11	O
].	O

They	O
were	O
suffering	O
from	O
vitamin	O
D	O
deficiency	O
based	O
on	O
new	O
perspective	O
towards	O
normal	O
serum	O
vitamin	O
D	O
concentration	O
[	O
46	O
].	O

Collectively	O
,	O
the	O
findings	B
from	O
this	O
pilot	O
study	O
provides	O
evidence	B
consistent	B
with	O
the	O
notion	B
that	O
glucose	O
homeostasis	O
in	O
pregnancy	O
is	O
sensitive	O
to	O
maternal	O
habitual	O
short	O
sleep	O
duration	O
and	O
snoring	O
during	O
pregnancy	O
.	O

Eligibility	O
Criteria	O
Articles	O
published	O
in	O
peer	O
-	O
reviewed	O
journals	O
between	O
January	O
2000	O
and	O
March	O
2014	O
were	O
included	O
in	O
this	O
review	O
.	O

PTH	O
was	O
not	O
elevated	O
(	O
median	O
1	O
.	O
0pmol	O
/	O
L	O
[<	O
0	O
.	O
3	O
-	O
3	O
.	O
1	O
]),	O
urinary	O
calcium	O
:	O
creatinine	O
ratio	O
not	O
suppressed	O
(	O
median	O
2	O
.	O
3	O
,	O
[	O
0	O
.	O
4	O
-	O
9	O
]),	O
25OHVitD	O
low	O
-	O
normal	O
(	O
median	O
44nmol	O
/	O
L	O
[	O
17	O
-	O
218	O
])	O
and	O
1	O
,	O
25	O
(	O
OH	O
)	O
2VitD	O
elevated	O
(	O
median	O
232pmol	O
/	O
L	O
[	O
64	O
-	O
720	O
]),	O
in	O
keeping	O
with	O
an	O
abnormality	O
in	O
CYP24A1	O
.	O

There	O
were	O
1754	O
infants	O
who	O
were	O
assessed	O
at	O
6	O
months	O
of	O
age	O
(	O
Lifestyle	O
Advice	O
n	O
=	O
869	O
;	O
Standard	O
Care	O
n	O
=	O
885	O
),	O
representing	O
82	O
.	O
1	O
%	O
of	O
the	O
eligible	O
sample	O
.	O

The	O
distinguishing	O
feature	O
of	O
AAOC	O
is	O
that	O
the	O
capillary	O
formation	O
is	O
not	O
lobular	O
as	O
seen	O
in	O
PG	O
but	O
rather	O
a	O
diffuse	O
pattern	O
.	O

In	O
this	O
pilot	O
study	O
,	O
we	O
assessed	O
associations	O
of	O
maternal	O
self	O
-	O
reported	O
sleep	O
duration	O
and	O
snoring	O
during	O
early	O
pregnancy	O
with	O
glucose	O
intolerance	O
and	O
a	O
diagnosis	O
of	O
GDM	O
later	O
in	O
pregnancy	O
.	O

PubMed	O
Central	O
:	O

3	O
.	O
2	O
.	O
2	O
.	O

In	O
this	O
case	O
,	O
the	O
optimum	O
slaughter	O
age	O
for	O
the	O
highest	O
profit	O
was	O
28	O
months	O
.	O

2	O
.	O
1	O
.	O

At	O
stage	O
94	O
dpc	O
1	O
,	O
001	O
probe	O
-	O
sets	O
differed	O
significantly	O
between	O
LP	O
and	O
AP	O
fetuses	O
(	O
541	O
LP	O
≻	O
AP	O
).	O

For	O
these	O
analyses	O
,	O
we	O
classified	O
women	O
by	O
the	O
joint	O
distribution	O
of	O
pre	O
-	O
pregnancy	O
lean	O
or	O
overweight	O
status	O
(<	O
25	O
vs	O
.	O
≥	O
25	O
kg	O
/	O
m2	O
)	O
and	O
snoring	O
during	O
early	O
pregnancy	O
(	O
no	O
vs	O
.	O
yes	O
)	O
thus	O
resulting	O
in	O
the	O
following	O
categories	O
:	O
lean	O
and	O
non	O
-	O
snorer	O
(	O
the	O
reference	O
group	O
);	O
lean	O
and	O
snorer	O
;	O
overweight	O
and	O
non	O
-	O
snorer	O
;	O
and	O
overweight	O
and	O
snorer	O
.	O

Differences	O
in	O
the	O
definition	O
of	O
atopy	O
,	O
a	O
lack	B
of	I
objective	O
measures	O
of	O
atopy	O
,	O
residual	O
confounding	O
,	O
and	O
bias	B
(	O
e	O
.	O
g	O
.,	O
detection	O
,	O
selection	O
,	O
interview	O
,	O
recall	O
)	O
are	O
important	O
to	O
consider	O
when	O
interpreting	O
the	O
above	O
studies	O
[	O
92	O
,	O
121	O
].	O

Also	O
,	O
at	O
6	O
months	O
,	O
children	O
exposed	O
to	O
excessive	O
GWG	O
had	O
near	O
significant	O
(	O
P	O
=	O
.	O
06	O
)	O
higher	O
odds	O
of	O
WFA	O
z	O
score	O
>	O
90th	O
percentile	O
compared	O
with	O
children	O
exposed	O
to	O
adequate	O
weight	O
gain	O
(	O
OR	O
=	O
6	O
.	O
2	O
(	O
0	O
.	O
94	O
,	O
41	O
.	O
1	O
),	O
but	O
no	O
significant	O
association	O
was	O
seen	O
on	O
WFA	O
z	O
-	O
scores	O
(	O
0	O
.	O
45	O
±	O
0	O
.	O
14	O
versus	O
0	O
.	O
08	O
±	O
0	O
.	O
18	O
;	O
P	O
=	O
.	O
11	O
).	O

Furthermore	O
,	O
the	O
median	O
age	O
of	O
miners	O
with	O
lung	O
cancer	O
was	O
44	O
years	O
,	O
compared	O
with	O
63	O
years	O
for	O
nonminers	O
with	O
other	O
cancers	O
.	O
18Decades	O
after	O
their	O
exposure	O
ended	O
,	O
standardized	O
mortality	O
ratios	O
and	O
relative	O
risks	O
for	O
lung	O
cancer	O
and	O
other	O
respiratory	O
problems	O
were	O
still	O
nearly	O
four	O
times	O
higher	O
in	O
Navajo	O
miners	O
than	O
in	O
nonminers	O
.	O
19	O
Community	O
Exposure	O
to	O
Uranium	O
Getting	O
the	O
ore	O
out	O
of	O
the	O
ground	O
was	O
only	B
the	O
first	B
step	O
in	O
a	O
long	O
process	O
.	O

However	O
,	O
thyroid	O
cancer	O
in	O
young	O
people	O
has	O
generally	O
an	O
excellent	O
prognosis	O
,	O
and	O
survival	O
among	O
women	O
with	O
thyroid	O
cancer	O
diagnosed	O
during	O
pregnancy	O
may	B
not	O
differ	O
from	O
that	O
in	O
age	O
-	O
matched	O
non	O
-	O
pregnant	O
women	O
with	O
similar	O
disease	O
.	O

Similar	O
results	O
were	O
observed	O
when	O
vitamin	O
D	O
status	O
was	O
based	O
on	O
clinical	O
definitions	O
of	O
deficiency	O
(	O
Additional	O
file1	O
:	O
Table	O
S1	O
).	O

In	O
the	O
present	O
study	O
,	O
the	O
mean	O
vitamin	O
D	O
concentrations	O
in	O
vitamin	O
D	O
group	O
were	O
significantly	O
higher	O
after	O
taking	O
2000	O
IU	O
of	O
vitamin	O
D	O
supplementation	O
per	O
day	O
for	O
at	O
least	O
8	O
weeks	O
.	O

She	O
initially	O
noticed	O
nail	O
discoloration	O
;	O
then	O
she	O
reported	O
progressively	O
worsening	O
discomfort	O
with	O
lifting	O
of	O
her	O
nail	O
plate	O
.	O

Ørskov	O
[	O
110	O
]	O
reported	O
that	O
up	O
to	O
42	O
%	O
of	O
dietary	O
starch	O
may	B
escape	O
ruminal	O
fermentation	O
and	O
reach	O
the	O
small	O
intestine	O
.	O

2	O
.	O
2	O
.	O

It	O
has	B
been	I
estimated	B
that	O
up	O
to	O
one	O
third	O
of	O
women	O
with	O
diabetes	O
,	O
had	O
a	O
GDM	O
pregnancy	O
earlier	O
in	O
their	O
life	O
,	O
2though	O
this	O
was	B
not	I
evident	O
in	O
a	O
recent	O
survey	O
of	O
women	O
with	O
type	O
2	O
diabetes	O
.	O
23	O
This	O
review	O
will	O
focus	O
on	O
the	O
medical	O
management	O
of	O
GDM	O
,	O
in	O
particular	O
self	O
monitoring	O
of	O
blood	O
glucose	O
and	O
diabetes	O
education	O
,	O
dietary	O
therapy	O
and	O
physical	O
activity	O
,	O
pharmacotherapy	O
,	O
and	O
post	O
-	O
partum	O
management	O
.	O

Women	O
with	O
T3	O
25OHD	O
≥	O
100	O
nmol	O
/	O
L	O
had	O
a	O
lower	O
OR	O
for	O
SGA	O
(	O
OR	O
=	O
0	O
.	O
32	O
,	O
p	O
=	O
0	O
.	O
031	O
)	O
compared	O
to	O
those	O
with	O
vitamin	O
D	O
deficiency	O
(<	O
30	O
nmol	O
/	O
L	O
).	O

Antenatal	O
care	O
services	O
are	O
offered	O
in	O
all	O
the	O
government	O
and	O
in	O
some	O
of	O
the	O
private	O
Health	O
facilities	O
.	O

Thus	O
,	O
the	O
dietary	O
energy	O
source	O
may	B
differentially	O
influence	O
marbling	O
and	O
IMF	O
deposition	O
,	O
depending	O
on	O
the	O
feeding	O
period	O
.	O

Hence	O
,	O
its	O
contribution	O
to	O
increased	O
risks	O
of	O
low	O
birth	O
weight	O
,	O
prematurity	O
,	O
and	O
maternal	O
morbidity	O
cannot	O
be	O
underscored	O
.	O

Some	B
studies	O
suggest	B
that	O
the	O
dietary	O
requirement	O
during	O
pregnancy	O
and	O
lactation	O
may	B
be	I
as	O
high	O
as	O
6000	O
IU	O
/	O
d	O
[	O
59	O
]	O
and	O
recognize	O
that	O
at	O
least	O
1500	O
–	O
2000	O
IU	O
/	O
d	O
of	O
vitamin	O
D	O
may	B
be	I
needed	O
in	O
order	O
to	O
maintain	O
a	O
blood	O
level	O
of	O
25	O
(	O
OH	O
)	O
D	O
above	O
30	O
ng	O
/	O
ml	O
[	O
24	O
].	O

2	O
.	O
5	O
.	O

ANC	O
coverage	O
in	O
Cameroon	O
in	O
2007	O
stood	O
at	O
82	O
%	O
with	O
60	O
%	O
of	O
pregnant	O
women	O
having	O
four	O
or	O
more	O
visits	O
[	O
2	O
].	O

A	O
lack	O
of	O
vitamins	O
and	O
minerals	O
can	B
adversely	O
influence	O
the	O
newborn	O
’	O
s	O
weight	O
,	O
even	O
if	O
the	O
dietary	O
intake	O
of	O
proteins	O
and	O
energy	O
is	O
adequate	O
[	O
5	O
,	O
6	O
].	O

The	O
cohort	O
study	O
was	O
designed	O
to	O
evaluate	O
the	O
influence	O
of	O
maternal	O
diet	O
,	O
physical	O
activity	O
and	O
the	O
other	O
life	O
style	O
factors	O
on	O
the	O
occurrence	O
of	O
preeclampsia	O
,	O
gestational	O
diabetes	O
mellitus	O
and	O
other	O
adverse	O
pregnancy	O
outcomes	O
.	O

Among	O
the	O
SGA	O
cases	O
defined	O
by	O
length	O
only	O
,	O
most	O
were	O
close	O
to	O
also	O
meeting	O
the	O
SGA	O
definition	O
for	O
birth	O
weight	O
.	O

All	O
the	O
microarray	O
data	O
is	O
MIAME	O
compliant	O
and	O
the	O
raw	O
data	O
has	O
been	O
deposited	O
in	O
a	O
MIAME	O
compliant	O
database	O
,	O
the	O
National	O
Center	O
for	O
Biotechnology	O
Information	O
Gene	O
Expression	O
Omnibushttp	O
://	O
www	O
.	O
ncbi	O
.	O
nlm	O
.	O
nih	O
.	O
gov	O
/	O
geo	O
(	O
accession	O
numbers	O
:	O
GSE25482	O
and	O
GSE31191	O
).	O

No	O
earlier	O
studies	O
that	O
we	O
are	O
aware	O
of	O
have	O
evaluated	O
the	O
relationship	O
between	O
adult	O
vitamin	O
D	O
levels	O
and	O
psychotic	O
symptoms	O
.	O

Pregnant	O
women	O
were	O
recruited	O
from	O
gestational	O
week	O
4	O
during	O
fall	O
2013	O
and	O
spring	O
2014	O
,	O
when	O
registering	O
at	O
one	O
of	O
the	O
participating	O
antenatal	O
care	O
units	O
.	O

A	O
synopsis	O
from	O
this	O
review	O
is	O
also	O
submitted	O
for	O
publication	O
on	O
the	O
WAO	O
homepage	O
(	O
http	O
://	O
www	O
.	O
worldallergy	O
.	O
org	O
/	O
adrc	O
/).	O

Furthermore	O
,	O
it	O
is	O
also	O
important	O
to	O
consider	O
the	O
broader	O
repercussions	O
of	O
regulatory	O
toxicology	O
.	O

The	O
dams	O
were	O
housed	O
individually	O
in	O
ventilated	O
plastic	O
transparent	O
cages	O
with	O
bedding	O
in	O
a	O
12	O
:	O
12	O
h	O
light	O
-	O
dark	O
cycle	O
(	O
lights	O
on	O
at	O
0700	O
at	O
22	O
±	O
1	O
°	O
C	O
).	O

Results	O
Among	O
the	O
1311	O
pregnant	O
women	O
participating	O
in	O
the	O
survey	O
,	O
there	O
were	O
271	O
from	O
Brussels	O
,	O
597	O
from	O
Flanders	O
and	O
437	O
from	O
Wallonia	O
(	O
Figure	O
1	O
;	O
Table	O
1	O
).	O

During	O
pregnancy	O
,	O
the	O
mother	O
'	O
s	O
thyroid	O
physiology	O
undergoes	O
many	O
well	B
-	I
defined	I
changes	O
,	O
leading	O
to	O
an	O
increase	O
in	O
thyroid	O
volume	O
which	O
is	O
often	O
associated	O
with	O
higher	O
urinary	O
iodine	O
excretion	O
.	O

The	O
recently	B
introduced	O
topical	O
calcineurin	O
inhibitors	O
(	O
pimecrolimus	O
and	O
tacrolimus	O
),	O
although	O
effective	O
in	O
the	O
treatment	O
of	O
atopic	O
eczema	O
,	O
are	O
not	O
recommended	O
for	O
use	O
in	O
pregnant	O
patients	O
because	O
of	O
the	O
lack	O
of	O
safety	O
data	O
.	O

In	O
addition	O
,	O
specific	O
deletion	O
of	O
Pten	O
in	O
the	O
liver	O
in	O
LPTENKO	O
mice	O
induces	O
a	O
strong	O
hepatic	O
steatosis	O
(	O
Stiles	O
et	O
al	O
.,	O
2004	O
;	O
Peyrou	O
et	O
al	O
.,	O
2015	O
),	O
but	O
improves	O
the	O
overall	O
insulin	O
sensitivity	O
,	O
and	O
decreases	O
the	O
fat	O
mass	O
.	O

summarized	O
causes	O
of	O
prolonged	O
labor	O
,	O
including	O
“	O
fetal	O
malposition	O
,	O
fetopelvic	O
disproportion	O
,	O
excess	O
sedation	O
,	O
inadequate	O
contraction	O
,	O
and	O
rupture	O
of	O
fetal	O
membranes	O
before	O
the	O
onset	O
of	O
active	O
labor	O
.”	O
However	O
,	O
these	O
complications	O
differ	O
in	O
severity	O
and	O
may	B
require	O
varied	O
quantity	O
of	O
induction	O
agent	O
used	O
at	O
distinctive	O
stages	O
of	O
labor	O
.	O

In	O
total	O
,	O
1810	O
women	O
had	O
samples	O
collected	O
both	O
in	O
T1	O
and	O
T3	O
.	O

Should	O
Men	O
Take	O
Prenatal	O
Vitamins	O
?	O

However	O
,	O
the	O
previous	B
study	I
was	O
based	O
on	O
cortical	O
and	O
hippocampal	O
tissue	O
from	O
adult	O
female	O
animals	O
,	O
whereas	O
the	O
current	O
study	O
was	O
based	O
on	O
tissue	O
from	O
the	O
nucleus	O
accumbens	O
in	O
adult	O
male	O
animals	O
.	O

Compared	O
to	O
that	O
,	O
the	O
reductions	O
in	O
neonatal	O
deaths	O
have	O
been	O
slower	O
.	O

The	O
study	O
investigates	O
the	O
indicated	O
variables	O
from	O
early	O
pregnancy	O
to	O
infants	O
up	O
to	O
12	O
months	O
.	O

1	O
.	O

The	O
corresponding	O
RR	O
for	O
lean	O
women	O
(<	O
25	O
kg	O
/	O
m2	O
)	O
was	O
3	O
.	O
23	O
(	O
95	O
%	O
CI	O
0	O
.	O
34	O
-	O
30	O
.	O
41	O
)	O
and	O
9	O
.	O
83	O
(	O
95	O
%	O
CI	O
1	O
.	O
12	O
-	O
86	O
.	O
32	O
)	O
for	O
overweight	O
women	O
(≥	O
25	O
kg	O
/	O
m2	O
).	O

Stridor	O
was	O
present	O
while	O
crying	O
and	O
the	O
infant	O
had	O
a	O
barking	O
cough	O
and	O
occasional	O
wheeze	O
.	O

At	O
middle	O
or	O
late	O
term	O
of	O
pregnancy	O
;	O
3	O
).	O

Nonetheless	O
,	O
the	O
effects	O
we	O
observe	O
may	B
be	I
due	O
in	B
part	I
to	O
maternal	O
diet	O
during	O
lactation	O
.	O

Slaughter	O
age	O
needs	O
to	O
be	O
optimised	O
to	O
get	O
maximum	O
profits	O
for	O
farmers	O
by	O
monitoring	O
the	O
QG	O
and	O
quantity	O
grade	O
of	O
carcasses	O
,	O
feed	O
costs	O
,	O
and	O
carcass	O
prices	O
(	O
auction	O
prices	O
).	O

APGAR	O
scores	O
were	O
0	O
,	O
4	O
,	O
and	O
7	O
at	O
one	O
,	O
five	O
,	O
and	O
ten	O
minutes	O
,	O
respectively	O
.	O

It	O
is	O
important	O
to	O
identify	O
the	O
mechanisms	O
responsible	O
for	O
initial	O
muscle	O
and	O
fat	O
cell	O
growth	O
during	O
the	O
developmental	O
stage	O
of	O
cattle	O
to	O
better	B
understand	I
IMF	O
deposition	O
in	O
later	O
life	O
.	O

As	O
the	O
level	O
of	O
insulin	O
resistance	O
varies	O
from	O
person	O
to	O
person	O
,	O
it	O
is	O
common	B
practice	I
to	O
commence	O
the	O
woman	O
on	O
small	O
doses	O
of	O
insulin	O
,	O
and	O
then	O
to	O
increase	O
the	O
doses	O
at	O
frequent	O
intervals	O
until	O
target	O
glucose	O
levels	O
are	O
attained	O
.	O

PubMed	O
Central	O
:	O

They	O
were	O
not	O
told	O
that	O
the	O
men	O
who	O
worked	O
in	O
the	O
mines	O
were	O
breathing	O
carcinogenic	O
radon	O
gas	O
and	O
showering	O
in	O
radioactive	O
water	O
,	O
nor	O
that	O
the	O
women	O
washing	O
their	O
husbands	O
’	O
work	O
clothes	O
could	B
spread	O
radionuclides	O
to	O
the	O
rest	O
of	O
the	O
family	O
’	O
s	O
laundry	O
.	O

Rodents	O
are	O
commonly	O
used	O
to	O
investigate	O
the	O
mechanisms	O
underlying	O
long	O
-	O
term	O
programming	O
of	O
energy	O
balance	O
in	O
the	O
offspring	O
.	O

Based	O
on	O
these	O
considerations	O
,	O
we	O
aim	O
to	O
focus	O
on	O
the	O
long	O
-	O
term	O
effects	O
on	O
cannabinoid	O
-	O
related	O
behaviors	O
(	O
i	O
.	O
e	O
.,	O
cannabinoid	O
receptor	O
antagonist	O
-	O
induced	O
suppression	O
of	O
feeding	O
),	O
and	O
effects	O
on	O
lipid	O
-	O
related	O
metabolic	O
pathways	O
of	O
a	O
maternal	O
exposure	O
to	O
a	O
moderate	O
caloric	O
restriction	O
during	O
the	O
preconceptional	O
and	O
gestational	O
period	O
.	O

Multiple	O
regression	O
(	O
for	O
continuous	O
outcomes	O
)	O
and	O
logistic	O
regression	O
(	O
for	O
categorical	O
outcomes	O
)	O
were	O
used	O
to	O
examine	O
predictors	O
of	O
infant	O
macrosomia	O
,	O
and	O
WFA	O
z	O
-	O
scores	O
at	O
birth	O
and	O
6	O
months	O
,	O
and	O
changes	O
in	O
WFA	O
z	O
-	O
scores	O
,	O
adjusting	O
for	O
treatment	O
group	O
,	O
infant	O
sex	O
,	O
recruitment	O
clinic	O
,	O
weeks	O
of	O
gestation	O
at	O
delivery	O
,	O
and	O
breastfeeding	O
(	O
in	O
6	O
-	O
month	O
analyses	O
).	O

Protein	O
Expression	O
in	O
the	O
Nucleus	O
Accumbens	O
of	O
Rats	O
Exposed	O
to	O
Developmental	O
Vitamin	O
D	O
Deficiency	O
Abstract	O
Introduction	O
Developmental	O
vitamin	O
D	O
(	O
DVD	O
)	O
deficiency	O
is	O
a	O
candidate	B
risk	O
factor	O
for	O
schizophrenia	O
.	O

Public	O
health	O
interventions	O
have	O
included	O
reducing	O
maternal	O
disease	O
,	O
prenatal	O
care	O
of	O
mothers	O
,	O
reduction	O
of	O
exposure	O
to	O
teratogens	O
(	O
agent	O
that	O
can	O
disturb	O
the	O
development	O
of	O
an	O
embryo	O
or	O
fetus	O
),	O
and	O
nutritional	O
interventions	O
[	O
2	O
].	O

Whether	O
brown	O
and	O
brite	O
adipocytes	O
display	O
some	O
degree	O
of	O
specialization	O
with	O
regard	O
to	O
these	O
different	O
functions	O
has	O
to	O
be	O
established	O
.	O

Issues	O
specific	O
to	O
pre	O
-	O
existing	O
diabetes	O
in	O
pregnancy	O
include	O
tight	O
glycemic	O
control	O
and	O
adequate	O
folate	O
supplementation	O
.	O
53	O
,	O
54Additionally	O
,	O
post	O
partum	O
evaluation	O
and	O
management	O
of	O
reversible	O
cardiovascular	O
risk	O
factors	O
such	O
as	O
smoking	O
,	O
obesity	O
,	O
hypertension	O
,	O
and	O
hyperlipidemia	O
should	O
be	O
undertaken	O
.	O

The	O
mothers	O
who	O
were	O
not	O
on	O
antidepressant	O
drugs	O
were	O
selected	O
as	O
the	O
control	O
group	O
.	O

The	O
current	O
stage	O
-	O
specific	O
feeding	O
program	O
for	O
producing	O
Korean	O
cattle	O
with	O
highly	O
marbled	O
beef	O
relies	O
heavily	O
on	O
feeding	O
a	O
concentrate	O
diet	O
during	O
the	O
fattening	O
period	O
.	O

This	O
process	O
is	O
active	O
and	O
specific	O
,	O
much	O
like	O
the	O
process	O
of	O
sensitization	O
[	O
119	O
].	O

Results	O
3	O
.	O
1	O
.	O

A	O
limitation	B
of	O
this	O
study	O
is	O
that	O
information	O
on	O
pregnancy	O
loss	O
,	O
except	O
IUFD	O
,	O
was	O
self	O
-	O
reported	O
.	O

The	O
aim	O
of	O
this	O
review	O
was	O
to	O
critically	O
appraise	O
literature	O
investigating	O
fish	O
intake	O
in	O
pregnant	O
women	O
to	O
assess	O
the	O
hypothesis	B
that	O
fish	O
consumption	O
during	O
pregnancy	O
positively	O
influences	O
foetal	O
neurodevelopment	O
.	O

Some	B
cross	O-
-	O-
sectional	O-
studies	I
show	B
the	O
same	O
positive	O
results	O
for	O
the	O
use	O
of	O
multivitamins	O
[	O
10	O
],	O
but	O
there	O
is	O
still	O
debate	O
as	O
to	O
whether	O
these	O
are	O
superior	O
to	O
iron	O
and	O
folic	O
acid	O
[	O
11	O
].	O

Summary	O
and	O
conclusions	O
Gestational	O
diabetes	O
is	O
a	O
common	O
disorder	O
which	O
in	O
the	O
majority	O
of	O
cases	O
,	O
should	O
initially	O
be	O
managed	O
by	O
dietary	O
measures	O
.	O

In	O
the	O
third	O
trimester	O
,	O
surgery	O
may	B
induce	O
premature	O
labour	O
.	O

As	O
adults	O
these	O
animals	O
had	O
larger	O
lateral	O
ventricles	O
and	O
reduced	O
NGF	O
expression	O
compared	O
to	O
controls	O
[	O
8	O
].	O

2009	O
).	O

Castration	O
also	O
increased	O
MS	O
in	O
Canadian	O
beef	O
carcasses	O
[	O
60	O
].	O

Second	O
,	O
the	O
fallow	O
up	O
of	O
mothers	O
and	O
infants	O
was	O
short	O
-	O
term	O
.	O

Information	O
of	O
the	O
single	O
datasets	O
are	O
stored	O
using	O
anonymous	O
IDs	O
.	O

The	O
process	O
of	O
skeletal	O
muscle	O
and	O
adipose	O
tissue	O
development	O
during	O
the	O
fetal	O
stage	O
in	O
laboratory	O
animals	O
and	O
livestock	O
including	O
ruminants	O
has	O
been	O
well	O
described	O
in	O
reviews	O
by	O
Du	O
et	O
al	O
[	O
16	O
–	O
18	O
].	O

We	O
also	O
noted	O
that	O
associations	O
between	O
short	O
sleep	O
duration	O
and	O
GDM	O
risk	O
were	O
particularly	O
pronounced	O
among	O
overweight	O
women	O
(	O
far	O
right	O
column	O
of	O
Table2	O
).	O

Previous	B
studies	I
identify	B
edible	O
fungi	O
as	O
the	O
primary	O
plant	O
-	O
based	O
dietary	O
source	O
of	O
Vitamin	O
D	O
.	O
However	O
,	O
edible	O
fungi	O
were	O
hardly	O
seen	B
in	O
the	O
dietary	O
records	O
among	O
participants	O
in	O
this	O
study	O
.	O

FA	O
for	O
TG	O
synthesis	O
is	O
derived	O
from	O
de	O
novo	O
synthesis	O
or	O
diet	O
-	O
originating	O
FAs	O
.	O

Of	O
these	O
,	O
49	O
.	O
6	O
%	O
recommendations	O
were	O
made	O
by	O
friends	O
and	O
neighbors	O
(	O
12	O
.	O
4	O
%)	O
mother	O
or	O
sister	O
(	O
12	O
.	O
4	O
%)	O
and	O
husband	O
(	O
10	O
%).	O

The	O
circulating	O
25	O
(	O
OH	O
)	O
D	O
is	O
then	O
metabolized	O
in	O
the	O
kidneys	O
to	O
its	O
biologically	O
more	O
active	O
form	O
,	O
1	O
,	O
25	O
-	O
dihydroxyvitamin	O
D	O
[	O
1	O
].	O

Hypocalcemia	O
has	B
also	O-
been	I
shown	O
to	O
occur	O
in	O
exclusively	O
breast	O
fed	O
babies	O
not	O
exposed	O
to	O
sunlight	O
and	O
in	O
infants	O
whose	O
mothers	O
are	O
deficient	O
in	O
vitamin	O
D	O
.[	O
1	O
]	O
Symptoms	O
of	O
hypocalcemia	O
in	O
children	O
include	O
lethargy	O
,	O
recurrent	O
respiratory	O
tract	O
infections	O
,	O
focal	O
clonic	O
seizures	O
,	O
jitteriness	O
,	O
carpopedal	O
spasm	O
and	O
rarely	B
stridor	O
due	O
to	O
laryngospasm	O
.	O

showed	B
a	O
statistically	O
significant	O
increase	O
in	O
autism	O
and	O
other	O
mental	O
health	O
disorders	O
following	O
ovulation	O
induction	O
[	O
41	O
].	O

Adjusted	O
relative	O
risks	O
(	O
aRR	O
)	O
of	O
pregnancy	O
complications	O
from	O
any	O
complication	O
,	O
preeclampsia	O
(	O
PE	O
),	O
gestational	O
hypertension	O
(	O
GH	O
),	O
gestational	O
diabetes	O
mellitus	O
(	O
GDM	O
),	O
spontaeous	O
preterm	O
birth	O
(	O
sPTB	O
)	O
and	O
small	O
-	O
for	O
-	O
gestational	O
age	O
(	O
SGA	O
)	O
according	O
to	O
vitamin	O
D	O
status	O
and	O
stratified	O
by	O
fetal	O
sex	O
.	O

This	O
resulted	O
in	O
41	O
distinct	O
bioinformatically	O
derived	O
classes	O
,	O
containing	O
at	O
least	O
one	O
CpG	O
,	O
based	O
on	O
bioinformatic	O
attributes	O
[	O
for	O
the	O
distribution	O
of	O
CpG	O
loci	O
by	O
bioinformatically	O
derived	O
class	O
,	O
see	O
Supplemental	O
Material	O
,	O
Table	O
2	O
(	O
http	O
://	O
dx	O
.	O
doi	O
.	O
org	O
/	O
10	O
.	O
1289	O
/	O
ehp	O
.	O
1103927	O
)].	O

Research	O
considerations	O
for	O
public	O
health	O
There	O
is	O
no	O
doubt	O
that	O
humans	O
are	O
exposed	O
to	O
a	O
range	O
of	O
environmental	O
factors	O
during	O
everyday	O
life	O
.	O

the	O
same	O
association	O
(	O
s	O
)	O
reported	B
in	O
multiple	O
independent	O
cohorts	O
or	O
multiple	O
association	O
(	O
s	O
)	O
that	O
contribute	O
to	O
the	O
same	O
biological	O
pathway	O
),	O
and	O
are	O
,	O
therefore	O
,	O
included	O
in	O
Supplementary	O
Table	O
2	O
.	O

Women	O
with	O
an	O
increase	O
in	O
25OHD	O
≥	O
30	O
nmol	O
/	O
L	O
from	O
T1	O
to	O
T3	O
had	O
the	O
lowest	O
odds	O
of	O
SGA	O
,	O
LBW	O
and	O
preterm	O
delivery	O
.	O

Our	O
recent	B
study	I
also	O
revealed	B
that	O
growth	O
performance	O
was	O
not	O
affected	O
by	O
mild	O
heat	O
stress	O
in	O
Korean	O
cattle	O
[	O
83	O
].	O

Vitamin	O
D	O
therapy	O
may	B
be	I
of	O
benefit	O
in	O
wheezing	O
children	O
.	O

However	O
,	O
there	O
is	O
again	O
a	O
limitation	B
with	O
interpreting	O
medical	O
records	O
,	O
such	O
as	O
prescribed	O
versus	O
actual	O
use	O
of	O
SSRIs	O
.	O

Measurement	O
of	O
caloric	O
intake	O
Food	O
intake	O
was	O
determined	O
by	O
subtracting	O
the	O
amount	O
of	O
food	O
left	O
in	O
the	O
cage	O
from	O
the	O
total	O
amount	O
of	O
food	O
provided	O
.	O

Using	O
a	O
nail	O
splitter	O
,	O
the	O
nail	O
plate	O
was	O
vertically	O
cut	O
and	O
reflected	O
proximally	O
to	O
completely	O
visualize	O
the	O
lesion	O
.	O

Residual	O
placental	O
tissues	O
were	O
obtained	O
from	O
479	O
patients	O
delivering	O
at	O
the	O
Women	O
and	O
Infants	O
Hospital	O
in	O
Providence	O
,	O
Rhode	O
Island	O
(	O
USA	O
),	O
from	O
September	O
2008	O
through	O
September	O
2009	O
.	O

Overall	O
,	O
however	O
,	O
the	O
current	O
study	O
'	O
s	O
findings	O
suggest	B
that	O
dietary	O
variables	O
may	O
exert	O
more	O
of	O
an	O
effect	O
than	O
maternal	O
psychosocial	O
variables	O
on	O
offspring	O
weight	O
outcomes	O
.	O

Outcome	O
measurements	O
Neonatal	O
deaths	O
We	O
will	O
investigate	O
all	O
neonatal	O
deaths	O
reported	O
by	O
the	O
SS	O
to	O
the	O
Field	O
Implementers	O
or	O
by	O
maternal	O
recall	O
at	O
the	O
final	O
follow	O
-	O
up	O
visit	O
at	O
42	O
days	O
postpartum	O
,	O
using	O
standard	O
questionnaires	O
collected	O
by	O
trained	O
staff	O
.	O

The	O
primary	O
aim	O
of	O
this	O
study	O
was	O
to	O
examine	O
the	O
impact	O
of	O
GWG	O
,	O
maternal	O
eating	O
and	O
exercise	O
behaviors	O
,	O
and	O
psychosocial	O
factors	O
on	O
offspring	O
weight	O
status	O
.	O

In	O
addition	O
,	O
it	B
is	I
possible	I
to	O
have	O
adverse	O
outcomes	O
that	O
are	O
reversible	O
.	O

To	O
the	O
best	O
of	O
our	O
knowledge	O
no	O
one	O
has	O
evaluated	O
the	O
impact	O
of	O
sleep	O
duration	O
and	O
snoring	O
on	O
maternal	O
glucose	O
metabolism	O
in	O
pregnancy	O
.	O

Phase	O
2	O
data	O
are	O
collected	O
at	O
22	O
weeks	O
’	O
gestation	O
(	O
window	O
±	O
12	O
days	O
)	O
when	O
anomaly	O
ultrasounds	O
are	O
typically	O
scheduled	O
.	O

In	O
animal	O
models	O
,	O
prenatal	O
exposures	O
to	O
overnutrition	O
,	O
high	O
-	O
fat	O
and	O
high	O
-	O
protein	O
diets	O
,	O
“	O
junk	O
”	O
food	O
,	O
and	O
stress	O
have	O
been	O
linked	O
with	O
greater	O
adiposity	O
in	O
offspring	O
[	O
10	O
–	O
12	O
].	O

Interestingly	O
,	O
mice	O
carrying	O
additional	O
copies	O
of	O
Pten	O
(	O
Ptentgmice	O
)	O
are	O
not	O
only	O
protected	O
from	O
cancer	O
and	O
exhibit	O
extended	O
longevity	O
,	O
but	O
,	O
according	O
to	O
the	O
authors	O
,	O
they	O
also	O
present	O
enhanced	O
energy	O
expenditure	O
that	O
participates	O
in	O
counteracting	O
the	O
development	O
of	O
obesity	O
.	O

This	O
trial	O
of	O
100	O
000	O
IU	O
(	O
2	O
·	O
5	O
mg	O
)	O
vitamin	O
D3	O
(	O
cholecalciferol	O
)	O
supplementation	O
along	O
with	O
antibiotic	O
treatment	O
of	O
children	O
younger	O
than	O
3	O
years	O
with	O
clinically	O
diagnosed	O
pneumonia	O
in	O
Kabul	O
showed	O
no	O
difference	O
in	O
the	O
time	O
to	O
recovery	O
between	O
the	O
groups	O
.	O

Furthermore	O
,	O
studies	O
have	B
shown	I
that	O
vitamin	O
D	O
supports	O
early	O
placental	O
development	O
[	O
44	O
,	O
45	O
]	O
in	O
which	O
,	O
abnormal	O
placentation	O
can	B
be	O
a	O
characteristic	O
of	O
a	O
number	O
of	O
pregnancy	O
complications	O
including	O
GDM	O
,	O
PE	O
,	O
sPTB	O
and	O
SGA	O
[	O
46	O
].	O

The	O
problem	O
of	O
pregnancy	O
-	O
associated	O
thyroid	O
cancer	O
can	B
affect	O
three	O
groups	O
of	O
patients	O
:	O
New	O
diagnosis	O
Patients	O
with	O
no	O
prior	O
history	O
of	O
cancer	O
,	O
in	O
whom	O
a	O
malignant	O
thyroid	O
nodule	O
is	O
suspected	O
or	O
diagnosed	O
during	O
pregnancy	O
.	O

The	O
routine	O
use	O
of	O
multivitamins	O
is	O
not	O
recommended	O
[	O
34	O
].	O

Steam	O
flaking	O
further	O
increases	O
marbling	O
in	O
cases	O
of	O
maize	O
and	O
sorghum	O
,	O
and	O
is	O
more	O
effective	O
for	O
sorghum	O
.	O

